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Abstract 
This work examines how environmental factors such as lipid membrane concentration, opioid 
agonist exposure, and inflammatory diseases impact cell communication. It explores the use of 
different cell models, specifically platelets and mast cells, to understand how disease states can 
impact cellular function. Throughout the thesis, a variety of analytical techniques including 
electrochemistry, mass spectrometry, dark field imaging, and microfluidics, are used to 
understand exocytosis, lipid concentration, manufactured inflammatory mediators, adhesion, and 
shape change in platelets and mast cells.  
Platelets are cell-like bodies that travel through the bloodstream and are known for their role 
in hemostasis and diseases like stroke and myocardial infarction. They have also been implicated 
in inflammatory diseases such as asthma. In addition, their anucleate nature and easy isolation 
make them an ideal model for studying variations in cell communication upon the modification of 
their lipid content. Platelets communicate through the exocytosis of their three distinct granule 
types (δ, α, and lysosome). These granules contain molecules that assist in the transmigration of 
immune cells to the site of activation and help with additional platelet aggregation and adhesion.   
In contrast, mast cells are found throughout the body in connective tissue and are one of the 
immune system’s first lines of defense. They are primarily known for their role in allergies and 
asthma. Upon detection of antigens that they are sensitized to, the mast cell secretes manufactured 
chemokines and pre-formed granule mediators, including histamine and serotonin, calling other 
inflammatory cells to the site of infection. 
Chapter One reviews single cell analysis techniques with a particular emphasis on the 
techniques used in this thesis, including electrochemistry and mass spectrometry.   
Chapter Two through four are focused on understanding how variations in membrane lipids 
and structure affect platelet function and exocytosis in general. Chapter Two focuses on 
  iv 
understanding the variations that the fusion pore undergoes when granules are being exocytosed. 
Traditionally, a granule release event, monitored using carbon-fiber microelectrode amperometry, 
has a quick rise in current (spike) and gradual decay.  The variations to this spike are classified as 
different forms of pre- and post-spike features and non-traditional granule secretion events. The 
role of cholesterol in changing the frequency and duration of these features is also discussed. 
Chapter Three discusses the role of phosphatidylserine (PS) in cellular communication using a 
platelet model. In this chapter, we explore how the stereochemistry of the head group and 
concentration of PS affects various platelet functions including granular content secretion, 
manufactured lipid release, and adhesion. The cholesterol level change upon addition of PS is 
also monitored. Finally, Chapter Four aims to understand how natural lipid variations affect cell 
function by comparing platelets from different species. This chapter highlights the importance of 
understanding your cell model relative to the actual cells involved in the disease or function being 
studied. 
Chapter Five and Six progresses from lipid function into developing a better understanding of 
how platelets respond to their environment, particularly in the context of inflammatory diseases. 
Chapter Five’s focus is on platelet response to opioids like those that are used in the treatment of 
pain due to inflammatory diseases, cancer, or surgery. Specifically, the effects on cell exocytosis 
as well as the presence of and role that opioid receptors play in platelets are characterized. 
Chapter Six focuses on studying how platelets respond to allergic asthma, including response to 
allergens and the chemoattractants (CXCL10 and CCL5) released during an asthma attack. Using 
bulk and single cell methods in conjunction allows us to obtain in-depth information on both the 
overall response and the granule fusion pore during exocytosis. 
Chapter Seven and Eight focus on mouse peritoneal mast cell (MPMC) function in the 
context of inflammatory diseases including allergic asthma and neurogenic inflammation, 
respectively. Chapter Seven aims to state the importance of understanding the cell line you are 
  v 
using since variations in response to allergens are noted between commonly used mast cell 
models (rat basophilic leukocytes cell line and primary culture MPMC). In addition, MPMC 
response to CXCL10 and CCL5 was monitored.  Finally, Chapter Eight explores the role of 
MPMC in neurogenic inflammation, a process wherein neurons release the neuropeptides 
substance P and calcitonin gene-related peptide. Mast cell response to these neuropeptides has 
been highly disputed, and this chapter focuses on the impact of IgE on MPMC bulk granular 
content secretion. It also aims to understand how these neuropeptides affect the fusion pore 
opening and closing during exocytosis. 
  vi 
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1.1 Overview 
Analysis of the fundamental mechanisms underlying cellular behavior and function is one of 
the top priorities in cell biology and medicine. Conventional measurements based on pooled cell 
populations obscure detailed information about the biological events taking place inside single 
cells as well as important outlier cell subpopulations in a homogenous cell culture. Recent 
progress in single cell analysis techniques allows for the quantification of intracellular biological 
molecules as well as the characterization of dynamic cellular processes with spatiotemporal 
resolution. These techniques reveal nuances in cellular function and enable the detection of 
unknown cell subpopulations that are highly correlated to functional variations in tissues or 
organs caused by disease pathogenesis. This chapter covers single cell electrochemical and mass 
spectrometry methods, limitations of these methods, recent research to overcome these 
limitations, and the recent advances in cellular biology made using these techniques. Single cell 
microscopy and spectroscopy will not be discussed.  
1.2 Introduction 
With the rapid development of new analytical techniques, the focus of biophysical and 
analytical chemistry has gradually shifted from investigating cellular behavior of bulk cell 
contents to performing analysis at the single cell level. The motivation for this shift is attributable 
to two major factors. First, single cell analysis is one of the best ways to dig deeply into the 
features of a particular cell type, often revealing real-time behavior or quantitative information. 
Second, even within a largely homogeneous cell population, subtle microenvironments or 
inherent stochastic factors in a small sub-population of cells may reveal cell cycle malfunction or 
disease state transition.
1, 2
 Exploration of these heterogeneities using single cell analysis not only 
reveals mechanistic insights into the cellular behavior, but also elucidates the relationship 
between cell-specific changes and biological phenomena pertaining to disease-related 
dysfunction. In recent years, state-of-the-art single cell techniques have been used to characterize 
intracellular events pertaining to genes, proteins, metabolites, and organelle function, as well as 
subcellular dynamics, cell communication, and pharmaceutical effects.             
This chapter provides an overview of several single cell techniques with particular focus on 
the techniques used throughout this thesis, including limitations, and recent advances. The 
electrochemical techniques covered include cyclic voltammetry, amperometry, field effect 
transistors, and patch clamp recording, with an emphasis on monitoring cellular communication 
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and a discussion on micro- and nanoelectrodes. The mass spectrometry section will focus on both 
the imaging based approaches, matrix assisted laser desorption ionization and secondary ion mass 
spectrometry for the analysis of cell structure and drug metabolism and uptake, and mass 
cytometry for the quantification of proteins on individual cells. This review concentrates largely 
on advances in detection techniques rather than single cell sampling approaches (e.g. microfluidic 
platforms). However, several relevant cell sampling approaches for each technique are mentioned 
and detailed information on microfluidics in single cell analysis can be found in other reviews.
3-5
 
1.3 Electrochemistry  
Single cell electrochemistry is a powerful method to monitor cellular communication 
proceeding either through exocytosis, a process wherein a chemical messenger-filled granule 
fuses to the cell membrane, or ion channel release. Single cell electrochemical methods have also 
been employed to monitor various intracellular processes including oxidative stress and oxygen 
consumption.
6, 7
 With the use of microelectrodes and nanoelectrodes, real-time monitoring of 
extracellular communication and intracellular contents can occur with minimal cell damage, even 
after puncturing the cell wall.
8, 9
 In addition, the small electrode surface area reduces the current 
needed to maintain the potential causing a reduction in noise compared to larger electrodes. An 
increased temporal resolution is also available due to a corresponding decrease in the electrical 
double layer (a layer of counter ions followed by a diffuse layer, consisting mostly of counter 
ions which surround the electrode surface and hinder the ability for an electroactive molecule to 
come into contact with the electrode).  
The use of microelectrodes dates back over half a century. By 1958, the use of carbon rods 
had already been established; however, they were difficult to manufacture. To overcome this 
difficulty, Ralph Adams developed a carbon paste which allowed electrodes to be produced in 
five minutes while still maintaining the accuracy of the electrode for several runs.
10
 In addition to 
carbon, microelectrodes are primarily made from boron-doped diamond material or encasing 
metals such as platinum and gold in an insulating layer.
11,12
 However, due to carbon’s high 
sensitivity, large potential range, stability, and biocompatibility with cells, many microelectrodes 
used to study cells are carbon based.
13, 14
 In particular, carbon-fibers have been the primary choice 
for microelectrodes since they were first developed in 1979. They were further optimized for use 
in studying single cell exocytosis, in the Wightman group, due to their capacity to support fast 
scan rates, their low cost, and ease of manufacture.
13-16
 To increase specificity and enable the 
detection of non-electroactive compounds, various groups functionalize the carbon surface. 
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Recent papers include modifications with platinum or enzymes for monitoring O2, H2O2, glucose, 
and other non-electroactive enzyme substrates.
8,17
 More in-depth information on both recent 
electrode modifications and the effects of electrode geometry can be found in the following 
reviews. 
11,18,19
 
1.3.1 Fast Scan Cyclic Voltammetry  
Common electrochemical techniques, including cyclic voltammetry and amperometry, have 
been used to monitor exocytosis in a variety of cells including PC12 cells, mast cells, chromaffin 
cells, and platelets.
20-23
 Fast scan cyclic voltammetry (FSCV), which capitalizes on the relatively 
broad range of reactivity of carbon, is used to confirm the molecular identity of cell-secreted 
species by comparison to known voltammograms. In FSCV, the current is varied at a scan rate 
ranging from 300 to several thousand volts/second, with a repetition rate of 10 scans per second 
for brain studies to several hundred scans per second (Hz) in cells with one electroactive 
compound.
24-27
 The quickly changing voltage causes surface-associated and capacitive currents. 
To correct for this interference, a background voltammogram is recorded prior to stimulation and 
subtracted from the subsequent sweeps.
28
 The collected voltammograms are combined to form a 
false color voltammogram revealing temporal data and achieving chemical species confirmation 
and quantitation, all of which are useful when studying complex environments such as the brain. 
Many recent advances in FSCV have looked at overcoming limitations including balancing the 
amount of data collected with the high time resolution, eliminating interference from 
electroactive molecules that obscure the molecules of interest, and calibration of electrodes for in 
vivo experiments.
27, 29-31 
Comparable techniques have scan rates less than 10 Hz, meaning that cyclic voltammetry 
starts off with better temporal resolution. However, to capture most real-time cell-cell 
communication, a higher scan rate is often needed, thus increasing the amount of data needing 
storage, hindering the ability to quickly transfer the data wirelessly, and increasing the energy 
consumption limiting the lifetime of the device. The balance between data storage and the scan 
rates needed for meaningful biological measurements has been considered by several groups. Kile 
et al. studied FSCV repetition rates in brain cells of live rat models and highlighted the difference 
in results between the standard 10 Hz collection data vs. 60 Hz. The increased collection rate at 
60 Hz showed increased sensitivity without decreasing detection levels when accounting for 
collection time compared to 10 Hz. The 60 Hz collection rate also allowed for faster detection of 
dopamine release, and the re-uptake time was shown to be 18% quicker than that determined 
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when using the 10 Hz repetition rate. However, no difference was noted between the 10 and 60 
Hz collection rates when they studied cells that had slower re-uptake and release times.
29
 Amos et 
al. compared 10 Hz to 1 Hz collection rates for both in vivo and in vitro studies. Their data 
indicated that at 1 Hz, the electrode was stable for 8 hours without a change in the limit of 
detection, and the data gathered was comparable to the 10 Hz experiment.
27
 Therefore, to gather 
the most relevant information, it is important to understand your data capacity but also the analyte 
adsorption/desorption kinetics when performing FSCV experiments. 
In addition to changing the collection rate, the waveform (a pattern that determines what 
potential will be held on the electrode at each time point) can be modified to enhance the 
detection of the molecules of interest. Recently, Schmidt et al. created a modified sawhorse 
waveform to quantify small tyrosine-containing peptides, which typically oxidize at higher 
potentials than catecholamines, to better understand the role of opioid peptides. The waveform 
increased at 100 V/s from -0.02 V until 0.6 V and then increased to 400 V/s from 0.6-1.2 Volts 
where it remained stable for 3 ms and then decreased voltage at 100 V/s. With the traditional 
waveform, the oxidation of catecholamines masks the detection of peptides. With the modified 
waveform, the initial slow increase in voltage within the catecholamine’s oxidation potential 
range helps decrease the current produced due to catecholamine oxidation and causes the 
oxidation of dopamine to occur at 400 mV, minimizing interference. Fouling is also decreased by 
holding the potential constant for 3 ms.
30
  
Homemade electrodes used for FSCV have high variability in their performance, requiring 
calibration for quantification of the molecule of interest. Post calibration is often difficult or 
impossible. To counteract this difficulty, Roberts et al. developed a method to calibrate the 
electrode using the background charging current. This approach was validated by comparison to 
traditional post calibration methods. Another advantage of this method is that it can be done at 
any point during the experiment, which is ideal for experiments that span hours or several days, 
where the electrode may decrease or increase sensitivity over time.
31
 
1.3.2 Carbon-Fiber Microelectrode Amperometry  
Carbon-fiber microelectrode amperometry (CFMA) is known for its high temporal resolution 
which facilitates in-depth studies of exocytotic biophysical variations due to drugs, environment, 
or membrane components. CFMA is capable of sub-microsecond time resolution detection of 
redox-active species at a fixed potential and has been used with a variety of cell types, including 
mast cells, chromaffin cells, platelets, PC12 cells, and more recently BON cells (cells derived 
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from a human carcinoid tumor) and Weibel-Palade bodies from endothelial cells.
22, 32-35
 In this 
technique, an electrode is placed near the surface of a cell, and the change in current is measured 
over time. As the redox-active species is oxidized or reduced, the current change will be recorded 
as a spike. Close inspection of the spike enables kinetic measurements of each granule’s fusion 
pore opening time (Trise, time from 10% to 90% of the current spike height), the slope of the rise 
time (Tslope, how fast the electroactive molecules initially come out of the fusion pore), the fusion 
event duration (T1/2, full width at half max), and decay time (the time it takes for the spike’s 
decay). By measuring the area (Q) underneath the spikes in the typical time vs current 
amperometric trace, the total moles of electroactive molecules secreted can be calculated using 
Faraday’s Law. Finally, the stability of the fusion pore opening and closing can be measured by 
looking at the features that deviate from the standard current spike, termed a foot (Fig. 1.1A).
13, 36
  
Typical limitations of CFMA include the inability to identify the oxidized or reduced 
molecule. To minimize this limitation, initial experiments on uncharacterized cell lines utilize CV 
to determine the molecules being secreted before conducting amperometry experiments. 
However, this method does not allow you to quantify the amount of each molecule being secreted 
if two or more molecules are secreted that oxidize at the potential being measured. One way to 
remove this problem is modifying your electrode surface to be selective for the molecule of 
interest or lowering the potential so that only one of the molecules will be oxidized. Finally 
because of these limitations, CFMA measurements are often limited to in vitro studies. 
Research using CFMA has focused on the fundamental aspects of cell communication, 
including how membrane components such as proteins and lipids impact exocytosis and how cell 
communication changes in response to various diseases and drugs. One area of recent interest has 
been focused on understanding what cell membrane components affect the fusion pore opening 
and closing kinetics in granule secretion events.
37-40
 In addition to looking at kinetics, the stability 
of the fusion pore can be studied by analyzing pre, post, and non-traditional secretion events. Fig. 
1.1A demonstrates an example of a traditional secretion event with both pre- and post-spike feet, 
which can indicate that the current fusion pore state may not be efficient in opening or closing, 
respectively. In a recent paper by Finkenstaedt-Quinn et al., the different types of these events 
were classified and compared to previous literature.
36
 In PC12 cells, and more recently, platelets, 
it was discovered that pre-spike foot events can be characterized as a ramp, plateau, or 
combination of both. In PC12 cells a correlation between flux in the pre-foot and the flux in the 
spike was noted.
36, 41
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Recent advances on the role of lipids in exocytosis have also been studied using CFMA. The 
role of cholesterol on fusion pore stability has been demonstrated by Finkenstaedt-Quinn et al. 
who analyzed the changes in foot features and non-traditional events. These data show that the 
percent of platelets with foot features increased as cholesterol levels increased (Fig. 1.1B). This 
was primarily due to a greater number of platelet granules undergoing non-traditional secretion 
(Fig. 1.1C).
36
 The roles of phospholipids including phosphatidylethanolamine (PE) and 
phosphatidylserine (PS) on fusion pore kinetics and secretion have been studied in PC12 cells and 
platelets. Results show that PE incubation causes changes in PC12 cell granule secretion time, 
and PS incubation caused changes in both platelet and PC12 cell secretion. In platelets, PS 
induced longer T1/2 time and had a greater number of pre-spike features. In PC12 cells, the 
number of granules secretion events changed.
20,42
 These differences suggest that the role 
phospholipids play in the exocytosis process changes depending on the cell type.  
 
Figure 1.1 Pre and post foot schematic and variations in spike features due to cholesterol. 
(A) Diagram indicating the parameters used to categorize and quantify various spikes. (B) The 
frequency of events with features upon the different cholesterol treatments. (C) Relative 
frequency of classes of spikes with the different cholesterol treatments. (*p ≤ 0.05, **p ≤ 0.01, 
***p ≤ 0.001, ****p ≤ 0.0001) This figure was adapted with permission from Finkenstaedt-quinn 
et al.
36
 Copyright 2016 Elsevier 
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CFMA has also been used to study the effects of various diseases-associated stimulants 
on exocytosis. Mast cells, a type of immune cell involved in asthma, exhibit secretion of 
serotonin when exposed to the common chemoattractants, CXCL10 and CCL5. This secretion 
was marked by decreased serotonin secretion and elongated Trise and T1/2 when compared to the 
allergic reaction pathway exocytotic events.
43
 Single cell CFMA can also be used to understand 
how diseases impact cell communication by comparing cells in a disease model to control cells. 
Manning et al. studied the effects of sickle cell disease on mast cells. Mast cells, associated with 
sickle cell disease, had impaired serotonin secretion and variations in their biophysical kinetics. 
However, mast cells from sickle cell mice treated with morphine did not show a difference 
relative to control mice.
44
  
1.3.3 Field-Effect Transistors  
Field effect transistors (FET) can be used for the detection of electroactive or non-
electroactive compounds with the use of antibodies for target molecules. FETs consist of a 
source, a gate, and a drain. A voltage is applied to the gate, which can be functionalized with 
antibodies specific to a non-electroactive molecule or protein of interest, changing the 
conductivity between the source and gate. Upon detection of the molecule or protein of interest, 
the conductivity change causes a measurable change in current between the source and drain. One 
type of FET used for single cell exocytosis analysis is a single-walled carbon nanotube FET 
modified with anti-chromogranin A (CgA). CgA has several important biofunctions including 
neuron inflammation mediation, assisting in the secretion of biomoleucles after Ca
2+ 
chelation, 
and is hypothesized to be a marker for neurodegenerative diseases. The use of FETs for 
measuring the secretion of CgA has been shown to be highly biocompatible, sensitive to low 
secretion concentrations, and displays a correlation between conductivity and concentration in 
both neurons and single chromaffin cells.
45, 46
   
Two recent expansions on FET platforms were demonstrated for studying cellular processes, 
other than exocytosis. The researchers were interested in understanding the adhesion, apoptosis, 
and detachment of single cancer cells in response to nanoparticles and anti-cancer drugs. To 
monitor this, they used impedance spectroscopy with an ion-sensitive field-effect transistor.
47-49
 
Zhang et al. created a nanometric FET by coating a dual electrode for the source and drain, with 
polypyrrole to form the transistor channel with a final diameter of 200 nm (Fig. 1.2). The pH 
sensor detects changes of ~0.1 pH units with a linear response between pH 5.0-7.5. The probe 
was used for the detection of pH in breast cancer tissue, a cluster of melanoma cells, and on a 
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single cancer cell (Fig. 1.2 G-I). Typically melanoma cells have higher acidic environments. 
Researchers found that the probe is able to measure an increase in acidity in both the tissue and 
cluster of melanoma cells as it approached the cells. However, no decrease in pH was noted on a 
single cell level, which was likely due to the rapid diffusion of the proton not obstructed by other 
cells.
50 
 With the addition of hexokinase (an enzyme that cleaves ATP and releases protons) to the 
tip of the nanometric-FET, the researchers also showed the applicability of this probe to detect the 
release of ATP at concentrations as low as 10 nM.
50
  
 
Figure 1.2 Nano-FET pH Biosensor. (a) A spearhead nano-FET made by deposition of 
polypyrrole (PPy) to comprise the channel. From I−VG curves (b), changes in pH value can be 
measured as change of average drain-source current or drain-source spike currents (c) as well as 
shift in gate voltage (d). (e) The pH-sensitive PPy nano-FET is applied to measure the local pH in 
the microenvironment of cell samples. (f) Prior to cell measurements the PPy nano-FET is 
calibrated with physiological pH variations from 5.0 – 7.5. Local pH measurements by alternating 
vertical approach and withdrawal of the PPy nano-FET probe to breast cancer tissue (g), a cluster 
of melanoma cells (h), and a single melanoma cell (i).Adapted with permission from Zhang, et al. 
Copyright 2016 American Chemical Society
50
 
 
1.3.4 Patch Clamp  
Unlike the previously discussed methods, patch clamp measures cell capacitance, which is 
proportional to the membrane area. In patch clamp, a gigaseal is formed between the cell and an 
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electrolyte-filled pipette; this serves to reduce the noise and prevents interference from ions in the 
extracellular solution. There are two major patch clamp methods. The first is cell-attached, where 
the capacitance is measured on a small area of the cell. This technique has lower noise and greater 
sensitivity to small changes.
51,52
 The other methods is a whole-cell method, which allows 
measurements of the entire cell’s capacitance and can measure larger changes in area. This 
method is completed by puncturing the cell membrane with the pipette. To obtain more in-depth 
information on exocytosis, patch clamp can be utilized in parallel with amperometry to obtain 
both fusion pore size and molecular secretion information.
51, 53
  
Finally, patch clamp can be used for measuring the release of ions from ion channels located 
throughout the plasma membrane. Upon stimulation, the ion channels open, selectively allowing 
ions to pass through based on charge and size, creating an electrical signal. In these studies, the 
gigaseal is formed over the ion channel(s) of interest, and the potential is held constant in the 
pipette. As ions pass through, the change in current from the potentiostat is measured. 
54
  
One of the largest problems with patch clamp is the scale-up of single cell measurements in 
vivo on a large scale, particularly in the brain to study the effects of drugs and disease on brain 
signaling because of the human hours needed for electrode placement. Training personnel to 
operate the patch clamp can also be time consuming. To start overcoming these limitations, 
Kodandaramaiah et al. developed an automated whole cell patch clamp system. In 3-7 minutes, 
the robot is able to fully patch clamp neurons with a success rate of 32.9%, which is higher than 
the success rate for trained personnel at 28.8%. The resulting data was found to have a similar 
quality relative to manual patch clamp.
55
   
1.4 Mass Spectrometry  
Mass spectrometry (MS) is a technique used to analyze the molecular species present in a 
cellular sample via the ionization and subsequent detection of fragment ions. Due to the detection 
method, MS often does not require labeling of the species of interest, allowing for both the 
detection of known and unknown ions, without theoretically limiting the number of different ions 
detected (accounting for the range of masses and resolution of the instrument). Mass 
spectrometers can be directly coupled with microfluidic devices, liquid chromatography, capillary 
electrophoresis, cell pressure probes, and nanoelectrospray tips.
2,56-58
 Recently, Aerts and 
colleagues made whole cell patch clamp measurements, then collected the intracellular contents 
for later analysis by MS.
59
 One lab that is particularly focused on direct measurements of live 
cells is the Masujima lab at the Riken research institution in Japan. They have developed and 
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optimized live single cell MS where specific organelles, the nucleus, or cytoplasm can be 
removed after a cellular event and routed directly into the MS to analyze metabolites.
60
  
1.4.1 Mass Spectrometry Imaging  
To directly measure single cells within tissue samples, many researchers use MS imaging 
(MSI). MSI consists of a secondary ion MS (SIMS) and matrix assisted laser desorption 
ionization (MALDI) setup.
61,62
 These techniques allow for the detection of molecules, proteins, 
and unique lipid compositions that could be obscured in bulk analyses. 
In static SIMS and dynamic SIMS, the species on the top layer of the cell or several layers in 
the cell, respectively can be identified. Dynamic SIMS is advantageous in that it gives a 3D 
picture of the cellular components. The bombardment of the surface with high energy particles 
(typically Cs
+
 or O
-
) or clusters (Bi3
+
 and C60
+
), allow for the desorption of atoms, molecules, and 
clusters. The secondary ions produced from this process are then analyzed.
63,64
 The layer 
thickness is typically several nanometers with a lateral resolution of ≤100 nm and attomolar 
detection limits. This high spatial resolution allows the concentration of various membrane 
components, including lipids and polysaccharides, to be analyzed on a single cell level. 
Medically, this can be used to understand the impacts of disease on cellular membrane 
components or reveal disease biomarkers. It can also be used to understand drug distribution.   
Park et al. modified the traditional time-of-flight (TOF)-SIMs method to better differentiate 
ovarian cancer cells from control cells by using multi-dimensional SIMS (MD-SIMS).
65
 In this 
method, samples first undergo TOF-SIMS then have gold deposited on them before a second 
SIMS analysis (metal-assisted-SIMS (MetA-SIMS)). The data showed that TOF-SIMS and 
MetA-SIMS identified 206 and 533 unique compounds, respectively and 426 compounds were 
found in both methods with 250 signals enhanced using MetA-SIMS compared to TOF-SIMS. 
When comparing the results between cancerous and non-cancerous tissue using partial least 
square discriminate analysis, MD-SIMS enhanced the number of cancer cells discriminated from 
non-cancer cells from 68.4% with TOF-SIMS to 82.6%. (Fig. 1.3). 
65
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Figure 1.3 Integrated analysis of TOF- and MetA-SIMS datasets. 3-D partial least square-
discriminate analysis score plots for TOF-SIMS (a) and MD-SIMS (b). The tables show that MD-
SIMS enhanced the power of discrimination of ovarian cancer samples (red) from normal 
samples (blue), compared to TOFSIMS. This figure was adapted from Park, et al. Copyright 2015 
Nature Publishing Group 
65
  
Variations in the way data was analyzed was compared to distinguish which method is better 
able to detect variations between injured or diseased and control cells. Hanrieder et al. imaged 
human spinal cord in positive and negative mode.
66
 The data was subjected to either principal 
components analysis (PCA) or maximum autocorrelation factor analysis (MAF) to perform 
unsupervised multivariate statistical image analysis. Both PCA and MAF separated and correctly 
characterized gray and white matter in the spinal cord. However, MAF was able to better 
distinguish sub-regions and regions with slight heterogeneities due to cell damage. One 
disadvantage to MAF is the length of time for computation making it better suited for smaller 
scale images. 
66
 
Being able to detect the drug distribution and metabolism inside a cell is important to drug 
efficacy. To locate and distinguish organelles of interest within a cell, Bloom et al. established a 
new technique using dye-enhanced imaging. This technique uses a molecular tag that is 
detectable by SIMs, but does not interfere with the mass spectra of other common cellular 
components. Using a nuclear stain, it was verified that the stain was successfully chemically 
imaged. Utilizing this method, further studies can probe various biological pathways and drug 
uptake, while being able to detect organelles of interest. Future work on other organelle stains 
still need to be verified.
67
 Bloom et al. have used cluster SIMS for detecting the uptake and 
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location of nanoparticles and subsequent delivery and degradation of the delivered drug within 
the cell. 
68
  
One limitation of SIMS is that it does not give information on the roughness of the material, 
such as the presence of protrusions, or differentiate between patchy and continuous signals. To 
enhance image quality and overcome these limitations, Tarolli et al. paired SIMs data with 
scanning electron microscopy. By using a pan-sharpening algorithm, their results provide both 
topographical information and chemical information. This approach was used to understand how 
the environment impacts the adhesion of B. braunii algal cells, known for their role in biofuels. 
The data collected helped clearly define cellular boundaries in the biological matrix. 
69
 
Another limitation is that not every cellular component and molecule can be detected by 
TOF-SIMS. There are a variety of reasons leading to this limitation, but a major cause is 
extensive fragmentation of the target molecules. To combat this, Carlred et al. developed a 
method to detect peptides that undergo extensive fragmentation which utilizes antibody-coupled 
liposomes.
70
 They paired this method with TOF-SIMS to understand where amyloid-β, a peptide 
associated with Alzheimer’s disease (AD), is located in the brain with respect to various lipids. 
Unlike traditional immunohistochemistry fluorescence imaging methods, this allowed for the 
detection of small structures located on the surface, which may be hidden in traditional methods 
due to fluorescence within the tissue, and resulted in a greater number of biological structures 
being measured. Their findings indicate that in AD mouse models, there are large buildups of 
amyloid-β in the hippocampus region (Fig. 1.4) with decreased levels of phosphatidylcholine 
signal.
70
 
Unlike SIMS, MALDI samples need to be prepared in a matrix that is ionized using a near 
UV laser (337-355 nm). The analyte molecules absorb the energy from the matrix, resulting in an 
ion plume which enters the mass spectrometer for analysis. This technique is often used when 
analyzing tissue rather than single cells due to its poor large lateral resolution of 20-30 µm. 
However, techniques to enhance the resolution have included using a scanning microprobe 
MALDI mass spectrometer and transmission geometry MALDI mass spectrometer, both of which 
have lateral resolutions around 1 µm.
71,72
 Despite these improvements in the resolution limit, 
many of the recent advances in MALDI single cell analysis involve the use of cell separation 
before performing MALDI mass spectrometry. Xie et al. created a microwell array microfluidic 
device for automatic and high throughput phospholipid detection in individual A549 lung cancer 
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Figure 1.4 High resolution TOF-SIMS images of liposomes bound to 6E10-labeled amyloid-
β deposits and selected lipids in transgenic Alzheimer’s disease mouse brain tissue. (a) 
deuterated POPC (1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine-1,1,2,2-d4-N,N,N-
trimethyl-d9) liposomes, (b) cholesterol (Chol−), (c) sulfatides (Sulf), (d) overlay showing 
liposomes (red), sulfatides (green) and cholesterol (blue), (e) phosphatidylcholine (PC), (f) 
phosphatidyletanolamine (PE), (g) CN− and CNO− ions, (h) overlay showing liposomes (red), 
PC (green) and CN− + CNO− (blue), (i) palmitic acid (16:0), (j) stearic acid (18:0), (k) oleic acid 
(18:1), (l) overlay showing liposomes (red), palmitic acid (green) and oleic acid (blue). Purple 
color in the overlays indicate colocalization of red and blue in the image, and cyan color 
represents colocalization of green and blue. (scale bar: 50 μm) Adapted from Carlred, et al.70 
Copyright 2014 American Chemical Society  
 
cells.
73
 This setup flows cells into the device where they attach in individual wells. The matrix is 
injected into the device, encasing the cells for MALDI. In a different approach, Phelps et al. 
utilized microextraction to remove individual organelles from adipocytes differentiated from 3T3 
L1 murine fibroblasts and placed them on a glass coverslide before being put into the MALDI.
74
 
This eliminated the need for extraction from multiple cells for each sample, reduced purification, 
and eliminated digestion compared to previous organelle extraction protocols. 
1.4.2 Mass Cytometry  
The last MS technique discussed is mass cytometry, which is often used when studying 
cancer and the immune system.
75, 76
 Mass cytometry was developed to overcome the spectral 
overlap limitations found in flow cytometry. Unlike the previous label-free imaging techniques, 
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mass cytometry uses antibodies attached to nonradioactive rare earth metal isotopes that bind to a 
protein of interest. After the cells are tagged with up to 45 different antibodies, the cells are 
individually introduced into the inductively coupled plasma by nebulization. Only the heavy ions 
are allowed to pass through the quadrupole before seperating by TOF. Finally, the number and 
identity of the rare earth metal are recorded for each individual cell.
76
  
Recent pushes in mass cytometry research have focused on implementing the instrument into 
clinical settings for patient diagnosis. The severity of surgical trauma is often related to immune 
response, and Gaudilliere et al. demonstrated the use of mass cytometry to correlate immune 
signatures with recovery time, pain, and functional impairment. Using serial whole-blood 
samples, three signaling responses in CD14
+
 monocyte subsets correlated with surgical trauma. In 
addition, this paper demonstrated the ability to use mass cytometry to survey immune cells in a 
clinical setting. 
77
 Mass cytometry also has been exploited to identify bacteria based on their cell 
surface and ability to bind lectins. Leipold et al. incubated E. coli with lanthanide-tagged 
nonspecific membrane stains and were able to distinguish three different strains of E. coli  in one 
sample using lectins labeled with lanthanide metals.
78
 The use of mass cytometry in clinical 
applications is still a new and budding field, with ongoing work to clarify old methodologies and 
develop new methodologies. To illustrate methodological issues, Gaudilliere et al. set up a study 
looking at immune signatures of women with a history of term birth vs. preterm birth and gave a 
list of considerations needed when considering doing experiments in a clinical setting. 
77
 
A major limitation of mass cytometry is that most methods require the sample to be in 
suspension before injection, therefore losing all spatial resolution. A recent innovation by Giesen 
and colleagues created a technique to gain spatial resolution by utilizing immunohistochemical 
and immunocytochemical methods with high-resolution laser ablation and mass cytometry to 
increase spatial resolution. In this method, the tissue of interest is extracted and fixed before 
staining with the metal-labeled antibodies. Using a UV laser, the sample is ablated and sent into 
the mass cytometer. The images are processed, giving single cell spatial resolution.
79
 
1.5 Conclusion 
Electrochemistry and mass spectrometry of single cells give us chemical insight into both 
cellular communication and cell structural components. Medically, these techniques can be used 
to understand how disease affects cells, distinguish cells that may be damaged or diseased, 
characterize drug metabolism in cells, and distinguish among bacterial strains. There are still 
major limitations to single cell analysis. However, new progress in the various techniques have 
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been made, including increasing specificity of electrodes, combining techniques together such as 
amperometry and patch clamp or SIMS and SEM to give more in-depth information, and creating 
new sample preparation and ionization methods. Together all of these techniques will bring us 
closer to understanding how cells works together and by themselves to impact disease and 
cellular function.  
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2.1 Overview 
Exocytosis is a highly regulated intercellular communication process involving various 
membrane proteins, lipids, and cytoskeleton restructuring. These components help control 
granule fusion with the cell membrane, creating a pore through which granular contents are 
secreted into the extracellular environment. Platelets are an ideal model system for studying 
exocytosis due to their lack of a nucleus, resulting in decreased membrane regulation in response 
to cellular changes. In addition, platelets contain fewer granules than most other exocytosing 
cells, allowing straightforward measurement of individual granule secretion with carbon-fiber 
microelectrode amperometry. This technique monitors the concentration of serotonin, an 
electroactive molecule found in the δ-granules of platelets, secreted as a function of time, with 50 
µs time resolution, revealing biophysical characteristics of the fundamental exocytotic process. 
Variations in fusion pore formation and closure cause deviations from the classic current versus 
time spike profile and may influence diffusion of serotonin molecules from the site of granule 
fusion. Physiologically, the delivery of smaller packets of chemical messengers or the prolonged 
delivery of chemical messengers may represent how cells/organisms tune biological response. 
The goals of this work are two-fold: (1) to categorize secretion features that deviate from the 
traditional mode of secretion and (2) to examine how changing the cholesterol composition of the 
platelet membrane results in changes in the pore formation process. Results herein indicate that 
the expected traditional mode of secretion is actually in the minority of granule content secretion 
events. In addition, results indicate that as the cholesterol content of the plasma membrane is 
increased, pore opening is less continuous. 
2.2 Introduction 
To maintain proper physiological function, cell-cell communication occurs through the highly 
regulated exocytotic process wherein granules dock on the cell membrane, utilizing SNARE 
proteins to assist in regulating attachment. These proteins are localized to cholesterol-rich 
microdomains throughout the cell membrane.
1
 The amount of cholesterol in these domains not 
only plays a role in the proper clustering of SNARE proteins, but also helps stabilize the negative 
curvature needed for formation and stabilization of the fusion pore between the docked and 
primed granule and the cell membrane. Cholesterol levels and membrane viscosity are directly 
correlated, and increasing viscosity is known to result in delayed movement of lipids between the 
leaflets, which has been hypothesized to increase fusion pore formation and closing times.
2,3
 
Chemical messenger molecules can be secreted through this dynamic fusion pore structure into 
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the extracellular space. Literature precedent has shown that cholesterol has a role in controlling 
exocytosis, but the extent to which it dictates the opening and closing of the fusion pore structure 
requires more exploration, ideally with a method that can quantitatively assess this dynamic 
structure.
2,3
 
In recent years, it has become clear that the process of granule fusion is more intricate than 
originally thought. Traditionally, exocytosis was considered to be an all-or-nothing process, but 
in the last decade the definition has changed to include kiss-and-run events where a granule 
temporarily fuses with the cell membrane before detaching. More recently, it has become 
apparent that most granule secretion events are in fact extended kiss-and-run events which do not 
result in full chemical messenger content secretion.
4-7
 Schematic portrayals of these various 
exocytosis events can be seen in Fig. 2.1A-C. Further countering the traditional view of 
exocytosis, individual granules have also been observed combining with one another, either 
before or during secretion, resulting in a process termed compound exocytosis.
8,9
 However, in 
platelets, our chosen exocytosis model due to its lack of nucleus and therefore decreased ability to 
up- or down-regulate proteins, granules can also fuse to the open canalicular system (OCS). The 
OCS is a tubular system located throughout the platelet, which is hypothesized to assist in the 
secretion of granular content into the extracellular environment.
10
 At the OCS-cytosol interface, it 
is possible for two granules to attach near one another and release their contents into the OCS, 
where the contents can combine and secrete simultaneously into the extracellular environment. 
This phenomenon could lead to chemical messenger secretion measurements characteristic of 
compound exocytosis. Unfortunately, current measurement technology does not allow us to 
distinguish between these two forms. Therefore we will describe all events with large amounts of 
serotonin secretion, typically larger than the average amount secreted in two separate granules 
(>960 fC) and a 10/90 slope of 6 or greater as bulk fusion (Fig. 2.1D).  
Even with this limitation, carbon-fiber microelectrode amperometry (CFMA) is an ideal 
technique for studying the dynamic variations in granule secretion events. In platelets, the only 
electroactive compound at 700 mV vs. Ag/AgCl is serotonin, which has been confirmed by cyclic 
voltametry.
11,12
 Statistical analysis has demonstrated that, due to the size of the cell relative to the 
electrode and the distance between the electrode and platelet, nearly 100% of all serotonin is 
detected.
11
 Electrical fouling is also checked by monitoring the IRMS and replacing the electrode if 
IRMS increases or the signal goes down. Therefore monitoring the oxidation of serotonin, found in 
the δ-granules, gives us a means to study changes in the pore dynamics when microelectrodes are 
placed in immediate contact with individual platelets. As each granule fusion pore opens, an 
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increase in current is detected as secreted serotonin is oxidized, resulting in a 
current spike. In some cases, an individual current spike will be flanked either before or after the 
current maximum by a smaller current feature known as a “foot” event; these foot events 
correspond to the relatively small number of serotonin molecules secreted when a fusion pore is 
not fully dilated. Due to the small number of granules in platelets and length of time between 
granule secretion events, it is possible to distinguish the start and end of each granule event, 
including feet events, without overlap from other granule secretion events. This event resolution 
allows analysis of the variations in each spike profile, revealing mechanistic biophysical 
information about pore fusion behavior for each granular secretion event. Since cells do not 
typically secrete their entire content and there is a limited quantity of δ-granules, it is possible that 
several of the recorded spikes in each cell amperometric trace are from the same granule.  
 
Figure 2.1 Various proposed modes of exocytosis, from least to most chemical 
messenger release.  A) Kiss-and-Run: In kiss-and-run events, the granule fuses briefly 
with the plasma membrane, releasing only a small portion of its contents without 
significant dilation of the fusion pore. B) Partial Fusion: In partial fusion events the 
granule initially fuses with the plasma membrane, releases some of its contents, and then 
closes and returns to the platelet cytoplasm. C) Full Fusion: In full fusion events, the 
granule fully fuses with the plasma membrane and releases all of its contents. D) Bulk 
Fusion: In bulk fusion, multiple granules are hypothesized to fuse with one another prior 
to fusing with the plasma membrane, this is commonly referred to as compound fusion. 
However, platelet granules can adhere to the OCS and release their contents into the 
extracellular environment together; which is indistinguishable from compound fusion 
using CFMA. Therefore, we termed all of these events as bulk fusion. 
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This work examines the modes of pore formation and closure and how membrane cholesterol 
levels impact these modes. Results indicate that as the cholesterol membrane content increases 
there is a corresponding increase in the number of secretion events with distinguishing 
characteristics. In particular, an increase in the number of non-traditional events (NTEs) was 
observed. It was also noted that at greater levels of cholesterol the NTEs have a slower fusion 
pore opening, increased secretion of serotonin molecules during each secretion event, and a 
longer duration in which the fusion pore remained open.   
2.3 Experimental Approach 
2.2.1 Materials and Methods 
Amperometric traces from individual rabbit platelets were recorded previously by 
Shencheng Ge using CFMA.
2
 Briefly, platelet cholesterol levels were manipulated by exposing 
platelets either to methyl-β-cyclodextrin (MβCD) (Sigma-Aldrich St. Louis, MO) to achieve 
cholesterol depletion or MβCD complexed with cholesterol (Sigma-Aldrich St. Louis, MO) to 
achieve cholesterol enrichment. Platelets with varying levels of cholesterol were stimulated using 
10 μM ionomycin and 2 mM Ca2+ in Tyrode's buffer. The secreted serotonin was oxidized by an 
in-house fabricated carbon-fiber microelectrode at 700 mV vs. a Ag/AgCl reference electrode 
held by an Axopatch 200B potentiostat (Molecular Devices Sunnyvale, CA), and the resulting 
current was measured as a function of time. Each collected current vs. time trace was filtered at 5 
KHz by a four-pole Bessel filter ahead of further analysis.   
Each amperometric trace (N= 75, 72, and 50 for MβCD, control, and cholesterol-loaded 
platelets, respectively) was then digitally filtered at 1000 Hz and analyzed using Mini Analysis 
software (Snyptosoft Inc. Fort Lee, NJ) for pre- and post-spike feet. The spikes were analyzed 
visually by using a gain of 15 and a block of 20 unless the current spike was too large for the 
frame, in which case the gain was decreased so that the entire spike was visible within the frame. 
After examining each trace, the various features were divided into categories based on the general 
shape of the secretion event, (Fig. 2.2A) resulting in pre- and post-feet (Fig. 2.3, Fig. 2.4). Each 
spike was analyzed manually using the “group analysis and curve fitting” option to determine the 
duration and area of both the foot alone and the spike and foot features combined. In addition to 
foot features, there are also current spikes that do not display the typical quick current rise due to 
serotonin secretion followed by a gradual current decay as serotonin diffuses away which were 
titled NTEs (Fig. 2.5). The NTEs were subdivided into six different categories 
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Figure 2.3 Representations of the various pre-spike feet types. The representative traces 
are all on the same current and time scale excluding the double spike. 
 
 
Figure 2.2 Schematic of spikes varriations and spike feature changes with cholesterol. 
A) Diagram indicating the parameters used to categorize and quantify various spikes. B) The 
frequency of events with features upon the different cholesterol treatments. C) Relative 
frequency of classes of spikes with the different cholesterol treatments. *p≤ 0.05, **p≤0.01, 
***p≤0.001, ****p≤0.0001  
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Figure 2.4 Representations of the various post-spike feet types. The representative traces 
are all on the same current and time scale. 
 
Figure 2.5 Representations of the various non-traditional events. The representative 
traces are all on the same current and time scale. 
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 (full fusion, partial fusion, bulk fusion, kiss-and-run, recurring kiss-and-run, and jagged top) 
based on the area (charge, Q) under each spike, which is proportional, through Faraday’s Law, to 
the amount of serotonin secreted, and how quickly the fusion pore opened relative to its 
maximum secretion (slope10/90, the slope between 10% and 90% of maximal current intensity) 
(Table 2. 1). Jagged top features were distinguished by continuous up and down fluctuations of 
serotonin secretion at maximum opening, and recurring kiss-and-run displayed several kiss-and-
run events within a second of each other.  
The cut-off criteria categorizing events with a 10/90 slope under 6 pA/ms was chosen 
empirically based on the manual analysis of many spikes that represented traditional and non-
traditional secretion events. Non-traditional secretion events were further categorized based upon 
the amount of serotonin secreted. To set an upper limit on the secretion that could be attributed to 
kiss-and-run, we averaged the spikes in the control platelets considered to be kiss-and-run and 
found the highest value within one standard deviation of the mean, then made this our maximum 
secretion value. Previous data obtained by HPLC indicated that a five minute ionomycin 
stimulation on rabbit platelets resulted in the average secretion of 52% of the total serotonin 
content.
13
 The average area (250 fC per granule in control platelets) was thus assumed to be 52% 
 
Table 2.1 Non-Traditional Events Characterizations. NTEs were characterized 
by their 10/90 slope and area. As NTEs are often characterized by slower pore 
opening, the 10/90 slope was determined to be a good indicator of NTEs. To 
distinguish between the different types of NTEs, the extent of release, or area under 
the current spike, was used. Commonly, events releasing twice the amount of 
serotonin or greater than the predicted concentration, had steep 10/90 slopes that 
were most likely due to more serotonin occupying the larger free space outside the 
dense-body core. Therefore, bulk fusion events had a 10/90 slope >6. All slopes 
and areas were calculated using the Mini Analysis software.   
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content secretion. Full fusion was set as a minimum of 80% content secretion, or 385 fC/event. 
Secretion events where granule fusion resulted in at least 200% content release, or greater than 
970 fC, and contained a 10/90 slope of 6 pA/ms or greater were categorized as bulk fusion events. 
For NTEs, the event area and event duration of the entire spike was analyzed manually using the 
“group analysis and curve fitting” option in mini analysis. 
 The percent frequency of each feature (pre-foot, post-foot, or NTE) was determined by 
dividing the total number of events with that feature by the total number of secretion events in 
each trace (Fig. 2.2). Within each feature type, the percent frequency was accounted for with 
respect to the total number of events with that feature (for example, within each trace, a pre-foot 
type was compared to the total number of granule secretion events with pre-foot features) (Table 
2.2, 2.3, 2.4). Significance was determined between conditions by one-way ANOVA with all 
error given as the standard error of the mean.  
 
Ramp Like Pre-Feet 
                
 
RAMP 
 
Jagged Rise 
 
Small Spike 
 
Long Decline 
MβCD 35.7 ± 5.3 % 7.0 ± 3.1 % 
 
6.8 ± 2.8 % 
 
8.7 ± 3.2 % 
Control 34.6 ± 4.7 % 11.4 ± 3.2 % 
 
7.0 ± 2.2 % 
 
9.0 ± 2.3 % 
Cholesterol 23.0 ± 4.3 % 16.4 ± 4.9 % 
 
7.5 ± 2.4 % 
 
3.9 ± 2.1 % 
Plateau Like Pre-Feet 
                
 
Short Plateau 
 
Jagged Plateau 
 
Long Plateau 
     MβCD 11.5 ± 3.5 % 5.1 ± 2.3 % 
 
0.9 ± 0.9 % 
     Control 10.6 ± 2.7 % 3.7 ± 1.9 % 
 
4.6 ± 1.7 % 
     Cholesterol 14.0 ± 4.5 % 10.1 ± 3.2 % 
 
10.4 ± 3.2 % 
     Other 
                   
 
Slow Rise 
 
Pre K&R 
 
Double Spike 
     MβCD 12.2 ± 3.5 % 3.2 ± 1.9 % 
 
8.7 ± 3.2 % 
     Control 8.1 ± 2.4 % 0.3 ± 0.3 % 
 
10.8 ± 3.2 % 
     Cholesterol 9.1 ± 3.3 % 0.3 ± 0.3 % 
 
5.1 ± 1.9 % 
      
Table 2.2 Percent frequency of each pre-spike foot feature with SEM: Only long 
plateau was significantly (p≤0.01) different between MβCD to cholesterol. 
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2.4 Results and Discussion 
2.4.1 Overall Trends 
Based upon previously established methods of secretion, exocytosis events have been 
categorized herein into four types 1) kiss-and-run, 2) partial fusion for both normal pore opening 
rates (10/90 slope > 6 pA/ms) and extended pore opening rates (10/90 slope < 6 pA/ms) (when 
discussing partial fusion for the remainder of the paper, we are referring to the extended pore 
 
Flat Tail 
 
Jagged Decline 
 
Small Convex 
MβCD 6.7 ± 4.3 % 
 
17.3 ± 7.3 % 
 
3.8 ± 3.8 % 
Control 9.0 ± 4.3 % 
 
18.5 ± 7.6 % 
 
15.4 ± 6.3 % 
Cholesterol 2.1 ± 1.5 % 
 
26.7 ± 8.4 % 
 
6.6 ± 2.9 % 
               
 
Post Kiss and Run 
 
Closing Ramp 
 
Large Convex 
MβCD 21.2 ± 7.9 % 
 
0.0 ± 0.0 % 
 
0.0 ± 0.0 % 
Control 29.0 ± 8.1 % 
 
0.0 ± 0.0 % 
 
8.6 ± 5.2 % 
Cholesterol 5.9 ± 4.3 % 
 
4.5 ± 2.6 % 
 
0.0 ± 0.0 % 
               
 
Partial Re-Open 
 
Re-Open 
  MβCD 27.9 ± 8.6 % 
 
23.1 ± 8.0 % 
     Control 8.3 ± 4.8 % 
 
11.1 ± 6.2 % 
     Cholesterol 46.5 ± 9.4 % 
 
7.6 ± 4.5 % 
      
Table 2.3 Percent frequency of each post-spike foot feature with SEM. Only 
partial re-open was significantly (p≤0.01) different between MβCD to cholesterol. 
 
Full Fusion 
 
Partial Fusion 
 
Bulk Fusion 
MβCD 6.4 ± 1.6 % 
 
36.5 ± 3.9 % 
 
17.8 ± 3.6 % 
Control 12.0 ± 2.2 % 
 
35.5 ± 3.4 % 
 
21.0 ± 3.9 % 
Cholesterol 11.8 ± 2.5 % 
 
32.6 ± 4.3 % 
 
18.1 ± 3.5 % 
                              
 
Kiss-And-Run 
 
Recurring Kiss & 
Run 
 
Jagged Top 
MβCD 33.2 ± 4.1 % 
 
2.1 ± 0.8 % 
 
4.0 ± 1.7 % 
Control 22.9 ± 3.1 % 
 
2.6 ± 0.8 % 
 
6.0 ± 1.9 % 
Cholesterol 27.3 ± 4.6 % 
 
4.3 ± 1.3 % 
 
5.9 ± 1.7 % 
 
Table 2.4 Percent frequency of each NTE with SEM.  
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opening rates and not the traditional spike formation), 3) full fusion, and 4) bulk fusion (including 
both granule-granule fusion and bulk OCS fusion). The different models are illustrated 
schematically in Fig. 2.1.
4-9
  
After platelets were enriched in cholesterol or depleted of cholesterol by platelet exposure to 
MβCD (132% and 68%, respectively, compared to control platelet cholesterol levels),2 the total 
percentage of events with either a foot or NTE secretion profile increased with increasing 
concentrations of cholesterol (52.6 ± 2.4%, 64.7 ± 2.2%, and 76.8 ± 2.8% for depleted, normal, 
and cholesterol-enriched platelets, respectively, Fig. 2.2B). Normal levels of foot events reported 
with CFMA are traditionally around 10-30%,
2,13,14
 which is nominally lower than what we have 
reported; this discrepancy is likely due to our inclusion of non-traditional type events and post-
foot containing events when determining the percentage of events with features-of-interest. When 
only events with pre-foot characteristics are taken into account, the percentage of events falls to 
previously described ranges with 15.2 ± 1.8%, 21.9 ± 2.0% and 21.8 ± 2.3% for increasing 
cholesterol concentrations, respectively (Fig. 2.2C). Post-foot events, which have been known to 
only occur ~2% of the time in PC-12 cells,
6
 occur relatively infrequently (4.8 ± 1.0%, 4.2 ± 0.8%, 
and 6.5 ± 1.2% for increasing cholesterol concentrations) in platelets and do not change 
significantly as the cholesterol content is changed. Changes in platelet membrane cholesterol 
have the largest impact on secretion via NTEs, with statistically significant (p≤0.05 for 
comparisons to control platelets and p ≤ 0.0001 from MβCD to cholesterol) increases from 33.5 ± 
2.5% for cholesterol-depleted platelets to 53.6 ± 3.6% of the events for cholesterol-enriched 
platelets, with a value of 42.7 ± 2.5% in control platelets. This suggests that cholesterol has a 
large impact on the whole fusion event rather than just the initial opening or closing of the pore. 
This difference is not attributable to a change in the number of granules undergoing exocytosis as 
the membrane cholesterol levels change. By counting the number of spikes in each trace, on 
average, each platelet secreted 12.7 ± 0.7, 12.6 ± 0.9, and 13.1 ± 0.9 granules per cholesterol-
depleted, control, and cholesterol-enriched platelet, respectively.  
2.4.2 Pre-Spike Feet Events 
The occurrence of pre-spike foot events only changes significantly as seen in a decrease for 
cholesterol-depleted platelets (p ≤ 0.05). When the pre-foot events are broken down into sub-
types, the majority of the pre-feet were present in two forms: those where the initial secretion 
took some sort of ramp (an initial slow opening) or those where the initial secretion took the form 
of a plateau (an initial opening which is held steady over an extended period of time) (Fig. 2.3). 
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These two general characteristics have been reported before in several papers.
6,14,15
 The most 
commonly reported and most discussed pre-spike foot type is the ramp. Amatore and colleagues 
reported that in chromaffin cells, of their pre-spike feet events, 70% were ramps, 20% were ramps 
with plateaus, and 10% were unclassified. They then found a positive correlation between the 
ramps’ maximum current and the maximum current given by the spike.14 Our data (Fig. 2.6A) 
show that the ramp-type pre-spike foot was the most frequently occurring of the pre-spike foot 
types, at 35.7 ± 5.3%, 34.6 ± 4.7%, and 23.0 ± 3.8% for cholesterol depleted-, control-, and 
cholesterol-enriched platelets, respectively. For the depleted and control conditions, the percent 
occurrence of the ramp was significantly enhanced (p ≤ 0.0001) compared to the other pre-spike 
foot types. The ramp frequency in cholesterol-enriched platelets was only significantly different 
from four out of the nine other pre-spike feet types (p ranging from 0.05 to 0.0001). This, along 
with previous work in other groups, leads us to believe that this ramp characteristic is 
representative of the traditional entryway for granular fusion. The ramp-like variants, such as 
jagged rise, could potentially correspond to the opening and closing of the fusion pore during 
formation, suggesting that the cell is not able to easily transition to the type of curvature needed 
in the membrane as the fusion pore opens. This inability to rapidly change the membrane 
curvature paired with increased membrane stiffness is also implicated in the significant increase 
in the occurrence of long plateau foot events between the cholesterol-depleted and enriched 
conditions (p ≤ 0.01)(Fig. 2.6B). In addition, the increase in the duration of the short plateau foot 
Figure 2.6 Pre-spike % relative frequencies for feet with ramp-like characteristics 
(A) and plateau-like characteristics (B) with the different cholesterol treatments. 
**P≤0.01 for indicated conditions 
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relative to the whole event as cholesterol content increases suggests that increasing membrane 
rigidity results in a barrier to the pore opening to the proper form (Fig. 2.7).   
 
2.4.3 Post-Spike Feet Events 
As the post-spike feet were not prevalent, it was difficult to identify variation in their forms. 
In total, eight different types of post-spike feet were identified, three of which were categorized 
as different forms of re-opening (Fig. 2.4 and Fig. 2.8). Of the re-opening type post-spike feet, the 
 
Figure 2.8 Relative frequency for post-spike foot types with varying cholesterol 
treatments.  **p≤0.01 
 
Figure 2.7 Percent of event area (A) and percent of time the foot feature occurred 
relative to the time of the whole event (B) for pre-spike feet. **p≤0.01, ****p≤0.0001  
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partial re-opening type foot showed a significant difference in frequency between the cholesterol-
depleted and cholesterol-enriched conditions, with the foot occurring 8.3 ± 4.8% and 46.5 ± 9.4% 
of the time, respectively. Since the significant increase is only seen in the partial re-open post foot 
event, where the pore begins to reopen directly after beginning to close, it indicates that the pore 
initially has difficulty closing, but after closure has been initiated, the cholesterol levels do not 
impact the process to the extent they do for pre-foot events. 
2.4.4 Non-Traditional Events 
The most interesting results arising from categorization of the spikes observed upon platelet 
activation was the prevalence of spikes that were not in the form of traditional secretion events, 
meaning that they lacked the typical fast rising current due to pore opening followed by a slow 
current decrease as serotonin diffuses out of the closing pore. These secretion events were sorted 
into six categories by examining a combination of the following characteristics: 10/90 slope, the 
lack of a foot character, and the area (Fig. 2.5 and Fig. 2.9). Table 2.1 gives the 10/90 slope and 
area characteristics for four out of the six types of NTEs observed. While the NTEs as a category 
showed significant increases in percent frequency of total events as the cholesterol increases (Fig. 
2.2C), when the NTEs are broken down into the various exhibited types, no significant changes 
are observed where one specific category is affected by the amount of cholesterol (Fig. 2.9). 
However, there are significant changes in the area and duration for the various features as the 
membrane-cholesterol levels are changed (Fig. 2.10). Most surprisingly, these changes in 
duration and area are seen in events that have set upper and lower limits for the amount of 
serotonin secreted, including partial fusion and kiss-and-run events. When comparing the average 
amount of serotonin secreted per ms during kiss-and-run events, there is no significant difference 
between cholesterol conditions (Fig. 2.11 A). This suggests that the cholesterol helps the pore 
stay open longer, but does not change the size of the pore, assuming that the serotonin diffusion 
characteristics are unchanged. Therefore, with the small standard deviation associated with each 
event type’s duration and amount of serotonin secreted and the fact that there is no difference in 
the rate of serotonin secretion between conditions, this suggests that all granules going through 
kiss-and-run will follow a similar pattern of secretion. In comparison, for partial fusion, there 
were no significant differences in rate of secretion, but a downward trend was noted as membrane 
cholesterol content increased (Fig. 2.11 B). This suggests that once the pore opens past the kiss-
and-run stage, it may not open as wide at higher cholesterol levels. However, due to the longer 
length of time it stays open, more serotonin is secreted which serves to make up for this decreased 
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rate of secretion. Finally, there is an apparent upward trend in percent occurrence for full fusion 
events and a corresponding apparent downward trend for partial fusion events as the conditions 
contribute to higher membrane cholesterol levels (Fig. 2.9). These trends can all be explained by 
the increased membrane rigidity due to the additional cholesterol. As previously hypothesized, an 
 
Figure 2.9 Relative frequency of each type of NTE with various cholesterol treatments.  
 
 
Figure 2.10 Area and duration of non-traditional events. A) Average area of each NTE 
type under the different cholesterol treatments.  B) Average duration of each NTE type under 
the different cholesterol treatments. *p≤ 0.05, **p≤0.01, ***p≤0.001 
 
Figure 2.11 Rate of release for kiss and run events (A) and partial fusion events (B). 
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increase in cholesterol would lead to longer inversion times for the phospholipids needing to 
change the curvature along the fusion pore, biasing towards full secretion events. 
2.5 Conclusion 
Close examination of the pre-foot and post-foot spike features from individual platelets with 
manipulated outer membrane cholesterol levels indicated a few styles of pore opening and 
closing. Pre-foot features tended to fall into two sub-categories: ramp-like and plateau-like, with 
the ramp occurring most frequently. There was a slight decrease in the occurrence of pre-foot 
features in cholesterol-depleted platelets, indicating that the pore opens more quickly at low 
cholesterol levels, bypassing the slower foot-inducing features. The post-foot features occurred 
fairly infrequently and had primarily re-opening characteristics. The most prevalent category of 
non-traditional secretion events showed an increase in frequency as the cholesterol content of the 
membrane increased. These events are characterized by an increase in the amount of serotonin 
secreted, increased duration of the pore opening, and a slowing in the opening of the pore. From 
these analyses, we conclude that as the cholesterol concentration in platelets is increased, the 
membrane-granule fusion curvature transitions are slowed due to increased rigidity, leading to a 
slower pore opening and closing.  
Even though the fusion pore dynamics of human platelets have not been studied directly with 
CFMA, it has been shown that platelets from other species (Chapter 4), in particular cow which 
has comparatively increased levels of cholesterol, demonstrate similar fusion pore dynamics as 
the rabbit platelets incubated with cholesterol. These included increased Trise and T1/2 times 
compared to rabbit platelets without cholesterol modification which are often associated with 
NTEs.
2,13
 In addition, since platelets are anucleate, the up- and down- regulation of proteins and 
receptors is limited, suggesting that the only difference between the conditions was the 
concentration of cholesterol. Therefore we believe these results, though they are measured in an 
animal system, can be generalized to human platelets and other cell types that undergo 
exocytosis. 
Human platelets have been shown to undergo changes in cholesterol membrane content due 
to various diseases, drugs, or pre-dispositions.
16,17
 In addition, platelets are known to increase 
cholesterol uptake in vitro when suspended in cholesterol-rich environments.
18
 Previous literature 
indicates that cholesterol plays a role in human platelet sensitivity, microtubule ring formation, 
and aggregate size due to cholesterol levels.
18,19
 Thus, it is likely that the results presented herein 
can inform understanding of human platelets and the diseases affecting them. 
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Chapter: 3 Stereochemistry- and Concentration-Dependent Effects of 
Phosphatidylserine Enrichment on Platelet Function 
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3.1 Overview 
Platelets use several forms of communication including exocytosis of three distinct granule 
populations, formation of bioactive lipid mediators, and shape change (allowing for adhesion). 
Typically known for their role in hemostasis, they can provide an excellent platform for studying 
the role of membrane components in cellular communication due to their ease of isolation, and 
anucleate nature, allowing limited up and downregulation of membrane components. In this 
chapter, the role of stereochemistry and concentration of phosphatidylserine (PS) on cell 
exocytosis will be studied. PS, most commonly found in the phosphatidyl-L-serine (L-PS) form, 
is exposed on the outer leaflet of the cell membrane, after the cell is activated, to communicate 
apoptosis to clearance cells. Knowledge about their impact is limited on other cell communication 
(particularly concentration and stereochemistry effects). This study found that platelets incubated 
in L-PS or phosphatidyl-D-serine (D-PS) are enriched to the same extent with their respective 
incubated PS. All levels of L-PS enrichment had an increase in platelet cholesterol, but only the 
50 μM D-PS incubation had an increase in cholesterol. The uptake of D-PS induced the secretion 
of granules and manufactured platelet activating factor (PAF) in otherwise unstimulated platelets. 
The uptake of L-PS had a greater impact on platelet stimulation by decreasing both the amount of 
δ-granule secretion and the amount of platelet activating factor (PAF) that is manufactured. 
3.2 Introduction 
Platelets are small (1-2 µm in diameter), circulating anuclear cell fragments that 
promote hemostasis by mediating the processes of clotting and angiogenesis. Although 
most widely known for their involvement in blood clot formation, they also play roles in 
inflammation and cancer malignancy. All of these actions are mediated by platelet 
secretion and adhesion, both of which are influenced by the platelet membrane 
composition.
1
 In addition to the importance of platelets in various physiological 
processes, the anuclear nature of platelets makes them an interesting platform for 
studying the role of membrane phospholipids in cell secretion and adhesion functions.  
Phosphatidylserine (PS) is a particularly important component of cellular membranes 
due to its critical role in the cell signaling cascades, in particular, those that lead to 
clearance of apoptotic cells. In most cells, phospholipids with an L-serine headgroup (L-
PS) compose 2-10% of the total phospholipid content, and until recently, it was thought 
that all naturally occurring PS phospholipids were L-PS.
2
 Recently, however, PS 
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containing a D-serine headgroup (D-PS) have been detected at quantities of 0.05 – 0.9% 
of the total PS content in rat tissues including cerebrum, heart, spleen, lung, testis, liver, 
and kidney,
2
 and it is not clear if the biological roles of L-PS and D-PS are identical. 
When cells are unactivated, L-PS is localized to the inner leaflet of the membrane while 
the localization of D-PS is unknown. Upon activation, aminotranslocase, which maintains 
L-PS in the inner leaflet, is down-regulated, inducing activation of lipid scramblase. This 
activation, in conjunction with the rapid influx of Ca
2+
, disrupts the phospholipid 
asymmetry, resulting in the exposure of L-PS to the outer leaflet of the membrane.
3-5
  The 
reorientation of L-PS to the outer leaflet of the platelet is important as L-PS exposure to 
the extracellular environment signals apoptosis to surrounding phagocytes.
6-12
 Several 
studies have also shown that the stereochemistry of the PS headgroup influences both the 
binding of cell signaling proteins and the clearance of apoptotic cells by phagocytes 
including macrophages, which only recognize L-PS.
13
 
These findings indicate that L-PS plays a larger role than D-PS on the stimulation of 
platelets decreasing the amount of serotonin secreted from δ-granules and the 
manufacturing of the lipid mediator PAF. D-PS, however, induces stimulation of the 
alpha, δ, and lysosome granules as well as the secretion of PAF in unactivated platelets. 
Finally, incubation with L-PS led to a greater increase in platelet cholesterol than 
incubation with D-PS. 
3.3 Experimental Approach 
3.3.1 Reagents 
Unless otherwise specified, all analytical grade reagents were purchased from Sigma-Aldrich. 
The α-D-(+)-glucose was purchased from Acros Organics (Fair Lawn, NJ), PAF and PAF-d4 
standards were purchased from Cayman Chemical (Ann Arbor, MI), and the L-α-
phosphatidylserine (product #840032C) and 1,2-dioleoyl-sn-Glycero-3-Phospho-D-serine 
(product #79098) were purchased from Avanti Polar Lipids (Alabaster, AL). For UPLC-MS/MS, 
LC/MS-grade H2O and acetonitrile (ACN) were purchased from J.T. Baker (Center Valley, PA). 
LC/MS-grade isopropyl alcohol (IPA), Na2CO3, and citric acid were purchased from Fisher 
Scientific 
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3.3.2 Platelet Isolation 
Male C57BL/6J mice were purchased at 9 weeks old from The Jackson Laboratory, 
euthanized via CO2 asphyxiation (according to IACUC-approved protocol #0806A37663), and 
blood was drawn via cardiac puncture using syringes pre-filled with 200 μL ACD. For all 
experiments, platelets were isolated by centrifuging whole blood for 10 min at 130 RCF with no 
brake, transferring the plasma layer to fresh tubes, diluting the plasma layers 6:1 with ACD, and 
pelleting the platelets at 524 RCF. 
3.3.3 Phospholipid Incubation 
Following isolation, platelets were incubated for 2 hrs with 10, 50, or 100 μM L-PS (Fig. 
3.1A) or D-PS (Fig. 3.1B) prepared in Tyrode’s buffer. To avoid solubility inconsistencies, 200 
μM solutions of L-PS or D-PS stock solutions were prepared as described previously15 and 
diluted as needed for incubations with different L-PS or D-PS concentrations. Briefly, solutions 
were prepared by evaporating the chloroform from appropriate volumes of the phospholipid 
solutions with a gentle stream of nitrogen, stirring overnight in Tyrode’s buffer, then filtering 
with 0.2 μm filters.  
All assessments of L-PS and D-PS enrichment, cholesterol content, and platelet secretory 
function were normalized to pelleted platelet protein content, which was quantified using a Pierce 
bicinchoninic acid (BCA) assay kit from Thermo Scientific (Rockford, IL). Where possible, 
measured values of secreted mediators were normalized to the pelleted protein content of 
individual replicates; when this was not possible, pelleted protein values represent the average of 
four biological replicates. 
3.3.4 UPLC-MS/MS Assessment of Relative L-PS and D-PS Enrichment 
Enrichment of L-PS and D-PS in platelet membranes was assessed using a Waters Acquity 
UPLC system in tandem with a Waters triple quadrupole mass spectrometer using a previously 
 
Figure 3.1 Structure of L-PS (A) and D-PS (B). Structures provided by Avanti Polar 
Lipids 
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reported method
15
 modified to include transitions for D-PS. Details of the UPLC method can be 
found in Koseoglu, et al. Briefly, aqueous mobile phase A was 20 mM ammonium acetate at pH 
5, organic mobile phase B was 90/10 ACN/IPA with 0.1% acetic acid, and a Waters BEH C8 2.1 
x 100 mm column at 60°C was used. Multiple reaction monitoring was used for mass 
spectrometric detection of the phospholipids: transitions monitored for L-PS, and D-PS can be 
found in Table 3.1. PAF-d4, with a transition from 524.4 > 184.1, was used as an internal 
standard. L-PS and D-PS were isolated from PRP after platelets incubated with the phospholipids 
were washed three times via centrifugation at 1000 RCF and resuspended in 4:1 Tyrode’s 
buffer:ACD. After the final centrifugation step, platelets suspended in 100 µL Tyrode’s buffer 
were sonicated with 400 µL chloroform and 200 µL methanol for 20 min, then sonicated for 10 
more min following the addition of 100 µL 0.1% acetic acid in 0.1 M NaCl. Samples were 
centrifuged for 5 min at 1500 RCF, the upper aqueous layers were discarded, and the lower 
organic layers were dried under vacuum. Samples were resuspended by sonication in 40/60 A/B 
and analyzed by UPLC-MS/MS. Using a calibration curve prepared exactly as the platelet 
samples, relative L-PS and D-PS concentrations were acquired for each sample. To account for 
differences in platelet pelleting that could arise from increased phosphatidylserine content, L-PS 
and D-PS values were normalized to pelleted protein content for each platelet incubation 
condition. Statistical differences between experimental conditions were assessed using one-way 
ANOVA.  
3.3.5 Cholesterol Content of Platelets Enriched With L-PS and D-PS 
The cholesterol content of platelets was assessed using an Amplex® Red cholesterol assay kit 
from Life Technologies (Grand Island, NY) as directed. Statistical differences between 
experimental conditions were assessed using one-way ANOVA 
3.3.6 Ensemble Measurements of Platelet Granule Secretary Function 
After incubation with either L-PS or D-PS, platelets were washed and incubated with either 
PBS buffer (control) or PBS containing 1.25 U/mL thrombin (activated). After 5 min of 
incubation, ACD was added for a final volume of 1:4 ACD: PBS and centrifuged at 1,000 RCF 
for 10 min to pellet the platelets. Supernatants were collected and analyzed for the presence of 
granule-specific secreted species and de novo manufactured bioactive lipids. Secretion of δ-
granules in a bulk suspension of platelets was assessed using an Agilent HPLC coupled to a 
Waters electrochemical detector as described previously.
15,16
 Supernatants analyzed for serotonin 
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were collected both after the wash step, to assess whether incubation with L-PS or D-PS induced 
platelet activation, and after stimulation with either PBS or thrombin, to assess the effects of L-PS 
and D-PS on δ-granule secretion. Dopamine served as an internal standard for serotonin 
detection. For all ensemble measurements, statistical differences between experimental conditions 
were assessed using one-way ANOVA. 
Lysosome secretion from platelets was assessed using an absorbance assay for β-
hexosaminidase (β-Hex), a lysosome-stored enzyme as described previously.14,15,17 Absorbances 
from L-PS- and D-PS-treated platelets were normalized to the absorbance of control platelets. 
Secretion of α-granules was assessed using an enzyme-linked immunoassay kit for platelet factor 
4 (PF4) purchased from R&D Systems (Minneapolis, MN) and used as directed. 
Platelet secretion of PAF, a de novo manufactured bioactive lipid, was assessed using a 
modified version of a previously described UPLC-MS/MS method.
14,15
 Although previous studies 
have focused on the detection of PAF-C16, this work focuses on the detection of PAF-C14. Due 
to the lack of available internal standards for PAF-C14, PAF-C16-d4 was used as an internal 
standard. 
3.3.7 Microfluidic Assessment of Platelet Adhesion Behavior 
The microfluidic device used in this study is fabricated using standard soft lithography 
techniques, and the detailed procedure can be found in a previously published paper.
18
 Briefly, a 
simple straight channel design was printed onto a transparent film (Cad/Art Service Inc.) and 
transferred onto a 5” x 5” blank chrome mask plate (Nanofilm). For the master copy, a silicon 
wafer was spin-coated with SU-8 photoresist (Microchem), and the device design was transferred 
onto the baked SU-8 silicon wafer with the previously completed mask. Once developed, a 
mixture of 10:1 PDMS monomer:curing agent (Ellsworth Adhesives, Germantown, WI) was cast 
onto the SU-8 master and cured overnight at 75 ℃. The cured PDMS layer is peeled, cut, and 
punched for the inlet and outlet holes, and then bound to a clean glass substrate via oxygen 
plasma treatment. Once completed, the device was brought into a biosafety hood and the channels 
were washed three times with 70 % ethanol solution in sterilized MilliQ water (Millipore) for 
device sterilization. Washed devices were dried and kept in the biosafety hood until use. The 
channel dimensions were 450μm (width) x 100μm (height) x 2500μm (length). 
A human endothelial cell line (Hy926, ATCC) was used to establish a confluent layer of 
endothelial cells in the microfluidic channels. The endothelial cells were cultured in Dulbecco’s 
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Modified Eagle Medium (DMEM) with high glucose media (4mM L-glutamine, 4.5g/L L-
glucose, and 1.5g/L sodium pyruvate (Gibco
®
)) supplemented with 10% fetal bovine serum and 
1% penicillin and streptomycin (Sigma Aldrich). Conventional T-flask culture at 5% CO2 and 
37℃ was maintained with an every other day feeding schedule and a once a week splitting 
schedule. Herein, endothelial cells were only used between the fifth and eighth passages.  
A 250 μg/mL human fibronectin solution was introduced into microfluidic channels for 30 
minutes ahead of endothelial cells to facilitate endothelial cell adhesion onto the microfluidic 
channel surface. In parallel, endothelial cells in a T-flask were trypsinized, washed, and re-
suspended into the same culture media at a cell density of ~10
7
 cells/mL. After exchanging the 
media in the microfluidic channel with endothelial cell culture media, 20 μL of the cell 
suspension was injected through the channel, kept in an incubator for an hour, and washed with 
the endothelial cell culture media. Finally, 20 μL of the cell suspension was injected through the 
channel, incubated for another hour, and washed with the culture media again. The devices were 
kept in an incubator until use with a 12 hour feeding schedule. After 1-2 days, a confluent 
monolayer of endothelial cells was established; devices that did not establish uniform layers of 
endothelial cells were discarded after visual inspection.  
After platelets had been incubated with L-PS, D-PS, or Tyrode’s buffer, they were labeled 
with 5-chloromethylfluorescein diacetate (CMFDA) dye to facilitate their visualization (2 μM, 20 
minutes). The labeled platelets were split into two populations - one of these populations was 
treated with 5µM ADP to activate them and the other was the same volume of Tyrode’s buffer as 
an unactivated control. As ADP activation may cause significant platelet aggregation before 
introduction onto the microfluidic device, incubation was avoided and preparation of endothelial 
cell-coated microfluidic devices (washing channels with Tyrode’s buffer) was done in parallel. 
Both platelet suspensions, activated by ADP or unactivated, were then introduced into the 
microfluidic channels at the flow rate of 30 μL/hour, where minimal shear-induced platelet and 
endothelial cell activation is expected, for 20 minutes. After exposure of platelet suspension to the 
endothelial cell layer, the microfluidic channels were washed with Tyrode’s buffer and devices 
were brought to the microscope stage for fluorescence imaging (Nikon microscope with 
QuantEM Photometrics CCD camera) Metamorph Ver. 7.7.5 was used as the imaging and 
analysis software. Statistical differences between experimental conditions were assessed using 
student’s t-test. 
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3.4 Results and Discussion 
3.4.1 L-PS and D-PS Platelet Enrichment 
Enrichment of L-PS and D-PS in platelet membranes was evaluated using UPLC-MS/MS 
following incubation of platelets with 10, 50, or 100 µM solutions of each phospholipid, and 
results of the enrichment are shown in Fig. 3.2 A and B and detailed in Table 3.1. Using UPLC-
MS/MS to determine relative enrichment offers several advantages to the analytical challenge of 
phospholipid detection. Selective reaction monitoring (SRM) enables the detection of specific 
mass transitions, which were set to the primary components of each L-PS and D-PS standard 
rather than blanket detection  all of the phosphatidylserine compounds in the membrane. A D-PS 
standard was selected that differed from the primary component of the L-PS standard by 2 mass 
units, or one unit of unsaturation, which enabled chromatographic separation of the two 
compounds, as shown in Fig. 3.2D. To evaluate platelet uptake of L-PS and D-PS, the 
concentration of L-PS in control platelets (not exposed to L-PS or D-PS) was normalized to 
100%, and concentrations of L-PS and D-PS were calculated as the percent enrichment of the L-
PS in control platelets. Comparing both phosphatidylserine species to the same levels of L-PS in 
control platelets enables a comparison of the abilities of the platelets to take up each of the 
phosphatidylserine species. 
Platelets demonstrated significant uptake of both L-PS and D-PS at all incubation 
concentrations examined, and the uptake of D-PS and L-PS at each incubation concentration were 
not statistically different from one another (p > 0.05 using one-way ANOVA), i.e. incubation 
with 10 µM L-PS produced the same percent enrichment of total PS as the 10 µM D-PS. This 
indicates that platelets were enriched to a similar degree with either L-PS or D-PS, and if any 
differences are observed between the L-PS and D-PS at the same incubation concentration (10, 
50, or 100 µM), are likely due to the stereochemistry of the head group. 
3.4.2 Effects of L-PS and D-PS Enrichment on Platelet Cholesterol Content 
Previous studies regarding the interaction between cholesterol and phosphatidylserine have 
generally been made using model membrane systems. The work of Wachtel and colleagues 
demonstrated that the solubility of cholesterol in membranes containing phosphatidylserine 
decreases as the molar ratio of phosphatidylserine increases. As such, it was hypothesized that 
increasing the phosphatidylserine content of the platelet membrane would expel cholesterol, thus 
decreasing the cholesterol content of the pelleted platelets and increasing the cholesterol content 
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of the supernatants, as compared to control platelets. This change in membrane cholesterol level 
may also have significant impact on critical cell functions such as exocytotic delivery of chemical 
messengers. 
 
 
 
Incubation Condition L-PS D-PS 
Transition used for relative quantitation 812.5 > 208 810.5 > 208 
Instrumental Precision (RSD) 6.97 7.74 
Biological Precision (RSD) 13.7 15.7 
Average Percent increase ± SD
a
 upon 
10 µM incubation for 2 hours 
345 ± 106 279 ± 91 
Average Percent increase ± SD
a
 50 µM 
incubation for 2 hours 
575 ± 68 638 ± 98 
Average Percent increase ± SD
a
 100 
µM incubation for 2 hours 
730 ± 76 749 ± 94 
Table 3.1 Relative enrichment of L-PS and D-PS in platelet membranes. 
a
Percent increase is 
reported as the percent increase over the nmol PS/µg pelleted protein, as the amount of D-PS 
present in control platelets was much lower than the D-PS detected in platelets incubated with D-
PS. The enrichment of D-PS as a percentage of D-PS content of control platelets was 2350 ± 767 
for platelets incubated with 10 µM D-PS, 5370 ± 822 for platelets incubated with 50 µM D-PS, 
and 6300 ± 625 for platelets incubated with 100 µM D-PS. 
 
Cholesterol is integral to cell membrane function, and the interaction between cholesterol and 
phosphatidylserine, examined in a variety of model membranes and monolayers, is clearly 
important in regulating the structure, fluidity, and function of the cellular membrane.
19
 To 
determine whether L-PS or D-PS enrichment induces the expulsion of cholesterol from the 
platelet membrane, the cholesterol content of the both the pelleted platelets and the supernatants 
following incubation with L-PS and D-PS were evaluated. Incubation with either D-PS or L-PS 
induced an increase in platelet cholesterol content (Fig. 3.2C), but the cholesterol levels in the 
supernatant were not significantly different from the cholesterol per protein content of the 
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incubation supernatants of control platelets. As Fig. 3.2C shows, the increase in platelet 
cholesterol content is higher following enrichment with 50 µM L-PS than 10 µM L-PS (p = 
0.004) and with 50 µM D-PS than with 10 µM D-PS (p = 0.0001). Additionally, 
the increase in cholesterol content following phospholipid incubation was higher with L-PS than 
with D-PS (p = 0.0003 for 10 μM incubations and p < 0.0001 for 50 µM incubations). 
The results of this study have demonstrated the opposite of the expected effect, indicating that 
either complexity of the platelet membrane affects the solubility of cholesterol in 
phosphatidylserine-containing membranes or cholesterol is expelled from the membrane but 
remains membrane-associated. Additionally, platelets were enriched to the same degree with 
either L-PS or D-PS, but the different forms of phosphatidylserine resulted in different levels of 
 
Figure 3.2 Determination of D-PS, L-PS, and cholesterol oncentration. Percent enrichment 
of A. D-PS and B. L-PS. The cholesterol content of platelets, C, after incubation with either 
D-PS or L-PS. D. Chromatograms of L-PS (top) and D-PS (bottom). *p ≤ 0.05, **p < 0.01, 
***p < 0.001, ****p < 0.0001 vs. indicated condition using one-way ANOVA. ǂ p ≤ 0.05, ǂ ǂ ǂ 
ǂ p < 0.0001 vs. cholesterol control using one-way ANOVA. Error bars represent mean ± 
standard deviation. 
  43 
cholesterol content. There are several possible explanations for this effect. Within a phospholipid 
membrane, it has been shown that cholesterol, like phospholipids, is asymmetrically distributed in 
the membrane. Previous studies of cholesterol in phospholipid membranes support the theory that 
cholesterol exists within the membrane in two forms, both dissolved and crystalline. As 
cholesterol has been shown to have decreased solubility in phosphatidylserine, due to the 
increased hydrogen bonding around the negatively charged headgroup, it is possible that 
enriching platelets with phosphatidylserine results in the conversion of dissolved cholesterol to 
crystalline cholesterol. Another possibility is that the rigidity of phosphatidylserine decreases the 
solubility of cholesterol, which results in the conversion of cholesterol to its crystalline form.
19
 
When this occurs, the platelet would experience a shift in the equilibrium concentration of 
cholesterol and increase cholesterol production to compensate for the potentially decreased 
membrane stability induced by additional phosphatidylserine. The formation of cholesterol to a 
lesser degree in platelets incubated with D-PS may be a result of the extra unit of unsaturation; 
when in the membrane, a completely saturated tail will be relatively straight, allowing for tighter 
packing and interaction with the other tails, leading to extra rigidity. The extra unit of 
unsaturation in D-PS may cause the tail to deform, decreasing the extent to which the lipid tails 
can interact and pack, and, thus, increasing membrane fluidity. As shown in the work done by 
Wachtel and coworkers, this greater fluidity causes the solubility of lipid cholesterol to be 
increased, resulting in less crystallite formation and a smaller equilibrium shift in unactivated 
platelet cholesterol content.  
3.4.3 L-PS vs. D-PS Effects on Ensemble Secretion of Chemical Species 
To evaluate the effect of phosphatidylserine enrichment on platelet secretion, several 
ensemble measurements were used, including measurement of both stored and newly 
manufactured chemical messenger species. These measurements include de novo synthesis of 
PAF-C14, serotonin secretion from δ-granules, β-Hex secretion from lysosomes, and PF4 
secretion from α-granules.  
Effects of exposure to exogenous L-PS and D-PS on the secretion of the manufactured lipid, 
PAF-C14, from platelets are shown in Fig. 3. 3. Exposure of control platelets to 1.25 U/mL 
thrombin for 30 min induced increased secretion of PAF-C14 (p = 0.04 vs. control unactivated 
platelets), while thrombin activation did not induce a significant increase in PAF-C14 secretion 
from platelets enriched with either D-PS or L-PS at 10 or 50 μM, when compared to their 
unactivated counterparts. For enrichment at 10 μM D-PS, this is almost certainly due to the 
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significant increase in PAF-C14 secretion of unactivated platelets (p = 0.003 vs. control 
unactivated platelets). For platelets incubated with 50 μM D-PS and 10 μM L-PS, small but non-
significant increases in the PAF-C14 secretion of unactivated platelets and small but non-
significant decreases in the PAF-C14 secretion of thrombin-activated platelets likely contribute to 
the observation of no significant increases in PAF-C14 generation in response to thrombin. For 
platelets incubated with 50 μM L-PS, thrombin-activated secretion of PAF-C14 is completely 
attenuated (p = 0.04 vs. thrombin activated control platelets). This attenuation of PAF secretion is 
consistent with previous results for 100 μM L-PS incubation.  
Serotonin, one species stored in δ-granules, was used as a marker of platelet δ-granule 
secretion. The effects of D-PS and L-PS enrichment on platelet δ-granule secretion are shown in 
Fig. 3.4. At all enrichment levels of D-PS and L-PS, thrombin increased δ-granule secretion 
compared to their unactivated counterpart (p ≤ 0.05 for each thrombin-activated condition vs. 
unactivated platelets of the same enrichment condition). Unactivated platelets enriched with 10 or 
50 μM D-PS or with 50 μM L-PS demonstrated increased δ-granule secretion vs. control 
unactivated platelets (p < 0.05). Meanwhile, thrombin-activated platelets enriched with 50 μM D-
PS or 10 or 50 μM L-PS demonstrated decreased δ-granule secretion compared to thrombin 
activation of control platelets (p ≤ 0.05). The suppression of thrombin-stimulated δ-granule 
secretion was more pronounced with L-PS than with D-PS and more pronounced at 50 μM 
enrichment than 10 μM enrichment for both phosphatidylserine species. This effect is in contrast 
to the effects of D-PS and L-PS on δ-granule secretion of unactivated platelets, where both 10 and 
50 μM D-PS enrichment induced δ-granule secretion, but only 50 μM L-PS did. Furthermore, 50 
μM D-PS enrichment induced a greater degree of δ-granule secretion from unactivated platelets 
than enrichment with 50 μM L-PS (p = 0.04). Lysosome secretion was assessed using an 
absorbance assay for β-Hex, one lysosome-secreted species, and the effects of L-PS and D-PS 
enrichment can be found in Fig. 3.5. When exposed to thrombin, control platelets and platelets 
enriched with 10 μM D-PS induced increased secretion of β-Hex. Unactivated platelets enriched 
with 50 μM D-PS increased lysosome secretion, but exposure to thrombin did not further increase 
the secretion of lysosomes from platelets.  
The effects of L-PS and D-PS enrichment on thrombin-stimulated platelet secretion of α-
granules are shown in Fig. 3.6.  PF4 was not detected in unactivated platelet samples. In 
thrombin-activated platelets, enrichment with 50 μM D-PS induced a decrease in the secretion of 
α-granules (p = 0.03 vs. thrombin-activated control), but enrichment with L-PS or with 10 μM D-
PS did not affect thrombin-stimulated platelet secretion of α-granules.  
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Figure 3.4 Effects of L-PS and D-PS enrichment on platelet δ-granule secretion. *p ≤ 
0.05, **p < 0.01 vs. condition as indicated using one-way ANOVA. ǂp ≤ 0.05, ǂǂp< 0.01, 
ǂǂǂǂp< 0.0001 vs. Control (resting platelets) using one-way ANOVA. ⱡⱡp < 0.01, ⱡⱡⱡⱡp < 
0.0001 vs. Control-Thrombin using one-way ANOVA. 
 
Figure 3.3 Secretion of PAF-C14 from platelets enriched with L-PS and D-PS. **p ≤ 
0.01 using one-way ANOVA. ǂp≤ 0.05 vs. control platelets. 
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Figure 3.6 Thrombin-stimulated α-granule secretion of platelets enriched with D-
PS or L-PS. *p = 0.03; **p = 0.002, using one-way ANOVA. PF4 was not detected in 
resting platelet samples. 
 
Figure 3.5 Lysosome secretion of platelets enriched with D-PS or L-PS. **p < 0.01 vs. 
condition indicated; ǂp = 0.02 vs. Control resting platelets; #p = 0.04 vs. 10 μM D-PS 
enriched resting platelets using one-way ANOVA. 
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In general, enriching platelets with L-PS or D-PS suppresses the thrombin-stimulated 
secretion functions of platelets, while inducing granule secretion by unactivated platelets. In 
particular, in unactivated platelets, incubation with 10 μM D-PS induces the secretion of PAF-
C14 and δ-granules, and incubation with 50 μM D-PS induces the secretion of δ-granules and 
lysosomes. Incubation with 10 μM L-PS did not affect the secretory behavior of unactivated 
platelets, and incubation with 50 μM L-PS induced the secretion of δ-granules, albeit to a smaller 
extent than with 50 μM D-PS. These results indicate that the incorporation of D-PS into the 
platelet membrane activates the protein machinery responsible for exocytosis, while L-PS 
incorporation into the platelet membrane does not. L-PS enrichment, unlike D-PS enrichment, 
had a greater effect on thrombin- activated secretion of PAF-C14 and δ-granules secretion. While 
several studies have detected very small amounts of D-PS in brain and other tissues, clearly the 
effects of D-PS on platelets differ than from those of L-PS.  
When considering the effects of L-PS or D-PS on platelet secretion function, it is important to 
also consider the increase in cholesterol with both L-PS and D-PS enrichment. The data in Fig. 
3.2C indicate that the cholesterol remains associated with the platelets, although it is not known 
whether the membrane cholesterol is localized to the interior or exterior of the membrane.
19
 One 
potential reason for the increased effect of L-PS on thrombin activation of platelets could be that 
excess cholesterol can impact the number of thrombin receptors and affinity
20
. Previous research 
by Tandon et al., correlated the responsiveness of platelets to thrombin with varying level of 
cholesterol while monitoring the change in thrombin affinity and receptor expression. Their 
research indicates that the cholesterol levels correlate positively with the number of receptors, but 
negatively with the affinity of the receptor towards thrombin. However, as the cholesterol level 
increased, platelet response (aggregation and secretion of serotonin) became more sensitive to 
lower concentrations of thrombin.
20
 The concentration of thrombin (1.25 U/mL) used in this study 
is relatively high, compared to concentrations used to stimulate platelets naturally, therefore the 
response from platelets in each experimental condition should be similar at 1.25 U/mL. This 
suggests that the impact of cholesterol on thrombin receptors is not solely responsible for the 
decreased amount of secretion caused by thrombin stimulation of platelets incubated with L-PS. 
Another factor to keep in mind is cholesterol solubility in phosphatidylserine. The solubility 
depends on the saturation of the lipid tail as well as the charge of the headgroup, the differences 
between the effects of L-PS and D-PS on platelet secretory function could arise from the 
solubility of cholesterol in L-PS vs. D-PS. 
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3.4.4 Microfluidic Assessment of Adhesion 
In addition to the secretion behavior, anotherr critical  function of platelets exposed to L-PS 
or D-PS was explored – adhesion. The platelet adhesion ability, following incubation with L-PS 
or D-PS, was evaluated on a layer of endothelial cells using a microfluidic platform. Few studies 
are available regarding the relationship between membrane phospholipid content and platelet 
adhesion. However, in a recent study,
15
 Koseoglu , et al. found that L-PS enrichment in platelet 
plasma membranes resulted in reduced adhesion of platelets to endothelial cells, and this work 
expands on the effects of PS on platelet adhesion through exploring the relative effects of L-PS 
and D-PS. Experimental conditions herein are unactivated and ADP-activated platelets, and each 
has five sub-conditions of control (no pre-exposure to either L-PS or D-PS), pre-incubated with 
L-PS (10 μM or 50 μM), and pre-incubated with D-PS (10 μM or 50 μM). Platelet adhesion to the 
confluent endothelial cell layer in the microfluidic device was assessed simply by counting the 
number of fluorescent platelets present following introduction and rinsing.  
As shown in Fig. 3.7A, unactivated platelets showed decreased adhesion to the layer of 
endothelial cells when they were pre-incubated with either phosphatidylserine species. 
Interestingly, while L-PS did not show concentration dependence, unactivated platelets pre-
incubated with D-PS showed concentration-dependent adhesion; in fact, unactivated platelets pre-
incubated with 50 μM D-PS showed higher adhesion than any other phosphatidylserine-pre-
incubated platelets. In contrast, ADP activation of platelets incubated with 50 μM L-PS or 50 μM 
D-PS demonstrated that D-PS has less impact on activated platelet adhesion behavior. This 
concurs with the ensemble measurements made of thrombin-stimulated platelet chemical 
messenger secretion. Again, all PS-enriched platelets showed lower adhesion to endothelial cells 
than control platelets. These impacts of L-PS and D-PS on platelet adhesion could result from 
changes in the membrane curvature due to the added phosphatidylserine content in the platelet 
membrane. However, the results herein also suggests the possibility that decreased adhesion is 
due to the increased PS membrane content reducing platelet secretion of chemical messengers. 
This possibility will be of significant interest for future study. 
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3.5 Conclusion 
This work explored the effects of phosphatidylserine on platelet function by evaluating the 
effects of enriching platelets with either L-PS or D-PS. It was determined that incubation with 
either D-PS or L-PS results in the same degree of phosphatidylserine enrichment, and that the two 
stereochemical forms of phosphatidylserine have different effects on platelet secretory and 
adhesion function. Surprisingly, enrichment of both L-PS and D-PS increased the cholesterol 
content of the platelets, although the localization of the cholesterol in or around the platelet 
membrane is unknown. In general, platelet exposure to D-PS induces platelet activation in 
unactivated platelets while both L-PS and D-PS suppress thrombin-induced platelet secretory 
function, with a greater effect with L-PS than D-PS enrichment. Phosphatidylserine 
stereochemistry has implications in a broad range of biochemical processes including signaling 
apoptosis and binding of cell signaling proteins. This study demonstrates its effects on cellular 
function: while platelets take up L-PS and D-PS to the same degree, there are clear differences 
between the effects of L-PS and D-PS on secretion and adhesion behavior of both unactivated and 
activated platelets. 
  
 
Figure 3.7 Microfluidic assessment of A. resting and B. ADP-activated platelet 
adhesion in platelets enriched with D-PS or L-PS. **p < 0.01; ***p < 0.001 using and 
unpaired t-test. In both A and B, all L-PS and D-PS enriched conditions are significantly 
different from the control platelet adhesion (p < 0.0001 using an unpaired t-test).  
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4.1 Overview 
Platelet exocytosis is highly regulated in part by the granular/cellular membrane lipids and 
proteins. In addition some platelets contain a membrane-bound tube, called an open canalicular 
system (OCS), which assists in granular secretion events and increases the membrane surface area 
for greater spreading. In addition, variations in membrane composition can cause changes in 
platelet secretion. Since platelet studies use various animal models, it is important to understand 
how platelets differ in both their composition and granular secretion, in order to understand 
whether conclusions drawn from one model system can be combined with or will translate to 
another model system. Relative phospholipid composition of the platelets, with (mouse, rabbit) or 
without (cow) an OCS, was quantified using UPLC-MS/MS. Cholesterol and protein composition 
in the platelets was measured using Amplex Red and BCA Assays, respectively. TEM and dark 
field imaging were used to characterize platelet morphology. Finally, quantitative and dynamic 
granular secretion was monitored with single cell carbon-fiber microelectrode amperometry. The 
results show that cow platelets contain greater amounts of cholesterol and sphingomyelin then 
rabbit and mouse platelets. In addition, they yield greater serotonin secretion, longer δ-granule 
secretion times, and greater fusion pore stability. This increased stability could be due to extra 
sphingomyelin and cholesterol, the primary components of lipid rafts. Finally, they showed 
greater spreading area with a greater range of spread than OCS containing platelets. Platelets 
from different species that contain an OCS had similarities in their membrane composition and 
secretion kinetics, both distinct from cow platelets.  
4.2 Introduction 
Platelets are a crucial component in maintaining hemostasis through the secretion of three 
distinct secretory granule populations: α-granules, δ-granules, and lysosomes. Due to the unique 
anucleate nature of platelets, the exocytosis of these granules is regulated primarily by proteins, 
cholesterol, and phospholipids in both the overall platelet and granule membranes. Variations in 
the chemical composition of the membrane or granules have been linked to disorders including 
Wiskott-Aldrich syndrome, Scott syndrome, and giant platelet syndrome.
1-3
 As researchers have 
delved into these differences, a variety of platelets from different species have been used to study 
both the fundamental molecular mechanisms of platelet function as well as the role of platelets in 
the aforementioned diseases. Platelets isolated from different species often share common 
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features; however, there are both structural and functional differences that must be explored to 
fully understand whether conclusions drawn from one model system can be combined with or 
will translate to another.
4,5
 
Comparison of the structural differences among platelets from different species will help 
illuminate the roles of these cellular structures. Additionally, comparative studies of platelet 
function across species can yield information on various ways in which platelets from different 
species adjust to the presence or absence of a particular feature. One such cellular structure of 
interest is the open canalicular system (OCS), a tubular membrane-bound system whose role in 
platelet function is not fully understood. The OCS is rare in nucleated cells, and in platelets it is 
only found in select species including humans, mice, and rabbits while platelets from cows, 
camels, and horses lack an OCS. This structure has been shown to help localize granules within 
the cell for easier export of their contents and is involved in the activation-initiated change in 
platelet morphology widely known as spreading.
6-9
 
Due to the uniqueness of the OCS, several studies have examined species-dependent 
variations in OCS-related protein and receptor expression in platelets.
6,10 
However, there is still 
limited information on how non-OCS platelets maintain hemostasis comparable to platelets with 
an OCS, thus making it harder to pinpoint the function of the OCS.  This study focuses on how 
the membrane of the platelets with (mouse and rabbit) and without (cow) an OCS changes to 
enable normal platelet function, including measurement of phospholipid and cholesterol content 
while accounting for platelet sizes before and after activation. Insight into the spreading size and 
cholesterol content is important in this context because it will help test the hypotheses that (1) 
granules are involved in the spreading of platelets without a readily available OCS and (2) 
changes in membrane phospholipid content facilitates secretion of granule contents.  
To follow platelet secretion dynamics, this work uses carbon-fiber microelectrode 
amperometry (CFMA) to elucidate the δ-granule involvement and changes in granule secretion. 
Traditional studies of platelet secretion have used ensemble cell assays, which measure secretion 
from thousands to millions of platelets at a time. While useful, ensemble measurements of 
cellular function obscure subtleties that can be observed on a single cell level using CFMA with 
sub-ms time resolution. This enables detailed evaluation of the kinetics of the secretory process 
and allows distinction within a heterogeneous set of platelets. For these studies two stimulants, 
ionomycin (a calcium ionophore) and thrombin (a natural platelet stimulant in the body) were 
chosen to determine OCS-dependent differences in activation. Stimulation with ionomycin 
bypasses several relevant physiological steps in platelet activation that are present following 
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thrombin stimulation. Therefore, exploring differences between the two stimulants may reveal 
differences in secretion induced by changes in activation mechanisms rather than how the platelet 
interacts with the membrane or OCS during exocytosis. 
Ultimately, using complementary analytical techniques including CFMA, biological assays, 
imaging, and mass spectrometry, we were able to determine the importance of platelet cell 
structure, including the OCS and lipid concentration, on cell activation secretion kinetics and 
spreading. 
4.3 Experimental Approach 
4.3.1 Platelet Isolation 
Blood was collected according to protocols approved by the University of Minnesota IACUC 
(protocol numbers 0211712011 and 1105A99774). A mid-ear artery was used for rabbit blood 
draw to ethylenediamine tetraacetic acid (EDTA)-containing tubes. Mouse blood was collected 
via cardiac puncture following CO2 asphyxiation into syringes pre-filled with ACD. Cow blood 
was drawn from the tail into EDTA-coated tubes.  In all cases, blood was diluted by addition of 
Tyrode’s buffer (NaCl, 137 mM; KCl, 2.6 mM; MgCl2, 1.0 mM; D-glucose, 5.6 mM; N-2-
hydroxyethylpiperazine- N'-2-ethanesulfonic acid (HEPES) 5.0 mM; and NaHCO3, 12.1 mM 
with pH adjusted to 7.3) and centrifuged for 10 min at 500xg for rabbit and cow or 130xg for 
mouse platelets. The PRP (platelet rich plasma) layer was separated, and washed platelets were 
obtained following a second 10 min centrifugation step (750xg for rabbit and cow, 500xg for 
mouse platelets). Pelleted platelets were resuspended in Tyrode’s buffer to a final concentration 
of 1 x 10
7 
platelets/mL.  
3.3.2 CFMA Measurements 
Carbon-fiber microelectrodes were fabricated as previously described.
11-14
 Amperometry 
experiments were performed with an Axopatch 200B potentiostat (Molecular Devices, Inc., 
Sunnyvale, CA) using low-pass Bessel filtering (5 kHz), a sampling rate 20 kHz, and gain 
amplification of 20 mV/pA, all controlled by locally written LabVIEW software and National 
Instruments data acquisition boards. Platelets were visually monitored during experiments with an 
inverted microscope equipped with phase contrast optics (40X magnification) (Nikon 
Instruments, Melville, NY). A drop of platelet suspension was added to the poly-L-lysine-coated 
glass coverslips containing Tyrode’s buffer. As the platelets sedimented onto the coverslip, a 
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carbon-fiber microelectrode was placed on an individual platelet for measurement (Fig. 4.1A). A 
stimulant-filled fire-polished capillary with an average tapered diameter of 10 µm was also placed 
close to the platelet of interest. Upon delivery of a 3 s bolus of either 10 U/mL thrombin solution 
in Tyrode’s buffer or 10 µM ionomycin in Tyrode’s buffer supplemented with 2 mM Ca2+, the 
platelet under the microelectrode was activated. Serotonin secreted from platelet δ-granules was 
oxidized at the carbon-fiber microelectrode at a potential of 700 mV vs. Ag/AgCl reference 
electrode, and data were recorded for 90s.  Each amperometric trace obtained from single platelet 
secretion was filtered at 500 Hz, and spike by spike analysis was performed using Mini Analysis 
software. The sub-millisecond temporal resolution of the CFMA technique enables real-time 
analysis of serotonin secretion from individual platelet granules, each appearing as an individual 
current spike in the amperometric trace (Fig. 4.1C). The amount of serotonin secreted from a 
single granule is determined based on the area under the spike (Q= mFn; where Q is the charge, 
m is number of moles of serotonin, F is Faraday’s constant, and n is the number of electrons (2) 
transferred during serotonin oxidation). The kinetics of secretion are revealed based on the Trise 
and T1/2 values for each current spike, indicating the kinetics of transition from fusion pore to full 
 
Figure 4.1 CFMA experimental setup and representative spikes. (A) Representative 
setup for CFMA measurements. The CFM (on the right) is placed on a single platelet. 
The stimulation pipette (on the left) is placed close to the platelet. (B) Typical 
amperometric trace obtained from single platelet secretion. Each spike corresponds to a 
single δ-granule release event. The bar under the trace shows time and the duration of the 
stimulation. (C) The parameters that are analyzed for single secretion events. (D) 
Representative spikes from mouse, rabbit and cow platelet exocytosis upon ionomycin 
(black) and thrombin (gray) stimulations 
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fusion and kinetics of the total secretion event, respectively. Finally, the percentages of spikes 
with feet (a small amount of secretion before the spike) were counted as well. The percentage of 
spikes with foot features indicates the stability of the fusion pore opening. The number of 
platelets that were monitored per condition was 23 and 32 for mouse, 35 and 34 for rabbit, and 39 
and 22 for cow for ionomycin and thrombin stimulation, respectively. 
4.3.3 Bulk HPLC Analysis 
A similar bulk cell HPLC procedure was used as previously described.
15
 Briefly, platelets in 
the PRP were diluted to 5x10
7
 cells/mL in Tyrode’s buffer. 125 µL of the diluted PRP was plated 
into a Millipore 96 well Multi Screen HTS filter plate with a 0.45 µm pore and mixed with 125 
µL of either Tyrode’s buffer or Tyrode’s buffer containing stimulant to reach a final 
concentration of 10 µM ionomycin with 2 mM Ca
2+
 or 10 U/mL thrombin.  After a five minute 
stimulation, the supernatant was spun down at 3000xg for five minutes, and 180 µL of the 
supernatant was pipetted into a vial with 20 µL of 5 µM dopamine internal standard in 0.5 M 
perchloric acid. HPLC analysis was performed on an Agilent 1200 HPLC with an auto sampler 
containing a 5μm, 4.6 x 150mm C18 column (Eclipse XDB-C18) attached to a Waters 2465 
electrochemical detector with a glassy carbon-based electrode.  The working potential was set at 
700 mV vs. an in situ Ag/AgCl reference electrode with a current range up to 50 nA. The samples 
were separated on the HPLC column at a flow rate of 2 mL/min in an aqueous mobile phase 
mixture consisting of 11.6 mg/L of the surfactant sodium octyl sulfate, 170μL/L dibutylamine, 
55.8 mg/L Na2EDTA, 10% methanol, 203 mg/L anhydrous sodium acetate, 0.1 M citric acid, and 
120 mg/L sodium chloride. The ratio of serotonin to dopamine internal standard concentrations 
were then measured against a 5 point calibration curve made in advance using standard solutions 
of serotonin diluted in 0.5 M perchloric acid (ranging from 28 to 1000 nM serotonin). The 
standard solutions were supplemented with 0.5 µM dopamine internal standard. 
4.3.4 TEM Measurements 
TEM samples of cow and mouse platelets were prepared by two step fixation of the platelets 
first with 0.1% gluteraldehyde (15 min) followed by centrifugation to pellet and then with 3% 
gluteraldehyde (30 min) in White’s saline as has been previously described.16 After fixation, the 
cell pellet was exposed to 1% osmic acid at 4ºC for 1h. The platelet pellets were dehydrated 
slowly in a graded series of alcohol and embedded in Epon resin. Thin sections were obtained 
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with a diamond knife. Uranyl acetate was used for contrast enhancement. TEM images captured 
on a JEOL 1200EX at an accelerating voltage of 60 keV were analyzed using ImageJ software. 
4.3.5 CytoViva Scope Measurements  
Darkfield scattering images were captured using an Olympus microscope from CytoViva 
(Auburn, Al) with an UplanFLM 100 x oil immersion objective and Dage XL camera. To prepare 
the slides, 4    of PRP were placed in the center of a cover slide. Gently, a coverslip was placed 
on top and sealed with clear nail polish. The un-activated platelets were imaged within 5-10 min 
of being placed on the cover slip. The activated platelets were given 1.5 hours to activate on the 
coverslip before being imaged. The perimeter of the platelets was analyzed using ImageJ 
software.  
4.3.6 Platelet Cholesterol and BCA Assay 
Platelet concentration was calculated with a hemocytometer to ensure similar platelet counts 
between species. 250 μL aliquots were put into a 1.7 mL microcentrifuge tube and spun down at 
1000 xg to pellet the platelets; the supernatant was removed, and the pellets were then used to 
measure cholesterol and total protein content.  
Cholesterol levels were determined with an Amplex Red Assay from Life Technologies 
(Carlsbad, Ca) as directed. Briefly, the pellet was mechanically homogenized to expose the 
cholesterol to cholesterol oxidase. Hydrogen peroxide was produced in situ and exposed to 
Amplex Red to form resorufin. The resorufin absorbance at 571 nm was detected using a BioTek 
Synergy 2 96 well plate reader, and a calibration curve was used to convert absorption intensity 
into concentration. 
The protein content was quantified using a Pierce BCA Protein Assay kit from Thermo 
Scientific (Rockford IL) as directed. Briefly, a working reagent was prepared by mixing 50 parts 
of BCA Reagent A and 1 part BCA Reagent B. The PRP pellet was resuspended into 25 μL of 
mammalian protein extraction reagent, and 200 μL of working reagent was added to solution. 
After 30 min of incubation, the absorbance was measured at 562 nm on a BioTek Synergy 2 96 
well plate reader and converted to a concentration using a calibration curve. 
4.3.7 Plasma Cholesterol Assay 
750 µL of whole blood from each species and 500 µL of Tyrodes buffer was alliquoted into 
1.7 mL ependorf tubes. The blood was centrifuged down at 200 xg for 10 min with minimal 
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braking. The plasma layer was removed and re-centrifuged at 1200 xg to remove remaining cells. 
200 µL of plasma and 50 µL of the 1x reaction buffer included in the Amplex Red Assay kit 
(described above) were alliquoted into ependorf tubes. 50 µL was then placed into a 96 well plate 
for a total of 5 replicates per specie. Finally, 50 µL of working solution was added to each well 
and the reaction was left to proceed for 30 min, at which time fluorescence was measured. 
4.3.8 Aggregation Assay 
Aggregation experiments were performed on a Chrono-Log Whole Blood Lumi 
aggregometer interfaced with Aggro/Link software. The platelets were concentrated at  4 x 10
7
 
platelets mL
-1
.  500 µL of platelet suspension was alliqoted into glass vials with a magnetic stir 
bar and placed in the aggregometer with a Tyrodes buffer blank.  Once the recorded absorbance 
was stable at 100%, 20 µL of thrombin was added for a final concentration of 9.7 units mL
-1
 
Thrombin. The aggregation was monitored until the absorbance levels stabilized. Three biological 
replicates were performed. The data was plotted and statistically analyzed in Graph Pad Prism.  
4.3.9 Relative Quantitation of Selected Phospholipids using UPLC-MS/MS 
The relative concentrations of selected platelet phospholipids were determined through a 
previously published ultra-performance liquid chromatography-tandem mass spectrometric 
(UPLC-MS/MS) method. Briefly, platelet concentrations were determined using a 
hemocytometer, and samples were diluted to ensure approximately the same platelet 
concentration for each species. PRP was aliquoted into glass tubes, and a modified Bligh & Dyer 
extraction was performed to obtain phospholipids. PRP samples were suspended in Tyrode’s 
buffer and mixed with 400 μL chloroform/200 μL methanol. As an internal standard, 10 μL of 
19.1 μM deuterated platelet activating factor (PAF)-d4 (Cayman Chemical, Ann Arbor, MI) was 
added to the extraction mixtures, and PRP samples were sonicated for 20 min. Following 
sonication, 100 μL of 0.1% acetic acid in 0.1 M NaCl was added to the samples, and they were 
sonicated again for 10 min and centrifuged for 5 min at 1500 xg for separation of the organic and 
water layer. The organic layer was retained and dried under vacuum. Finally, the sample was 
resuspended in 40/60 A/B with 0.1% acetic acid mobile phase where A was 20 mM ammonium 
acetate (pH 5) and B is 90/10 acetonitrile/acetone. 
For UPLC-MS/MS relative quantitation of the selected phospholipid species, a calibration 
curve was prepared from solutions composed of phosphatidyl-L-serine (PS), sphingomyelin 
(SM), phosphatidylethanolamine (PE), and phosphatidylcholine (PC) from Avanti Polar Lipids 
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(Alabaster Al) and PAF-d4 internal standard. Calibration solutions were prepared without 
platelets and subjected to the same extraction procedure as PRP.
17
 The samples and calibration 
curve were run on a Waters Acquity UPLC-MS/MS system in tandem with a Waters triple 
quadrupole mass spectrometer as previously described.
17
 A modified version of chromatography 
suggested by Rainville and Plumb was used with a Waters BEH C8 2.1x100 mm column, and 
chromatography conditions as well as electrospray ionization mass spectrometry parameters can 
be found in Koseoglu, 2014.
17,18
 
4.4 Results and Discussion 
4.4.1 Comparison of Lipid and Protein Content 
Phospholipids, the primary component in cell membranes and granules, are important for 
maintenance of both the structure and function of cells. Upon exocytosis, lipids assist in 
localizing and activating the proteins needed to fuse granules and help change the rigidity of the 
fusion pore.
19
 Even without proteins, manufactured lipid cells have been shown to mimic regular 
fusion.
20
 In addition, significant variation in kinetics and secretion among different cell types with 
varying phospholipid concentrations suggest that the phospholipids facilitate and enhance fusion 
Phospholipid Rabbit (%) Mouse (%) Cow (%) 
Instrumental 
Precision 
(RSD) 
Percent of PC compared to 
mouse PC (RSD) 
14.2 ± 7.1 ** 
100.0 ± 
12.3 
344.6 ± 13.3 
***  
8.6 
Percent of PS compared to 
mouse PS (RSD) 
101.3 ± 27.8 100.0 ± 4.7 
181.8 ± 8.1 
**** 
20.5 
Percent of PE compared to 
mouse PE (RSD) 
84.2 ± 24.7 
100.0 ± 
20.7 
104.2 ± 17.8 12.3 
Percent of SM compared to 
mouse SM (RSD) 
109.1 ± 7.7 
100.0 ± 
11.6 
1065.6 ± 15.6 
**** 
4.1 
Table 4.1 Relative concentration of phospholipids compared to mouse.
+ 
+ 
Platelet concentrations for each of the three species were counted with a hemocytomer and 
diluted to the same concentration to ensure a similar number of platelets in each sample. All 
the data collected was then normalized to the mouse data. ** p<0.01 vs. the respective mouse 
phospholipid, **** p<0.0001 vs. the respective mouse phospholipid using one way ANOVA. 
Rabbit is also significantly (p<0.0001) different from cow for PC, PS, and SM. There is no 
difference between the three species for PE. 
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and exocytosis.
19,20
 Due to their impact on exocytosis, the concentration of the four most common 
cell phospholipids, PC, PS, PE, and SM, were quantified then compared to the percent of each 
specific phospholipid in mouse platelets in Table 4.1. All phospholipid data are compared to 
mouse platelets, both because mice are the typical model organism and because the phospholipid 
standards contained a mixture of a primary phospholipid component as well as the presence of 
other tail lengths. In addition, the instrumental precision was calculated for each phospholipid. 
Comparison across the different species show a significant increase in phospholipid concentration 
for cows compared to an approximately equal number of mouse platelets for PS, PC, and SM. In 
particular, the PC and SM concentrations, two phospholipids known to be mainly located in the 
outer leaflet of the platelet membrane, have increased concentrations, approximately 3 to 10 fold 
more than mouse. By contrast, PS and PE, primarily inner leaflet phospholipids in unactivated 
platelets, show much smaller differences. The differences between mouse and rabbit (both which 
contain OCS) can only be seen in the concentration of PC, which is significantly smaller for 
rabbit. 
Cholesterol is another ubiquitous lipid species in cell membranes, with critical importance in 
membrane fluidity and curvature. Cholesterol regulates the spatial distribution of not only 
membrane phospholipids but the SNARE proteins involved in secretory events.
14,20,21
 Platelets 
incubated in or depleted of cholesterol have shown significant variations in secretion kinetics, 
 
Figure 4.2 Platelet protein and cholesterol content. (A) Total % protein content for 
the same number of platelets compared to the total protein content of mouse platelets. 
(B) % ratio of the amount of cholesterol to the total protein content of platelets from 
each species compared to the mouse cholesterol ratio. Error bars are SD. For 
significance testing, one way ANOVA was used * for p<0.05, ** for p<0.015, **** for 
p<0.0001 
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with platelets containing more cholesterol showing greater secretion times and more foot events.
14
 
Due to the role cholesterol plays in fusion pore stability, determining the cholesterol 
concentration may help explain some of the kinetic differences among species’ granule secretion. 
In addition to cholesterol content, it is important to understand the total protein to cholesterol 
content ratio because in studies where the ratios of lipids to proteins were varied, differences in 
lipid mixing during fusion were noted. In particular, SNARE proteins were studied and were 
shown to cause leakage and greater cell lysis as the ratio of proteins to lipids rose.
20,22
 The total 
protein content and cholesterol to protein ratio in each species is shown in Fig. 4.2A and Fig. 
4.2B, respectively. Relative to mouse protein content, rabbit only contained 77.7 ± 9.0% and cow 
contained 690.4 ± 1.8% total protein. However, when comparing the cholesterol to protein ratio, 
the amount of cholesterol located in cow platelets is balanced out by the high concentration of 
protein compared to mouse giving 129.0 ± 15.7% µg cholesterol/µg protein cow to the 100.0 ± 
39.2 % µg cholesterol/ µg protein mouse. The rabbit cholesterol level was much lower than the 
protein level ratio only giving 30.7 ± 41.9 % µg cholesterol/µg protein compared to mouse. The 
concentration of cholesterol in platelets is not related to the amount found in the plasma of each 
species. Compared to mouse plasma, rabbit and cow plasma only contained 83 ± 4 % and 82 ± 
6% of the total amount of cholesterol, respectively (Fig. 4.3). 
 
Figure 4.3 Concentration of cholesterol in the plasma of each animal compared to 
mouse plasma. Error bars given in SD and significance was determined using one way 
ANOVA. *** p<0.001 
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4.4.2 Platelet Perimeter 
 
Due to the variance of phospholipids, cholesterol, and protein in each of the species’ platelets, 
it is important to determine if these differences are correlated to platelet size.  In addition, the 
OCS has been hypothesized to be involved in platelet spreading, thus the spreading perimeter will 
allow us to understand how having an OCS may change the size of activated platelets. The size of 
the platelets was measured on both unactivated (TEM) (Fig. 4.4 A and B) and activated 
(CytoViva scope) platelets (Fig. 4.4 C and D) by measuring the perimeter of platelets from each 
species. The distribution of the unactivated perimeter size for each of the three species has a span 
of approximately 5.5 to 10 µm with average perimeters and standard deviation of 7.06 ± 1.17 µm 
for rabbit, 8.58 ± 1.71 µm for mouse, and 7.57 ± 1.74 µm for cow (n=125, 91, and 79, 
respectively). 
 
Figure 4.4 Activated and Unactivated platelet perimeter. Comparison of the platelet 
perimeter measured with Image J using TEM images for the unactivated platelets and 
darkfield microscopy images for activated platelets. Histogram of the perimeter of the 
unactivated platelets (A) and activated platelets (C) from each species showing the 
distribution of perimeters. The average perimeter is also shown for unactivated platelets 
(B) and activated platelets (D). Cow platelets show very little difference in their spread 
of perimeters and are approximately the same size as rabbit platelets when resting. 
However, upon activation, cow platelets have a wide spread and are significantly bigger 
than both mouse and rabbit. Significance was determined using one way ANOVA **** 
for p<0.0001. Error bars shown are SD. 
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Figure 4.5 Platelet images. (A,D) rabbit, (B,E) mouse, and (C,F) cow images taken using TEM 
(A,B,C) and dark field microscopy (D,E,F). Rabbit TEM image taken by Emily Woo 
 
Figure 4.6 Normalized aggregation data for each species from time of thrombin 
infusion. Each plot contains three aggregation trials. The slope for the line of best fit for 
each data set was determined from the time of infusion until the absorbance value 
stabilized. These slopes were determined using Graphpad Prism software with the value 
of the combined slopes being   -0.3222 for rabbit, -0.1610 for mouse, and -0.3731 for 
cow. The three slope values are statistically different from one another (p≤0.0001 using 
linear regression analysis in Graph Pad Prism) 
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Upon activation, the distance between the range of the total perimeter size increased. The 
majority of rabbit and mouse platelets had a range difference of 29.9 and 30.5µm respectively, 
while the majority of cow platelets had a span of 60.6 µm from the shortest to the longest 
perimeter of the platelets measured (Fig. 4.4C).The average spreading perimeter and standard 
deviation (Fig. 4.4D) for rabbit, mouse, and cow were 16.39 ± 4.07, 21.14 ± 5.81, 35.49± 13.72 
µm, respectively. The activated shape of the platelets also varied between OCS and non-OCS 
species, with cow platelets creating a larger spread out square center with longer lamellipodia 
than either rabbit or mouse platelets. The rabbit platelets had shorter lamellipodia than either cow 
or mouse, but still maintained a similar center ellipse shape. Representative images of each of the 
species’ unactivated and activated platelet structures can be seen in Fig. 4.5 A-C and D-F, 
respectively. In addition to spreading on a coverslip, the aggregation of platelets in suspension 
upon activation with 9.7 U/mL thrombin was monitored using an aggrogometer (Fig. 4.6). Each 
species aggregated various amounts with a 74 ± 8 %, 82 ± 4 %, and 90 ± 4 % change in 
absorption for rabbit, mouse, and cow, respectively. 
4.4.3 CFMA General Spike Shape Analysis 
δ-granule secretion upon exposure to two different agonists was evaluated by CFMA to 
determine effects caused by stimulation method vs. membrane structure. Fig 4.1D shows 
representative spikes corresponding to single secretion events upon thrombin (10 U/mL) or 
ionomycin (10 µM) stimulation of platelets isolated from different species. Although a numerical 
analysis of amperometric data is always needed, sometimes the shape of the representative spikes 
can reveal a lot about the amount and the kinetics of the secretion events. Except the mouse 
platelet, the spikes resulting from ionomycin and thrombin stimulation looked almost identical 
within the same species. Compared to the ionomycin stimulation spike, the representative spike 
for the thrombin-induced mouse platelet secretion is wider and shorter, indicating different 
secretion behavior that will be discussed later in detail. The representative spikes for cow 
platelets are both wider and larger than that of mouse and rabbit spikes. This indicates a slower 
but larger amount of serotonin secretion that will also be discussed below in detail. 
4.4.4 Comparison of the Quantal Secretion Among Different Species 
Regardless of the stimulation type, cow platelets secreted significantly more serotonin per 
secretion event (Fig. 4.7A and D) than either mouse or rabbit platelets (Q= 275.7±25.1, Q= 
331.2±25.9, and Q=498.5±40.9 fC for rabbit, mouse and cow platelet secretion, respectively upon 
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ionomycin stimulation; Q=271.5±21.7, Q=313.9±29.5, and Q=654.9±116.4 fC for rabbit, mouse, 
and cow platelets secretion upon thrombin stimulation, respectively). Compared to cow platelets, 
both rabbit and mouse platelets secreted a significantly higher number of discrete δ-granules per 
exocytotic event (N= 9.6±1.3, 8.1±1.1, and 4.2±0.3 granules for rabbit, mouse and cow platelets, 
respectively, for ionomycin stimulation. For thrombin stimulation, N=17.2±2.1, N=6.9±0.6, 
N=3.0±0.3 for rabbit, mouse, and cow) (Fig. 4.7B and E). Using Faraday’s Law, N and Q gives 
the average moles of serotonin secreted from each platelet; the number of moles of serotonin 
calculated from N*Q values by using Faraday’s Law are 17.5×10-18, 13.8×10-18, 9.6×10- (Fig. 
4.7C and F) assuming that all secreted serotonin is measured. 
Previous studies on α-granule secretion in cow platelets show that they fuse with each other 
during exocytosis, prior to fusion with the plasma membrane.
23
 A similar phenomenon for δ-
granule secretion could explain the higher Q and lower N values for cow platelet secretion 
compared to the other two species. The frequency distribution of the Q values was analyzed (data 
 
Figure 4.7 Comparison of the quantal release between the species upon ionomycin 
(A-C) (N = 23, 35, 39 for rabbit, mouse, and cow) and thrombin (D-F) (N= 32, 34, 22 
for rabbit, mouse and cow) stimulations. (A, D) Cow platelets release significantly 
more serotonin molecules per release event (as denoted by Q, the charge under the 
amperometric spike). (B, E) The number of granules released per single platelet 
exocytosis. (C, F) N*Q represents the total amount of serotonin secreted from individual 
platelets in each condition.  Using one way ANOVA * for p<0.05, ** for p<0.01, and *** 
for p< 0.001. Error bars are SD. 
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not shown), expecting a bimodal distribution to show that a sub-population of δ-granules fuse 
with each other ahead of plasma membrane fusion. However, frequency analysis did not show 
such a distribution; a single non-Gaussian distribution similar to the previously reported 
distribution for rabbit granular secretion was observed instead,
13
 making the possibility of fusion 
of two or more δ-granules unlikely. In addition, TEM images were used to analyze the size of δ-
granules in cow and mouse platelets (Fig. 4.8). Results showed that cow platelets not only have 
larger δ-granules but that the dense core of the δ-granules, where most of the serotonin is stored, 
is significantly larger in cow platelets (average granule diameter is 230.6±6.1 nm for mouse 
platelet δ-granules versus 343.0±11.1 nm for cow platelet granule). This larger dense core and 
granule are the likely reason that more serotonin is secreted during each individual event. 
As described by Ewing and colleagues, it is not necessarily true that the entire content of a 
granule is released upon stimulation and exocytosis; in fact, PC12 cells, a model exocytotic cell, 
only release 45% of their vesicular content.
24
 Herein, we evaluated the percentage of total δ-
granule content release using bulk HPLC measurements by lysing the cells with HClO4 and 
analyzing the total serotonin content and comparing this amount with the serotonin secreted 
following exposure to either 10 U/ml thrombin or 10 µM ionomycin. Data presented in Fig. 4.9 
 
Figure 4.8 TEM analysis of cow (26 granules) and mouse (86 granules) platelet δ-
granules. Cow platelets, on average, have larger δ-granules (A) and dense core 
diameters (B). The cartoon granules show the distance measured for each graph 
Representative TEM images of a single mouse platelet (C) and cow platelet (D). 
Significance was determined with a T test **** for P< 0.0001 and error bars are 
standard deviation. 
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show the percent of total serotonin secreted upon stimulation for each species and stimulant. 
From the data, it is clear that more serotonin is secreted in OCS-containing species upon thrombin 
activation as compared to ionomycin activation.  In both rabbit and mouse platelets, the granules 
secrete more than 50% of the total serotonin content; however, only 27.5 and 41.1% of the 
serotonin was secreted from cow platelets with ionomycin and thrombin stimulation, respectively 
(p<0.001). Application of human thrombin to stimulate non-human platelets cannot be the reason 
for this behavior since it has been shown previously that human thrombin was 89% homologous 
to cow thrombin, and cow platelets are known to respond similarly to human and cow thrombin.
6
 
This may indicate that the reduced cow platelet secretion, compared to that by rabbit and mouse 
platelets, may not be due to the effectiveness of the stimulant but efficiency of the response to the 
stimulant, perhaps related to the use of the OCS. 
4.4.5 Comparison of the Secretion Kinetics among Different Species 
In amperometric traces, Trise values measure the time required for transition from 10% to 90% 
of the spike amplitude maximum, revealing the chemical messengers secreted as the granule 
transitions from the initial pore opening to full fusion. During this time, the soluble (non-
polyphosphate-associated) serotonin present in the granules is secreted.
25
 In contrast, T1/2 is a 
measure of the total time of a serotonin secretion event which can be influenced by the opening of 
the fusion pore, the size of the expanded pore, dissolution of the matrix-bound serotonin, and 
diffusion of that serotonin into the extracellular space.  When stimulated with ionomycin, cow 
platelets showed slower secretion kinetics than either rabbit or mouse platelets (larger Trise and 
 
Figure 4.9 Bulk serotonin analysis using HPLC with electrochemical detection.  
% of the total serotonin secreted with (A) ionomycin stimulation or (B) thrombin 
stimulation. Using one way ANOVA **** for P<0.0001 
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T1/2 values) (Fig. 4.10). Mouse and rabbit platelets showed comparable secretion kinetics upon 
ionomycin stimulation (T1/2= 13.9±1.1 and 14.7±1.1 ms for mouse and rabbit, respectively). 
Thrombin, however, induced distinct secretion behavior for each species. Although mouse and 
rabbit platelets secrete similar amounts of serotonin from δ-granules, mouse platelet secretion was 
much slower than that from rabbit platelets (T1/2= 20.3±1.2 and 15.4±1.2 ms for mouse and 
rabbit, respectively).  Cow platelet secretion kinetics were slower in thrombin-induced 
stimulation with a T1/2 value of 26.8± 2.1 ms compared to 29.2±.1.7 ms with ionomycin. 
4.4.6 Comparison of Fusion Events between Species 
During platelet granular secretion, fusion of the granular membrane with plasma membrane 
gives rise to a fusion pore of limited stability. Fusion pore formation and stability influences both 
the quantal secretion and kinetics of secretion.
26,27
 In amperometric traces, the fusion pore can be 
 
Figure 4.10 Comparison of the secretion kinetics from individual granules with 
either (A, B) ionomycin or (C, D) thrombin stimulation (A, C). Larger Trise values 
from cow platelet secretion indicate slower transition to maximal release. (B, D) 
Duration of the total secretion was longest in cow platelets regardless of the stimulant. 
Although the T1/2 values from rabbit and mouse platelets were similar in the ionomycin 
condition, thrombin stimulation resulted in higher T1/2 values, and thus, slower release 
from mouse platelets compared to rabbit platelets. Using one way ANOVA * for 
p<0.05, ** for p<0.015, *** for p<0.001, **** for p<0.0001 N values for Ionomycin 
stimulation are 23, 35, 39 for rabbit, mouse and cow respectively and 32, 34, 22 for 
thrombin stimulation. Error bars are representative of the standard deviation. 
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identified as a subtle increase in the current due to the diffusion of soluble serotonin as the fusion 
pore opens (Fig. 4.1C); this current feature is commonly known as a “foot.” 25 
The analysis of the foot events among amperometric spikes shows that the stability of the 
fusion pore is highly dependent on the species and mechanism of the activation (Fig. 4.11).  
Mouse platelets showed the highest, though not significant, percent of fusion pore events when 
they were activated with ionomycin (18.1±3.6% of the mouse secretion events showed a foot 
feature as opposed to 9.5±2.0 and 13.5±2.5% fusion pore events in rabbit and cow exocytosis, 
respectively). Stimulation of mouse platelets with thrombin caused a drastic decrease in secretion 
events initiated through a stable fusion pore (9.3±2.3% events with foot). On the other hand, 
thrombin stimulation caused a significant increase in the stability of the fusion pore during rabbit 
and cow platelet dense granule secretion (%Foot= 15.0±2.1 and 23.7±5.1 for rabbit and cow 
platelets, respectively). This indicates that fusion pore stability based on the variations in 
formation of foot for rabbit, mouse and cow, is both species and stimulant dependent, and there is 
no correlation between the presence of OCS and fusion pore occurrence. 
4.4.7 Discussion 
Revealing the differences among platelets of different species will help clarify the role of 
each component of platelet secretion and determine how a cell may compensate for a missing 
component. One of the major structural differences between platelets from different species is the 
presence of a system of tunneling invaginations from the plasma membrane known as the 
OCS.
4,6,28
 Work done by various groups has demonstrated that the OCS influences platelet 
morphology during activation and that the presence of the OCS helps platelets interact with 
 
Figure 4.11 Platelet fusion pore analysis. (A) Ionomycin stimulation (B) Thrombin 
stimulation. Thrombin resulted in the most stable fusion pores in cow platelets, higher 
than those measured from mouse or rabbit platelets. Using one way ANOVA ** for 
p<0.01. Error bars are reported with standard deviation 
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surfaces better by facilitating platelet spreading and pseudopodia formation.
23,29
 Moreover, it was 
shown that the OCS membrane contains SNARE proteins, including syntaxin 2, SNAP 23 and 
VAMP 3 and is involved in platelet granular secretion by serving as intermediate fusion sites for 
the granules before plasma membrane fusion.
28
 However, the very active hemostatic function of  
camel platelets (lacking an OCS) raises the question of the actual need and use of these tubular 
structures in platelets.
4
 In 2010, the Whiteheart group showed that the proteins that regulate the 
actin cytoskeleton are expressed at higher levels in OCS-containing platelets.
6
 This work inspired 
the hypothesis that the OCS is critically involved in granule trafficking and docking ahead of 
chemical messenger secretion. 
During granule docking with the platelet plasma membrane, granules are thought to dock 
preferentially in cholesterol-rich microdomains which have been shown to contain almost twice 
as much SM and 4 times the amount of cholesterol compared to the regular membrane.
30
 These 
sphingolipid/cholesterol rich microdomains are known to play a significant role in exocytosis due 
to their ability to stabilize the fusion pore and also concentrate certain soluble NSF attachment 
protein receptor (SNARE) proteins while excluding regulating SNARE proteins.
14,21
 This work 
shows that cow platelets contain a significantly greater concentration of SM, with over a 10 fold 
increase and a 600% increase in cholesterol compared to mouse and rabbit platelets, respectively 
even while accounting for unactivated platelet size. This excess cholesterol and SM could be an 
indication of the platelet being able to form a larger number of lipid rafts to facilitate granule 
docking since these platelets do not have an OCS which is easily accessible throughout the 
platelet. In addition, the cow δ-granules have shown greater stability than those from mouse or 
rabbit as seen by their longer trise, T1/2 times and also their ability to form more foot features (Fig. 
4.11). These trends of increased stability with increasing cholesterol have been seen in a previous 
work from our group. In this prior study, rabbit platelets were depleted of 32% of their cholesterol 
using methyl-β-cyclodextrin or incubated in cholesterol, increasing the concentration to 132% of 
the original cholesterol content. As cholesterol increased, Trise, and foot features increased.
14
 If a 
similar cause is the source of cow platelet behavior, this suggests that cow platelets, which do not 
contain an OCS, may have a membrane richer in lipids that are beneficial to stability during 
secretion.  
Measurement of total serotonin content vs. total secreted serotonin with HPLC facilitates 
evaluation of the efficacy of the secretion among the OCS- and non-OCS containing platelets.  
Cow platelets secrete a drastically smaller percentage of total serotonin than either mouse or 
rabbit platelets. Furthermore, the parameter that was used to determine the kinetics of the 
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secretion event (T1/2) was significantly larger for cow platelets. Although the higher T1/2 value 
may be due to the higher amount of serotonin secreted, it is possible that the absence of the 
tubular structure retarded secretion kinetics. All these observations indicate that the OCS may not 
be necessary for chemical messenger secretion, but it indeed influences the efficacy of the 
secretion.  
Previous research has shown differences in “spreading” between platelets with and without 
an OCS. According to Grouse et al., “bovine platelets do not spread, they unfold” since only OCS 
platelets are able to fill in the spaces between pseudopods. One hypothesis for this difference in 
spreading behavior is that the OCS provides extra surface area upon activation and slight 
variations in the cytoskeletal organization.
29
 However, even without the extra membrane space of 
the OCS, cow platelets are still able to increase their total perimeter to a much greater extent than 
either mouse or rabbit platelets. This is partially due to the long pseudopods that extend out into 
the extracellular environment (Fig. 4.5). The range of activated cow platelet perimeters are spread 
out to a greater extent than either rabbit or mouse. In OCS platelets (mouse and human), it has 
been shown that alpha granules fuse with the plasma membrane and contribute to platelet 
spreading.
31 
With the excess cholesterol and SM helping stabilize the granule, it would be 
reasonable for more granules to go through full fusion instead of endocytosing therefore helping 
spread. Due to the larger size of the δ-granule and slight variations in how many granules are able 
to reach the membrane, this amount of spreading would be widely variable within a population of 
platelets. 
4.5 Conclusion 
In conclusion, by using a variety of complimentary techniques to determine kinetic secretion, 
lipid composition, and imaging, we have demonstrated the similarities and differences in platelet 
δ-granule secretion behavior and membrane composition of platelets from different species. In 
addition, membrane lipid composition indicates that cow platelets may have increased their SM 
and cholesterol composition to compensate for the lack of OCS. Finally, variations in secretion 
between stimulants did not show trend changes except for percentage foot values, indicating that 
secretion is affected to a greater extent by the composition of the platelet than the stimulation 
used to initiate activation. 
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Chapter 5: Characterization of the Presence and Function of Platelet Opioid 
Receptors 
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5.1 Overview 
Opioids are typically used for the treatment of pain related to disease or surgery. In the body, 
they enter the blood stream and interact with a variety of immune and neurological cells that 
express the µ-, δ-, and K-opioid receptors. One bloodborne cell-like body that is not well 
understood in the context of opioid interactions is the platelet. The platelet is a highly sensitive 
anucleate cell-like fragment that is responsible for maintaining hemostasis through the secretion 
of chemical messengers and shape change. This research delves into characterizing platelet opioid 
receptors, how specific receptor agonists impact platelet exocytosis, and the role of the K-and µ-
receptors in platelet function.  Platelets were found to express opioid receptors, but upon 
stimulation with their respective agonist, no activation was detected. Furthermore, exposure to the 
opoid agonists did not impact traditional platelet secretion stimulated by thrombin, a natural 
platelet activator. In addition, with the use of knockout mice, these data suggest that the agonists 
may be interacting non-specifically with platelets. Finally, K-knockout platelets showed 
variations in their ability to adhere and aggregate compared to control platelets. 
5.2 Introduction 
Opioids, a class of drug molecules including heroin, opium, codeine, morphine, oxycodone, 
and fentanyl, are used for the treatment of moderate to severe pain caused primarily by cancer, 
surgery, and arthritic diseases. 
1-3
 In 2009, over 250 million prescriptions were written in the US, 
an increase of 82 million prescriptions since 2000. 
4
 In addition, the abuse of illegal opioid 
substances has increased over 414% from 1997 to 2007. 
5
 Upon introduction into the body, 
opioids bind to at least one of the three G protein-coupled receptors (mu (µ), kappa (Κ), and/or 
delta (δ)).6-9 In addition, opioids are able to cross-interact between the receptors, activating 
different signaling pathways. One example includes morphine, which binds to the µ- and δ-opioid 
receptors. However, the affinity of morphine, a common pain reliever, is 50x greater for the µ-
receptor than the δ-receptor. 10, 11  In contrast, agonists for the K-receptor have been noted to play 
a more direct role in the immune system. Several immune cells are known to express opioid 
receptors, and many, including natural killer cells, mast cells, and neutrophils, have shown a 
significant evolution in cell response when exposed to opioids over an extended period of time. 
6, 
8, 12-14
 
One immune cell-like body that has been largely overlooked in opioid research is the platelet. 
Platelets play a crucial role in hemostasis, but are also intimately involved in serious health risks 
including stroke and myocardial infarction upon unwanted clotting or excessive bleeding. Upon 
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activation, platelets secrete chemical messengers from three distinct granule types, the δ-granule, 
the alpha granule, and the lysosome.  The δ-granule contains small molecules including serotonin, 
adenosine diphosphate (ADP), adenosine triphosphate, Ca
2+
, and histamine, all of which play a 
role in vascular constriction, inflammation, and activation. The alpha granules contain platelet 
factors (PFs) including PF4, clotting proteins, and adhesion molecules. The lysosomes, which are 
rare in platelets, contain hydrolases including beta hexosaminidase (β-Hex). 15, 16 Due to the 
heavy use of intravenously injected opioids during surgery, and 40-60% of the opioid content 
entering the blood stream, platelets have ample opportunity to interact directly with these drugs. 
8
 
Current platelet-opioid interaction research has been focused on studying the effects of 
various opioid anesthetic agents on perioperative bleeding. 
17-19
 To the best of our knowledge, 
only one paper has studied platelets directly by observing the binding attachment of naloxone, an 
opioid antagonist, on human platelets. 
20
  The purpose herein is to explore the fundaments of how 
the opioid receptors and receptor agonists impact platelet function by establishing which G 
protein-coupled opioid receptors are present on platelets, how stimulation of each individual 
receptor impacts granule secretion, and which roles the receptors play in normal platelet function. 
For stimulation, to prevent cross-interaction when studying receptors, the agonists [D-Ala
2
, NMe-
Phe
4
, Gly-ol
5
]Enkephalin (DAMGO), [D-Pen
2,5
]Enkephalin, [D-Pen
2
,D-Pen
5
]Enkephalin 
(DPDPE), and U-50488 were used to stimulate the µ-, δ-, and K-receptors, respectively.  To 
determine the role of individual receptors, Κ- (Jackson Laboratory B6.129S2-Oprk1tm1kff/j) and 
µ- (Jackson Laboratory B6.129S2-OPRM1TM1KFF/J) opioid receptor knockout (KO) mice were 
purchased. Due to limited availability, δ-KO mouse studies could not be included in this work. 
5.3 Experimental Approach 
5.3.1 Reagents 
All chemicals for the buffers and HPLC mobile phase were purchased from Sigma Aldrich. 
Western blot stock solutions were purchased from Bio-Rad laboratories unless otherwise 
indicated. 
5.3.2 Platelet Isolation  
Control C57BL/6J, µ - KO B6.129S2-Oprm1
tm1Kff
, and K - KO B6.129S2-OPRK1
TM1KFF/j
 
mice were purchased from The Jackson Laboratory. Blood was collected via cardiac puncture 
following IACUC protocol #1403-31383A. Briefly, mice were euthanized via CO2 asphyxiation, 
and then a syringe filled with 200 µL acid citrate dextrose (ACD) was used to draw blood via 
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cardiac puncture. The blood was diluted with Tyrodes buffer (NaCl, 137 mM; KCl, 2.6 mM; 
MgCl2, 1.0mM; D-glucose, 5.6 mM; N-2-hydroxyethylpiperazine- N'-2-ethanesulfonic acid 
(HEPES) 5.0 mM; and 12.1 mM NaHCO3, with pH adjusted to 7.3) and centrifuged at 130 x g for 
10 min with reduced braking to prevent platelet activation. The top platelet rich plasma layer was 
collected, and additional ACD and Tyrodes buffer were added. The platelets were pelleted at 524 
x g for 10 min with reduced braking. The pellet was re-suspended in fresh Tyrodes buffer and 
platelets were counted using a hemocytometer. All platelets were diluted to the lowest platelet 
density for each experiment, which typically ranged between 1x10
7
-1x10
8
 platelets/ml. 
5.3.3 Western Blot  
Platelets were re-pelleted at 524 x g and re-suspended in a couple hundred μLs of Tyrodes 
buffer to increase concentration. For the opioid control, brain cells were extracted from C57BL/6J 
purchased from The Jackson Laboratory after euthanasia via CO2 asphyxiation following IACUC 
protocol #1403-31383A. Platelets used for western blotting were tested both from samples 
recently collected from mouse donors and samples frozen at -80 °C. The brain collected after CO2 
euthanasia under IACUC protocol #1403-31383A was broken into small chucks and put in 
Tyrodes buffer. The brain cells were frozen at -80 °C. After thawing, both platelets and brain 
cells were roughly pipetted and sonicated for 10 minutes. A 5% by volume solution of 2-
mercaptoethanol in Laemmli buffer was added to the cell solution in a 1:1 ratio. The sample was 
vortexed for 30 seconds, put into a heating block, and boiled for 5 minutes.  
12.5% Criterion™ Tris-HCl Gel purchased from Bio-Rad laboratories was inserted into a gel 
electrophoresis housing containing 1x Tris/Glycine/SDS (TGS). Samples and a precision plus 
protein standard dual color ladder from Bio-Rad were pipetted into their respective wells. The 
power was set at 110 volts, and the gel was run until the bottom of the ladder was near the end of 
the gel (around 90 min). A blotting sandwich was set up, keeping the components wet with cold 
Towbin buffer (1x Tris/Glycine (TG) in 20% methanol). The sandwich was placed in the transfer 
apparatus and inserted into the transfer cell filled with cold Towbin buffer and a stir bar. The 
power supply was set at 500 mA or ~100 volts and run for 120 min in a cold room on a stir plate. 
The nitrocellulose membrane was incubated with 5% (w/v) powder skim milk in 1x tris 
buffered saline with 0.1% Tween-20 (TBS/T) buffer for 60 min on a shaker at 300 rpm. The 
membrane was washed 3x for 5 min in TBS/T buffer at 300 rpm and finally placed into baggies 
containing the antibody in 4% powdered skim milk in TBS/T buffer. The µ, δ and K antibodies 
(Millipore anti- µ opioid receptor AB1580-1 rabbit polyclonal, Thermo Fisher Scientific PA5-
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26138 OPRM1 antibody, Millipore Ab1560 rabbit anti-δ opioid receptor polyclonal antibody, and 
Abcam Anti- K opioid receptor antibody ab10566) were diluted 1:1000. The bags were placed in 
a cold room overnight with gentle rotation. The membrane was removed and washed 3x with 
TBS/T buffer on a shaker at 300 rpm and finally incubated with Rockland Immunochemical’s 
secondary anti-rabbit HRP-conjugated antibody (1:5000 dilution) in 4% powdered skim milk for 
60 min. After incubation, the membranes were washed 3 X with TBS/T buffer in a rotator at 300 
rpm for 5 minutes. 
While washing the membrane, a mixture of 1:1 luminol solution and stable peroxide solution 
from the Super Signal West Femto Maximum Sensitivity Substrate kit (Pierce) was mixed. The 
membranes were laid onto plastic wrap, and the substrate was pipetted dropwise over the 
proteins/antibodies. After 5 minutes, the membrane was dabbed to remove excess reagent and 
wrapped into plastic wrap. X-ray film was placed over the membrane and developed using a 
SRX101A medical film processor (Konica Minolta Medical and Graphic Inc.) 
5.3.4 Figure 1 Platelet Stimulation Procedure 
 125 µL of platelet suspension was put into 1.7 mL Eppendorf tubes. The platelets were then 
incubated with 125 µL of opioid agonist in Tyrodes buffer at a final concentration of either 10 
nM DAMGO, 3 µM DPDPE, 100 nM U-50488, or Tyrodes buffer. The platelets were pelleted at 
1200 xg, and the supernatant was collected for serotonin detection. The platelets were re-
suspended in 125 µL Tyrodes buffer and incubated for 15 min before 125 µL of 1 U/mL 
thrombin was added for a final concentration of 0.5 U/mL thrombin. After 20 minutes of 
thrombin stimulation, the platelets were spun down at 1200 xg, and the supernatant was collected 
for serotonin detection. 
5.3.5 Figure 2 - 4 Platelet Stimulation Procedure 
 125 µL of platelet suspension was put into 1.7 mL Eppendorf tubes. The platelets were then 
incubated with 125 µL of stimulant in Tyrodes buffer at a final concentration of  10 nM 
DAMGO, 3 µM DPDPE, 100 nM U-50488, 0.5 units/mL thrombin, Tyrodes buffer, or 0.25 M 
HClO4 in water. After 30 min, 100 µL of ACD was added and the platelets were spun down at 
500 xg. The supernatant was used for the serotonin, PF4, and β-hex assays. The platelet pellet 
was used for the BCA assay. The platelets in the Tyrodes buffer were used for cholesterol 
detection. 
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5.3.6 Serotonin Detection 
200 µL of the supernatant was filtered using a Millipore 96 well Multi-Screen HTS filter 
plate (Billerica, Ma) with a 0.45 µm pore size. The supernatant was filtered through at 3000 xg 
for 5 minutes, and 180 µL of it was combined with 20 µL of 5 µM dopamine internal standard in 
0.5 M perchloric acid. The serotonin was detected using a previously developed HPLC method 
using electrochemical detection.
21, 22
 Briefly, a Waters 2465 electrochemical detector with a 
glassy carbon electrode was attached to a Agilent 1200 HPLC with a 5 µm 4.6 x 150 mm C18 
column (Eclipse XDB-18). The samples were auto injected into the mobile phase (11.6 mg/L of 
sodium octyl sulfate, 170 μL/L dibutylamine, 55.8 mg/L Na2EDTA, 10% methanol, 203 mg/L 
anhydrous sodium acetate, 0.1 M citric acid, and 120 mg/L sodium chloride) flowing at 2 
mL/min. The dopamine (an internal standard) and serotonin spikes were detected using a 
potential of 700 mV vs. Ag/AgCl and a current range of 50 nA.  Concurrently, a calibration curve 
was run with serotonin concentrations varying from 0-1 µM serotonin and 0.5 µM dopamine 
internal standard in 0.5 µM perchloric acid.  
5.3.7 PF4 ELISA Assay  
Alpha granule content secretion was detected as directed using an enzyme linked 
immunoassay kit for PF4 (R&D Systems). Briefly, supernatants were diluted with Calibrator 
Diluent RD5-26 (1X). Assay Diluent RD1-40 and the sample were added to each well in the 
provided plate. The plate was incubated for 2 hours, and the wells were washed. Mouse PF4 
Conjugate was added to each well, incubated, and washed. Finally, substrate solution was put in 
the wells for incubation, and then a quenching solution was added. The optical density was 
determined with a BioTek Synergy 2 96 well plate reader.  
5.3.8 Β-Hexosaminidase Assay 
 An absorbance assay for β-Hex was prepared as previously described.23 Briefly, a solution of 
1 mM p-nitrophenyl acetyl-D-glucosamine in 0.1 M citrate buffer was added to the sample and 
incubated for an hour. Ice cold 0.1 M carbonate buffer was added to stop the reaction. The 
absorbance was read at 405 nm with background subtraction at 630 nm.  
5.3.9 BCA Protein Assay  
Platelet protein content was measured using the Pierce BCA Protein Assay kit (Thermo 
Scientific) following included directions. Briefly, after collecting the supernatant used in 
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experiments from Fig. 2 and 4, the pellet was homogenized in 25 µL of Tyrodes buffer. 200 µL 
of working reagent was added to each well and the plate was incubated for 30 min at 37
o
C. The 
plate was read at 562 nm on a BioTek Synergy 2 96 well plate reader. Due to small pellets, when 
the supernatant was removed, a small portion was left inside each vial as to not disturb the pellet. 
Therefore, upon addition of Tyrodes buffer, there may have been slight variations in the total 
pellet dilution.  
5.3.10 Platelet Cholesterol Assay  
The concentration of cholesterol was determined as directed using an Amplex Red 
Cholesterol Assay Kit (Life Technologies).  To ensure similar platelet count between mouse 
models, the concentration of platelets was determined using a hemocytometer and diluted to the 
lowest platelet concentration among the three conditions. 125 µL of platelet suspension was 
pelleted, and the pellet was mechanically homogenized in 1x Reaction Buffer to expose internal 
cholesterol. The absorbance was measured at 590 nm after exciting at 530nm using a BioTek 
Synergy 2 96 well plate reader.  
5.3.11 Platelet Adhesion  
Platelet adhesion studies were performed on a straight channel microfluidic device as 
previously described.
24,25
 Briefly, channels were coated with a confluent monolayer of hy926 
human endothelial cells (ATCC). Platelets were labeled with CMFDA (5-
chloromethylfluorescein diacetate) dye (2 µM, 20 min) for easier visualization and then 
stimulated with 5 µM ADP or left un-stimulated in the Tyrodes buffer. ADP was utilized because 
it can initiate adhesion without secretion, therefore decoupling secretion and adhesion in this 
assay.
26
 The cells were flowed through the device at 30 µL/hr for 20 minutes. The device was 
washed with Tyrodes buffer, and the number of adherent cells was counted using a Nikon 
Microscope with a QuantEM Photometrics CCD camera. Metamorph Ver. 7.7.5 was used as the 
imaging and analysis software. 
5.3.12 Platelet Aggregation  
500 µL of 2 x 10
8 
platelets were placed in a small glass tube with a stir bar. The tube was 
placed into a Chrono-Log Whole Blood Lumi aggregometer interfaced with Aggro/Link software. 
A tube with Tyrodes buffer was placed into the aggregometer for baseline comparisons. After the 
absorbance stabilized at 100%, 120 µL of 25 U/mL thrombin was added for a final concentration 
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of 4.8 U/mL thrombin. The % absorbance over time was measured until the absorbance no longer 
changed. The data was then converted to % transmittance. To calculate the change in 
transmission, the % transmittance was averaged before stimulation and then the average percent 
transmittance after the decrease was subtracted. For rate of aggregation calculations, the time was 
considered from when the thrombin was injected until the % transmittance reached the average 
final value. 
5.3.13 Platelet Dark Field Imaging  
4 µL of the platelet suspension was deposited on a glass slide, and a coverslip was gently 
placed on top before being sealed with clear nail polish. The platelet samples were allowed to 
settle and activate before imaging. Images were captured on an Olympus microscope from 
CytoViva with and UplanFLM 100x oil immersion objective and Dage XL camera.  The image 
exposure time was adjusted manually in the Exponent 7 software and had to be increased for both 
the µ- and K-KO platelet images based on lower overall scattering signals. 
5.3.14 Data analysis  
GraphPad Prism 6 was used to analyze all statistical data. All significance was determined 
using one way ANOVA. Figure error bars show standard deviation. Fig. 1 had 5 biological 
replicates for all conditions except Tyrodes which had 10 biological replicates. Figures 5.2, 5.3, 
5.4, and 5.6 had 4 biological replicates except for the PF4 Tyrodes conditions, which only had 3 
biological replicates due to limited space. Fig. 5.5 had 5.6 replicates for each condition. For dark 
field imaging, two slides were prepared for each type of platelet and ~10-15 images were 
recorded for each slide.  
5.4 Results and Discussion 
Literature precedent on the effects of opioids and their receptors on platelets have focused on 
the aftereffects of anesthetic agents on clotting. While this is important to understand for surgical 
use, it is also important to understand the fundamentals of how the agonists are interacting with 
the platelets by leveraging analytical and biological chemistry techniques.  This knowledge of the 
role each opioid receptor has on platelet function can then be exploited to predict how certain 
drugs will interact with platelets and influence platelet function. 
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5.4.1 Verification of Opioid Receptors on Platelets  
Platelets are sensitive to a vast array of molecules that cause activation including thrombin, 
collagen, and ADP. These compounds induce different coagulation pathways causing varied 
amounts of aggregation and exocytosis of the alpha, δ, and lysosome granules. Activation also 
induces upregulation of different fibrinogen binding sites and cytoskeleton rearrangement for 
better adhesion/interaction.
27
 In addition to natural stimulants, many drugs affect normal platelet 
function, varying from direct platelet activation to prevention of exocytosis. 
28
 To fully 
understand the effects of opioids on platelets, it is important to first determine which receptors the 
platelets express. Previous literature has demonstrated that platelets are impacted by the 
antagonist naloxone, which primarily binds to the µ receptor, but also has slight affinity for the δ 
and K receptors. 
20
  
Western blots using µ-, δ-, and K-antibodies demonstrate the presence of all three receptors 
on control mouse platelets. In addition, western blots on the µ- and K-KO mice demonstrated that 
the K- KO mice had a knocked-out K receptor and still contained both the µ- and δ-receptor. 
However, the same experiments on the µ-KO mouse demonstrated that all three receptors were 
still present. A different antibody and a new µ-KO mouse were purchased for confirmation with 
the same outcome. In addition, tail clippings from the original mice were sent to TransnetYX 
(Cordova, TN) to confirm the µ-gene was knocked out. While the gene knock-out was confirmed, 
the results indicated all three receptors were still present in the western blot. This suggests either 
that both µ-antibodies are binding non-specifically or that there may be a µ-like receptor 
expressed by the platelet.  
5.4.2 Platelet Secretion in Response to Opioid Agonists  
The role of each receptor in platelet granule secretion was analyzed using receptor-specific 
agonists.  For initial experiments, control platelets were incubated for two hours with the opioid 
agonists DAMGO, DPDPE, or U-50488 that target the µ-, δ-, and K–receptors, respectively. The 
supernatant was analyzed for serotonin from δ-granule secretion after the platelets were spun 
down (Fig. 5.1A). The platelets were re-suspended and then stimulated with thrombin, a natural 
platelet stimulant, for 20 minutes. The supernatant was collected and analyzed (Fig. 5.1B). 
Secretion from δ-granules was not apparent in platelets incubated with the agonists, nor did these 
agonists influence natural platelet stimulation by thrombin. 
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These data are comparable to previously cited data examining post-operative bleeding and 
clotting, which did not show significant differences when comparing platelets that had and had 
not come into contact with opioids.
17-19
 However, there was a downward change in serotonin 
secretion in the agonist-activated platelet supernatant compared to our negative control, Tyrodes 
buffer. These data suggest that the opioids may help stabilize un-stimulated platelets, but upon 
thrombin stimulation, the total amount of serotonin secreted is not impacted. To further 
investigate this trend, the first part of the experiment was run again with 30 minute thrombin 
stimulation (Fig. 5.2A). Again, the downward change in serotonin secretion from δ-granules was 
detected. Some of the supernatant from the platelet suspension was also used to analyze the 
amount of platelet factor 4 secreted from alpha granules (Fig. 5.2B) and β-Hex from lysosomes 
(Fig. 5.2C).  For both alpha granules and lysosomes, there was no significant difference in 
content secretion with opioid stimulation compared to the negative control. This indicates that 
platelets interacting with opioids are not always more stable as demonstrated with the δ-granule, 
but also may have no secretion to very little secretion. 
The role of the individual receptors and specific agonist-receptor interactions was analyzed 
using K- and µ-KO mouse platelets. The δ-granule secretion response was monitored in both 
resting platelets (Fig. 5.3B) and thrombin-stimulated (Fig. 5.3C) platelets relative to the total 
amount of serotonin they contained (to ensure that the KO platelets were 
 
Figure 5.1 Effects of opioid agonists on platelet function. Control platelets were incubated 
with Tyrodes buffer (negative control), DAMGO (μ opioid receptor agonist), DPDPE (δ 
opioid receptor agonist), or U-50488 (K opioid receptor agonist) for two hours. The platelets 
were pelleted, and the supernatant serotonin concentration was analyzed (A). The platelet 
pellet was re-suspended and stimulated with thrombin or Tyrodes buffer for 20 minutes, and 
the serotonin release was measured (B).  
++++
 P≤0.01 vs. Tyrodes condition 
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functioning normally).  Comparing the percent of total serotonin secreted gives general insight 
into whether the biophysical characteristics of granule secretion may be affected by knocking out 
the opioid receptors.  The control C57 mouse platelets were found to contain the greatest amount 
of serotonin, which was significantly higher than both K- (p≤0.0001) and µ- (p≤0.001) KO mouse 
platelets. µ-KO mouse platelets had slightly more serotonin than the K-KO mouse platelets 
(P≤0.05). Even with this difference in total serotonin content, platelets reacted similarly in 
Tyrodes buffer and with stimulation by thrombin, releasing similar percentages of their total 
 
Figure 5.3 Knockout mouse serotonin concentration and secretion in response to 
thrombin. Initial experiments were performed to determine if the knockout platelets reacted 
differently from control platelets in control environments. The concentration of serotonin 
was measured after lysing the platelets with 0.5 µM HClO4 (A), incubating them in a non-
stimulant Tyrodes buffer(B), or stimulating them with the natural stimulant thrombin (C). 
The knockout mice showed significant changes in their total concentration of serotonin (A). 
However, the percentage of serotonin released in a resting state (B) and upon stimulation (C) 
was statistically indistinguishable for the knockout platelets compared to the control C57 
mouse platelets.  *P≤0.05 ***P≤.001 ****P≤0.0001 Vs. indicated position. 
 
Figure 5.2 C57 platelet granule secretion upon opioid agonist stimulation. δ- granule 
secreted serotonin (A), α granule-secreted PF4 (B), and lysosome-secreted β-Hex (C) from 
C57 control mouse platelets after a 30 minute stimulation. All data is relative to the BCA-
based protein content to normalize for variable platelet count. ** P≤0.01 *** P≤0.001 **** 
P≤0.0001 vs. thrombin condition 
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serotonin content. Without doing single cell analysis, we cannot confirm that granule secretion, 
trafficking, and kinetics are the same, but the similar response on a bulk cell level helps support 
the fact that knocking out the receptors did not impact the platelets’ ability to secrete granular 
content. Cholesterol concentrations in the platelets were also measured because cholesterol has 
been shown to play a role in granular secretion.
21,29,30
 In this work, there was no significant 
difference in the amount of platelet cholesterol in the various strains of mice (data not shown).  
 
When the K- and µ-KO mice platelets (Fig. 5.4) were exposed to the same treatment as the 
C57 mice (Fig. 5.2), similar trends were seen and, in some cases, enhanced. For K- and µ-KO 
platelets, the agonists had a decreased change in average secretion of δ-granule contents 
(significantly different only for the µ-KO platelets P≤0.001) compared to Tyrodes buffer (Fig. 
5.4A and D).  For the µ-KO platelets, the µ-agonist DAMGO still had a slight impact on δ-
granule secretion. However, it significantly secreted over twice the amount of serotonin in the 
presence of U-50488 stimulation (p≤0.05). This increased change in secretion of serotonin by 
DAMGO compared to the other agonists is still seen in the control and K-KO platelets, but to a 
lesser extent, suggesting that some μ-like receptors are still located on the cell surface (which was 
 
Figure 5.4 KO platelet granule secretion upon opioid agonist stimulation  δ- 
granule-secreted serotonin (A)(D), α granule-secreted PF4 (B)(E), and lysosome-
secreted β-Hex (C)(F) granule content release from K-knockout (A, B, C), and μ-
knockout mice (D, E, F) platelets after a 30 minute thrombin stimulation.   *P≤0.05 ** 
P≤0.01 *** P≤0.001 **** P≤0.0001 vs. thrombin condition   +++ P≤0.001 ++++ 
P≤0.0001 vs. Tyrodes condition and # P≤0.05 ## P ≤0.01 vs. indicated conditions. 
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one hypothesis generated from the western blot data) or the agonist is interacting non-specifically 
with the platelet. 
For alpha granule secretion (Fig. 5.4B and E), the differences in C57 PF4 secretion in the 
presence of U-50488 is continued in the K–KO and µ-KO platelets with an average increased 
difference of 0.03 ng PF4/mg protein in both samples compared to Tyrodes. The K-KO platelets 
average difference was 0.02 and 0.05 ng PF4/mg protein in secretion from DAMGO and DPDPE, 
respectively compared to Tyrodes. The lysosome secretion was no different between C-57 (Fig. 
5.2C) and µ-KO platelets (Fig. 5.4F). However, in the lysosome secretion from the K-KO 
platelets, there was a significant (p≤0.05) increase (~0.03 ng PF4/mg protein) for all three 
agonists compared to Tyrodes buffer (Fig. 5.4C).  These data suggest that there might be a role 
for the K receptor in hindering lysosome secretion when exposed to opioid, whereas the µ 
receptor could play a potential role in assisting in δ-granule secretion when exposed to opioids. 
To confirm this association, a more focused study is needed to determine if/how the receptors 
interact with the granules populations of interest. Finally, even though western blot analysis 
revealed that the K-receptor was not knocked out as expected, the U50488 K-agonist did not 
induce a difference in response compared to the other agonists and showed similar secretion 
trends compared to the C57 and µ-KO platelets. This suggests that the K-agonist is interacting 
with the same receptor as the other agonists or a receptor that has a similar pathway for granule 
secretion.  
5.4.3 Platelet Adhesion Variations in Knockout Mouse Platelets 
Another important component in hemostasis is the platelets’ ability to adhere to both the 
endothelial cell wall and each other to form clots and prevent bleeding. Using a microfluidic 
channel coated with endothelial cells to mimic vasculature, platelets were flowed through the 
straight channel device after no stimulation (Tyrodes buffer) (Fig. 5.5A) or activation with ADP 
(Fig. 5.5B). The number of adherent KO platelets were counted and compared to the number of 
C57 platelets that adhered (Fig. 5.5).  In non-activated platelets, only K-KO mouse platelets 
adhered significantly less than control platelets (p≤0.05). Even after activation with ADP, K-KO 
platelets still had decreased adhesion compared to both the µ - KO and C57 control platelets 
(P≤0.05 and P≤0.01, respectively). To further investigate possible reasons for the K - KO platelet 
decreased ability to adhere, both the rate of aggregation (Fig. 5.6) and activated platelet images 
(Fig. 5.7) were acquired.  
  84 
5.4.4 Platelet Aggregation Variations in Knockout Mouse Platelets  
Both aggregation behavior and morphological image analysis showed differences between 
the KO platelets and the control platelets.  For aggregation experiments, the change in light 
transmission through 2 x 10
8
 suspended platelets was measured after thrombin stimulation. 
Compared to control platelets, µ-KO platelets had a larger change in total transmission (Figure 
6A) with a 25.1% change in transmission compared to 22.5% and 18.1% for K-KO and control 
platelets, respectively.  This difference was statistically significant only between C57 and µ-KO 
platelets (p≤0.05). Surprisingly, though the overall change in aggregation behavior did not impact 
the rate of aggregation with both µ-KO and C57 platelets having a 1.1% change in transmission 
each second. On the other hand, the K-KO platelets took significantly longer to aggregate than 
both C57 (p≤0.01) and µ-KO platelets (p≤0.05) with a change of transmission of 0.82% per 
second. This slower aggregation could be one possible reason that fewer K-KO platelets adhered 
to the microfluidic device in the time frame and distance measured. Another factor that has the 
potential to impact adhesion behavior is activation shape.  
 
Figure 5.6: Platelet aggregation 
measurements upon 4.8 U/mL 
thrombin stimulation.  The change in 
light transmission (A) and the rate of 
change were measured (B). *P≤0.05 vs.  
indicated position 
 
 
Figure 5.5 Measurement of platelet adhesion 
in a microfluidic channel coated with 
endothelial cells. Platelets were not activated 
(A) or activated with 5µM ADP (B), a natural 
platelet stimulant, before being flowed through 
the device.  *P≤0.05 ** P≤0.01 **** vs.  
indicated position 
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5.4.5 Platelet Dark Field Imaging 
Images of control (27 images, 2 different samples), K-KO (30 images, 2 different samples), 
and µ-KO (25 images, 2 different samples) platelets with a minimum of 20 platelets per image 
were visualized using dark field microscopy to characterize the platelet shape without need for a 
fluorescent label (Fig. 5.7). Neither the K- nor µ-KO platelets were able to scatter light as 
efficiently as the C57 platelets. Thus, to obtain an image of these KO activated platelets, exposure 
time was increased compared to the control platelets. The activation shapes of the different types 
of platelets were visually distinct. C57 platelets (Fig 5.7A) often showed two to three filopodia 
spread across the platelet while still maintaining a smaller circular center. The K-KO platelets 
displayed a more flattened look with a larger lamellipodia structure and small filopodia 
surrounding the entire platelet, giving the platelets a spiky appearance (Fig. 5.7B). Finally, µ-KO 
platelets were intermediate in appearance between the K-KO and C57 platelets. They contained 
distinct filopodia like the C57 platelets, but also contained a greater number of these features than 
C57 platelets and had a more spread out appearance (Fig. 5.7C).The platelets’ ability to flatten 
out and form filopodia and lamellipodia affect how they adhere. When a platelet’s shape flattens 
out, it enables the platelets to adhere more closely to the endothelial cell surface. The filopodia 
bind fibrin strands and the long extensions help interwine the platelets while forming a clot, 
whereas the lamellipodia bind to the wounded surface closing vasculature leaks.
31-33
 An 
experiment performed by Stenberg et al. studied Wistar Furth rats whose platelets had hereditary 
macrothrombocytopenia. These platelets have previously demonstrated prolonged bleeding times 
and decreased adhesion. To further explore these phenomena, Stenberg et al. studied the shape 
change and formation of filopodia and lamellipoida and compared this shape change to normal rat 
platelets. They found that the Wistar Furth rats had few and short filopodia, but were still able to 
eventually go to the fully spread platelet stage. They also hypothesized that the limited filopodia 
formed more fragile clots which increased bleeding time.
32
 Like the Wistar Furth rat platelets, the 
K-KO platelets also demonstrated these smaller filopodia, suggesting that the decrease in 
adhesion and increasesd aggregation time is likely due to the shape of the activated platelet. 
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5.5 Conclusion 
In conclusion, platelets contain opioid receptors; however, control platelets incubated with 
opioid receptor agonists do not degranulate in direct response to the opioid agonists, and the 
agonists do not affect platelet δ-granule secretion upon thrombin stimulation. When the receptors 
are knocked out, several unique features are seen, suggesting subtle roles for the opioid receptors. 
K-KO mouse platelets display decreased lysosome secretion upon opioid agonist exposure 
compared to the negative control. In addition, the K-KO platelets are not able to adhere as well, 
take longer to aggregate and have a more spread out appearance with less distinct filopodia than 
control platelets. The µ-KO mouse platelets had inhibited δ-granule secretion to a greater extent 
upon opioid agonist stimulation than both the K-KO and C57 platelets. There was also a 
difference in the final platelet shape which did not affect adhesion properties but had slightly 
enhanced aggregation. Medically, these data suggest that normal healthy platelet function will not 
be adversely affected when exposed to drugs containing opioids, including morphine and 
ketamine during surgery. However, one caveat is that these experiments do not mimic long-term 
platelet exposure to opioids nor does it account for how platelet behavior may change 
downstream of other cell types that are impacted by opioids.  
 
 
Figure 7 Representative activated platelet dark field scattering images for C57 
control mice (A), K-KO mice (B), and µ-KO mice (C). Microscope image exposure 
time for the knockout mouse platelets was increased compared to the control mouse 
platelets due to lower scattering efficiency. 
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Chapter 6: Platelets in Asthma: Platelet Response to Allergens, CXCL10, and CCL5 
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6.1 Overview 
Asthma is a chronic respiratory disease initiated by a variety of factors, including allergens. 
During an asthma attack, the secretion of C-X-C motif chemokine 10 (CXCL10) and chemokine 
ligand 5 (CCL5) cause the migration of immune cells, including neutrophils, mast cells, and 
platelets, into the lung and airways. Platelets, which contain three classes of chemical messenger-
filled granules, can secrete vasodilators (serotonin, adenosine diphosphate (ADP),  adenosine 
triphosphate (ATP), platelet activating factor (PAF)) and chemokines (CCL5, PAF4, C-X-C-
motif chemokine 12 (CXCL12)), amplifying the asthma response. The goal of this work was 
three fold: 1) to understand if and how IgE affects platelet response to the common platelet 
activator thrombin associated with clotting and bleeding, therefore allowing us to compare 
platelet function between people without (no IgE)  and with allergies or allergic asthma (IgE). It 
also gives a benchmark on whether any changes measured are due to IgE attachment or the 
allergic asthma related stimulants or a synergistic combination of the two; 2) to understand how 
allergen stimulation compares to thrombin stimulation; and 3) to monitor platelet response to the 
chemokines CXCL10, CCL5, and N-Formylmethionyl-leucyl-phenylalanin (fMLP). Herein, 
HPLC with electrochemical detection and/or carbon-fiber microelectrode amperometry were 
utilized to measure granular secretion events from platelets with and without IgE in the presence 
of an allergen, thrombin, CXCL10 or CCL5. Platelet adhesion and chemotaxis was measured 
using a microfluidic platform in the presence of the allergen TNP-Ova, CXCL10, or CCL5. 
Results from this study indicate that IgE binding changes δ-granule secretion in response to 
platelet stimulation by thrombin in bulk. Single cell results on platelets with exogenous IgE 
exposure show changes in membrane-granule fusion behavior during chemical messenger 
delivery events after thrombin stimulation. This change was further enhanced when IgE-
incubated platelets were exposed to the allergen TNP-Ova. Extent of platelet chemical messenger 
secretion in the presence of TNP-Ova is comparable to the secretion levels induced by thrombin 
stimulation. In addition to secretion, TNP-Ova stimulation enhanced platelet adhesion to 
endothelial cells. Finally, only after incubation with IgE did platelets secrete chemical messengers 
in response to stimulation with the chemokines CXCL10, CCL5, or fMLP. 
6.2 Introduction 
In 2011, Asthma, a chronic respiratory disease affecting around 25 million people in the 
United States according to the CDC and the prevalence of asthma is rising. 
1
 Asthma is triggered 
by a variety of factors, including exercise, air temperature, stress, respiratory infections, and 
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allergen presentation. During an asthma attack, smooth muscle cells contract to narrow the 
airways while epithelial cells initiate inflammatory processes through the secretion of 
chemokines, including CXCL10 and CCL5. CXCL10 and CCL5 help influence the movement of 
eosinophils, activated T-lymphocytes, macrophages, mast cells, and platelets into the lungs and 
lower airways including the airway smooth muscles and bronchial submucosa through the 
chemokine receptors CXCR3 and both CCR1 and CCR3, respectively.
2-9
 
Allergic asthma is brought on by an allergen crosslinking IgE bound to cell surfaces through 
the Fcε receptors on a variety of immune cells including mast cells, eosinophils, neutrophils and 
platelets. Platelets, which have been shown to express both the high and low affinity IgE 
receptors, have recently garnered attention for their role in the enhancement of asthma 
symptoms.
9-11
  
Platelets, a cell-like body commonly known for their role in hemostasis contain two main 
types of chemical messenger-filled granules (δ, α). The δ-granules contain small molecules 
including serotonin, adenosine diphosphate (ADP), adenosine triphosphate, Ca
2+
, and histamine 
which enhance vasodilation and cell activation.
12
 The α-granules contain a variety of growth 
factors, clotting factors, platelet factor 4, chemokines such as CCL5, and membrane adhesion 
molecules such as p-selectin.
13
 Upon activation, platelets can secrete their granular contents 
through exocytosis, which is a highly conserved biological process where the granule docks to the 
cell membrane, forming a fusion pore between the granule contents and extracellular space. Upon 
fusion pore formation, part or all of the granular contents are secreted into the extracellular 
environment. In parallel, platelet shape change and adhesion to endothelial cells and leukocytes 
additionally enhance the asthmatic response. Platelet attachment to leukocytes allows for 
migration into the interstitium, and previous research has demonstrated that asthmatic patients 
show elevated levels of platelet-leukocyte complexes in the lungs.
14
 The attachment to endothelial 
cells causes the secretion of additional chemokines by the endothelial cells, including IL-8, and 
the expression of the adhesion molecules ICAM on the endothelial cell surface.
15
  Finally, 
exposure to thee adhesion molecule p-selectin on platelets helps to prime eosinophil adhesion to 
the endothelium and eosinophil migration.
16
 
Platelets were first hypothesized to play a role in asthma in the early 1980s, 
17
 and since then 
have been shown to augment asthma symptoms through multiple pathways. Platelets with Fcε 
receptors have been found to migrate both in vitro towards the allergen they are sensitized to and 
in vivo from the vessels into the airways after an allergen challenge.
9
  Platelets also have the 
ability to activate and secrete their granular contents within ten minutes of an allergic response.
18-
  90 
21
 The secretion of chemokines and vasodilators drives the recruitment of eosinophils, leukocytes, 
and T-helper 2 cells. The expression of p-selectin, CD154, and CD40 on activated platelets then 
assist with the platelet-cell interaction, activation, and endothelial cell wall migration of these 
cells.
15,16,19
  Studies undertaken in platelet depletion models revealed a decrease in the progression 
of allergic asthma and reduced airway hyperresponsiveness, suggesting an important role for 
platelets and new therapeutic routes.
14,19,21,22
 
 Patient and animal models with allergic asthma present elevated levels of IgE in serum, often 
increasing with severity of the asthma.
23,24
 Platelets exposed to increasing concentrations of 
serum IgE correlated significantly with platelet abnormalities, including changes in aggregation, 
and response to strong and weak agonists when compared to control platelets.
25,26
 Platelet count 
was also decreased in patients with persistant asthma compared to healthy patients.
27
 In this 
study, we further explore the role of IgE on platelet response to thrombin, a natural platelet 
activator, using electrochemistry to monitor serotonin secretion from the δ-granules on both bulk 
(HPLC with electrochemistry) and single cell (carbon-fiber microelectrode amperometry 
(CFMA)) levels.  
In addition to measuring the effects of IgE on platelet function, the platelet response to 
allergens and the chemokines, CXCL10, CCL5, and N-formylmethionyl-leucyl-phenylalanine 
(fMLP), was monitored to determine if they can affect platelet secretion.  CXCL10 and CCL5 are 
chemokines known to induce both chemotaxis and activation of mast cells on a bulk and single 
cell level in the context of asthma and other inflammatory conditions. 
2, 28
  In contrast, fMLP is a 
bacteria-derived chemokine that is not associated with asthma, but has been shown to cause 
platelet chemotaxis and was used as a positive control to assess the microfluidic chemotaxis 
measurements.
29
 To the best of our knowledge, stimulation of platelets by these chemokines has 
not been probed. The platelets adherence to endothelial cells in a microfluidic device after 
stimulation in response to these chemokines and TNP-Ova will be discussed due to their role in 
activating endothelial cells and assisting in migration of leukocyte-platelet complexes into the 
lung during an asthma attack as discussed above.
14-16
 Due to the preliminary nature of this work, 
the discussion will identify trends seen in the data even when not statistically significant. 
Ongoing experimental replicates will allow conclusions with more statistical power. 
The results presented herein show that IgE-exposed platelet secretion changes with the 
incubation of IgE on a bulk cell level when responding to thrombin, a natural platelet stimulant. A 
biophysical change in the character of the membrane-granule fusion behavior during the chemical 
messenger delivery events was detected. Upon allergen (TNP-Ova) exposure, the membrane-
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granule fusion pore behavior change was enhanced, and the rate of serotonin secretion was highly 
variable compared to thrombin stimulation of IgE-incubated platelets. In these data, platelets 
secrete their δ-granule contents in response to the chosen chemokines only after incubation with 
IgE. Finally, of the conditions conditions considered, only activation by allergens increased 
platelet adhesion significantly compared to the negative control.  
6.3 Experimental Approach 
6.3.1 Reagents 
CXCL10 and CCL5 were purchased from Shenandoah Biotechnology, and fMLP was 
purchased from Sigma Aldrich. Stock powder was diluted into Tyrodes buffer (NaCl, 137 mM; 
KCl, 2.6 mM; MgCl2, 1.0mM; D-glucose, 5.6 mM; N-2-hydroxyethylpiperazine- N'-2-
ethanesulfonic acid (HEPES) 5.0 mM; and 12.1 mM NaHCO3, with pH adjusted to 7.3) at a final 
concentration of 100 μg/mL.  CXCL10 and CCL5 were stored at -80 oC, and fMLP was stored at 
-20 
o
C.  Anti-trinitrophenol (TNP) IgE and TNP-Ova were purchased from BD Biosciences and 
Fischer Scientific, respectively. The TNP-Ova was diluted in Tyrodes buffer before storage at -80 
o
C. All other reagents were purchased from Sigma Aldrich and used as received.  
6.3.2 Platelet Preparation 
Blood was drawn via cardiac stick from male C57BL/6J mice (Jackson Laboratories) 
following IACUC protocol #1403-31383A. After CO2 euthanasia, blood was drawn into syringes 
filled with 200 μL ACD (2 g citric acid, 5.6 g sodium citrate, 5 g glucose, and 250 mL Milli-Q 
water pH ~5.1).The blood was diluted with Tyrodes buffer, and centrifuged at 130 xg for 10 
minutes with brake level 2. The resultant platelet-rich plasma was put into 1.7 mL eppendorf 
tubes with 200 μL ACD and Tyrodes buffer before centrifugation at 524 xg for 10 minutes with 
brake level 2.  The pellet was then re-suspended in Tyrodes buffer. 
6.3.3 Bulk Serotonin Analysis 
For each sample, 125 μL of platelet suspension at 4 x 107 platelets/mL were incubated in 
either 125 μL of Tyrodes buffer or 1 μg/mL IgE in Tyrodes buffer for two hours at 37oC. 20 μL 
ACD was added to each vial, and samples were washed at 800 xg for 5 minutes. The platelets 
were resuspended in 125 μL Tyrodes buffer and 125 μL of stimulant for a 45 minute stimulation. 
The final concentration of each stimulant was 100 ng/mL for CXCL10, CCL5, fMLP, and TNP-
  92 
Ova, 1 unit/mL thrombin, Tyrodes buffer (negative control), or 0.25 μM HClO4 (lysis). All 
conditions had 5 biological replicates. 
The supernatant was filtered in a 96 well Millipore Multi Screen 0.45 µm filter plate at 3000 
xg for 5 min. 180 μL of supernatant was added to 20 μL of 5 μM dopamine internal standard in 
an HPLC vial. The sample was separated following a previously published protocol 
28
 using a 5 
μm, 4.6 mm × 150 mm Eclipse XDB C18 column on an Agilent 1200 HPLC with a Waters 2465 
electrochemical detector. The serotonin was detected with a Waters glassy carbon electrode set at 
a potential of 700 mV vs. Ag/AgCl. The mobile phase run at 2 mL/min, consisted of 11.6 mg/L of 
the surfactant sodium octyl sulfate, 170 μL/L dibutylamine, 55.8 mg/L Na2EDTA, 10% methanol, 
203 mg/L sodium acetate anhydrous, 0.1 M citric acid, and 120 mg/L sodium chloride. 
In addition, a calibration curve was run with serotonin concentrations ranging from 0.0625 
μM to 1 μM. The area underneath the serotonin spike and a dopamine internal standard spike was 
measured, and the ratio of serotonin to dopamine was recorded.  
6.3.4 Carbon-Fiber Microelectrode Fabrication 
Microelectrodes were fabricated as previously described.
30
 Briefly, carbon-fibers were 
aspirated through glass capillaries and then halved with a pipette puller. After trimming the 
carbon-fibers, the electrodes were epoxied using Epon Resin 828 (Miller-Stephenson) and 
metaphenylene diamine hardener, and finally cured at 25, 100 and 150
o
C overnight, for 4-16 
hours, and then for 2-6 hours, respectively. Before the experiment, the microelectrodes were 
beveled at 45
o
 with a diamond-coated polishing wheel and placed into isopropyl alcohol until 
needed.  
Glass micropipette puffers for stimulant delivery were made the day of the experiment. Glass 
capillaries were halved with a pipette puller, and the tips were trimmed to form an opening of 10-
50-μm-diameter. 
6.3.5 Carbon-Fiber Microelectrode Experiments and Data Analysis 
Amperometry experiments were performed using an Axopatch 200B potentiostat (Molecular 
Devices) with a 5 kHz low-pass Bessel filter, 20 mv/pA output gain, and 20 kHz collection rate. 
LabVIEW Tar Heel CV software (National Instruments) written by Michael L.A.V. Heien 
controlled computer interface settings and data acquisition.  
The platelet suspension was prepared as described above, and a final concentration of 
2x10
7platelets was incubated with 0.5 μg/mL IgE or Tyrodes buffer for 2 hours and washed at 
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800 xg for 5 minutes. A couple μL of platelet suspension was pipetted onto a poly-L-lysine-
coated cover slip and monitored with an inverted microscope equipped with phase contrast optics 
at 40x magnification (Nikon Instruments). Before measuring, the puffer (containing either 10 
units/mL thrombin or 100 ng/mL TNP-Ova) and electrode were placed near and on top of the 
platelet, respectively, using Burleigh PCS-5000 piezoelectric micromanipulators (Olympus 
America). The potentiostat was set to 700 mV vs. Ag/AgCl reference electrode. A picospritzer 
was used to puff a 3 second bolus of stimulant onto individual platelets, and the current was 
measured over a 90 second period. Each trace was filtered at 500 Hz and then converted to the 
correct file type with ABF Utility. The spikes were analyzed in Mini Analysis software written by 
Justin Lee (Synaptosoft).   
The number of spikes or individual granule secretion events in each trace (N) reveals the 
platelet’s ability to traffic granules to the cell membrane and achieve fusion. By analyzing each 
individual spike, membrane fusion pore stability and chemical messenger secretion kinetics can 
 
Figure 6.1 Carbon-fiber microelectrode amperometry and example traces. Carbon-
fiber microelectrode amperometry electrodes and puffer setup (A) with platelets on a 
coverglass coated with poly-L-lysine. After stimulation, the change in current for each 
granule secretion event is seen as a spike. Upon inspection of the spike, several biophysical 
parameters can be obtained including Trise, T1/2, the slope of the rise (10/90 slope), and the 
area underneath the spike (Q) which is associated with the molecules of serotonin secreted. 
The fusion pore stability can be observed by looking at the number of events with pre-, 
post-, and non-traditional spike features. (B) Finally, the number of granule secretion events 
per each trace can be counted. A representative trace from each condition is shown. (C) 
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be observed (Fig. 6.1 A and B). The integrated area underneath each time versus current spike 
reveals the charge (Q), which is translated to the number of serotonin molecules secreted from 
that granule using Faraday’s law. Trise, the time it takes for the current spike to rise from 10 to 
90% of its amplitude, and the 10/90 slope, the change in current over time from 10 to 90% of the 
total current amplitude, give insight into the opening of the fusion pore. T1/2 is the length of time 
of the full width at half maximum current amplitude and gives insight into how long the fusion 
event is allowing serotonin secretion. Finally, the presence of non-traditional current events, pre- 
or post-spike feet features, give indications about the stability of the dynamic fusion pore. More 
information on these features can be found in the following reference and chapter 2. 
31
 Current 
spikes classified as non-traditional events typically had hump-like features and did not follow the 
traditional quick rise and exponential decay. Pre-spike features included plateaus, ramps, and 
small spikes in current before the main spike. Typically, post-spike features indicate the granule 
re-opening causing another current spike or a continuous serotonin flux out of the granule after 
the initial spike. In this work, the number of traces analyzed for thrombin stimulation only 
experiments without and with IgE were 23 and 19 amperometric traces, respectively. For the 
thrombin vs. TNP-Ova conditions, 20 and 32 traces were analyzed, respectively. 
6.3.6 Adhesion  
Straight channel microfluidic devices were made as previously described. 
32, 33
 Briefly, the 
microfluidic channels were fabricated using standard photolithography techniques. The channel 
patterns were transferred onto the negative photoresist coated-silicon wafer via UV exposure. 
Polydimethylsiloxane (PDMS) was poured on the silicon wafer and cured overnight before 
permanent attachment to a glass coverslip. The final dimensions of each channel were 1.5 cm (L) 
x 100 μm (H) x 1 mm (W). Each device contained 4 channels for parallel adhesion experiments. 
To coat the device with human endothelial cells (hy926, ATCC), 2.5 mg/mL human fibronectin 
(Invitrogen) was incubated in the channel for an hour before endothelial cell injection. Then, an 
endothelial cell suspension (~60 μL) with the desired cell density (5-6 × 106 cells/mL) was 
injected into the channel for surface coating. After 2 hours, the media was exchanged to remove 
any non-adherent cells. The cells in the device were fed with fresh media every day for 3 to 5 
days. 
On the day of experiments, platelets (4x10
7 platelets/mL) were incubated with 0.5 μM IgE for 
2 hours and washed at 800 xg for 5 min after the addition of ADC. The pellet was suspended in 2 
mL Tyrodes buffer for a final concentration of ~2x10
7 
platelets/mL. Next, the platelets were 
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incubated with 2 μM 5-chloromethylfluorescein diacetate (CMFDA) dye for 20 minutes at 37 oC 
with minimal exposure to light before washing at 800 xg and re-suspending in Tyrodes. Finally, 
500 μL of platelet suspension was spiked with 0.5 μg/mL TNP-Ova, CXCL10, or CCL5 at a final 
concentration of 100 ng/mL. Control platelets were kept in Tyrodes buffer. Immediately 
following exposure to the stimulant, the platelets were flowed through the device at 60 μL/hour 
for 30 minutes. The device was then washed with Tyrodes buffer at the same rate for 15 minutes 
to remove unadhered or loosely adherent platelets.  Five random 204.8 μm x 204.8 μm areas of 
each channel were imaged using a Nikon Microscope with a 40x oil immersion objective and a 
QuantEM Photometrics CCD camera. Metamorph version 7.7.5 image analysis program was used 
to count the number of platelets adhered in each channel based on the fluorescence signal. The 
platelet count was compared to the control channel in the same device. 4 devices with 4 channels 
in each device were used to monitor platelet adhesion giving a total of 4 analytical replicates per 
condition.  
6.3.7 Platelet Chemotaxis 
Two adhesion devices were used to monitor chemotaxis. Both microfluidic platforms (Fig. 
6.2) were molded and fabricated as previously described.
34
  For the gradient device (Fig. 6.2A), 
2.5 mg/mL human fibronectin (Invitrogen) was injected into the channel for 1 h to coat the 
surface before endothelial cell addition. Then, an endothelial cell suspension (20 μL) with the 
desired cell density (4-5 × 10
6
 cells/mL) was introduced into the cell inlet for channel coating. 
The cells in the device were fed with fresh media every day for 3 to 5 days. To form a chemical 
gradient, 100 ng/mL fMLP and Tyrodes buffer were injected through left and right inlets, 
respectively, at a flow rate of 100 μL/h for 30 min.  
For the gel device (Fig. 6.2B), the gel chamber was injected with 30 μL of 1 mg/mL poly-D-
lysine (PDL) solution and incubated at 37
o
C for a minimum of four hours before washing with 
Milli-Q water and putting into the oven at 65 
o
C for 24-48 hours. After cooling, the gel device 
chambers were filled with 2 mg/mL Collagen type I gel solution (BD Biosciences) while being 
kept in a humid pipette box for 40 minutes at 37 
o
C with 5% CO2. After gel polymerization, 20 
µL of DMEM medium was introduced into each side channel, and the four reservoirs were 
aspirated before 10 μL endothelial cell suspension was added into one side channel at a density 
between 8 and 10 × 10
5 
cells/mL. All non-adherent cells were washed out with fresh media after 
30 min initial incubation, and then the devices were placed in the incubator overnight at 37 
o
C 
with 5% CO2, and a confluent endothelial layer was observed on the side wall of the gel. Before 
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platelet addition, 50 ng/mL fMLP solution was added into the side channel without endothelial 
cells while Tyrodes buffer was added into the other side channel to create a gradient across the 
gel chamber. The formation of stable chemical gradients takes 2 h according to the molecular 
diffusion simulation results.
33 
Platelets, IgE, and CMFDA dye incubation were done as previously described in the adhesion 
studies.  After incubation, platelets were either activated with 5 μM ADP or 100 ng/mL TNP-Ova 
or not activated before injection into the bottom cell chamber of gradient device and endothelial 
cell side channel of the gel device, respectively. The fluorescently labeled platelets were imaged 
on a Nikon Microscope with a 40x oil immersion objective with a QuantEM Photometrics CCD 
camera. The Metamorph version 7.7.5 image analysis program was used to track platelet 
movement in the gradient device and count the number of platelets that moved into the gel.  In the 
gradient device, single cell movement was monitored for 30 min with images recorded every 20 
seconds. In contrast, the gel device was imaged every other hour for 5 hours. 
6.3.8 Data Analysis 
All graphs were made and analyzed in Graphpad Prism 6, and the error bars represent the 
standard error of the mean. Statistical differences were tested using one-way ANOVA. Any 
outliers in the bulk analysis were q-tested out with 95% confidence. For CFMA, traces with only 
one granule secretion event were also removed from statistical analysis.  
 
Figure 6.2 Chemotaxis devices. Gradient (A) and gel (B) microfluidic devices used to 
monitor platelet chemotaxis. To understand chemotaxis, cell motion in the gradient device 
was monitored, while cell count in the chemotaxis chamber of the gel device was used to 
characterize platelet infiltration 
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6.4 Results and Discussion 
6.4.1 Thrombin Response after IgE incubation 
Bulk platelet serotonin secretion from δ-body granules in response to 1 units/mL thrombin or 
0.5 μM HClO4 (lysis condition) was monitored after incubation with 0.5 μg/mL IgE in Tyrodes 
buffer or Tyrodes buffer alone (Fig. 6.3). The amount of serotonin secreted during IgE incubation 
was measured, and no difference was noted between platelets incubated with Tyrodes buffer or 
Tyrodes buffer with IgE (data not shown), suggesting that IgE incubation does not cause platelet 
activation. In addition, the total platelet serotonin content, determined by cell lysis, did not 
significantly change after incubation with IgE. When stimulated with thrombin, a strong platelet 
activator associated with clotting and bleeding, both thrombin conditions secreted less serotonin 
than both lysis conditions (p≤0.01 for IgE-incubated platelets and p≤0.0001 for non-IgE 
incubated platelets). Between the thrombin conditions, IgE incubated platelets secreted 
significantly more serotonin than non-IgE incubated platelets (p≤0.001). This difference suggests 
that IgE incubation is causing variations in granular secretion, since platelet populations and 
stimulation are similar.  
To investigate these differences, the fusion pore stability and chemical messenger secretion 
kinetics during the granule-membrane interaction, as well as the platelets’ ability to traffic 
 
Figure 6.3 Serotonin secretion of platelets with and without IgE in response to 
thrombin. Percent of total serotonin release from platelets after incubation with or 
without IgE and then stimulation with HClO4 (lysis) or  thrombin (natural platelet 
stimulant). ++ p ≤0.01 and ++++ p≤0.0001 vs. both lysis conditions ***p≤0.001 vs. 
indicated position. 
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granules to the platelet membrane, were monitored using CFMA. Representative traces for 
thrombin stimulation can be seen in Fig. 6.1C. Unlike the bulk cell secretion measurements, the 
total amount of serotonin secreted by individual platelets and the amount secreted per granule 
were not significantly different when measured with and without IgE incubation (Fig. 6.4A and 
B). However, it is clear that the average amount of serotonin secretion per platelet after 
incubation with IgE is more likely the cause of the increased serotonin secretion in the bulk rather 
than the number of granules being secreted, which did not change between the platelets incubated 
with and without IgE (Fig. 6.4C). This is reasonable considering that IgE is interacting with the 
membrane and should not impact the ability for the platelet to transport granules to the membrane 
surface. The fusion pore kinetics was also not significantly different (Fig. 6.4 D and E). The slight 
variations suggest there may be small differences in the membrane-granule interaction, but 
nothing that impacts the net chemical messenger secretion. Finally, the stability of the granule-
membrane fusion pore was analyzed by counting the number of spike feature variations often 
termed feet or non-traditional events as described in Chapter 2 (Fig. 6.1 B and Fig. 6.4F)The 
number of post-spike feet increased in IgE-incubated platelets compared to non-incubated 
platelets from 10.1% to 28.5% (p≤0.05). The percent of post spike feet for the control in this 
experiment was unusually high considering that post-spike feet are the least common type of 
spike feature, often seen around 2-4% of the time in PC12 cells and platelets.
31,35
 However, the 
282 % increase is still a large increase considering that in  previous research from our lab, a 31% 
increase of cholesterol in platelets, which helps with inhibiting both opening and closing of the 
fusion pore, only caused ~155% increase in post-spike feet features.
31, 36
 It was also noticed that 
both pre- and post-spike feet features would occur in the same spike with an occurrence of 9.5% 
in platelets incubated with IgE vs. only 1.1% of the time in control platelets. This co-occurrence 
suggests that the change in membrane in the presence of IgE hinders the ability for the lipids to 
transition between positive and negative curvatures smoothly to open and close the fusion pore. 
Overall, these data suggest that IgE can affect the platelet’s ability to secrete δ-granule 
contents in response to thrombin on a bulk cell level and single cell results show an average 
increase in secretion from individual granules. This increase might be caused by changes in the 
opening and closing of the granule’s fusion pore that varies with IgE incubation. 
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6.4.2 Platelet Response to Allergens 
Platelet response to allergens has already been established. 
18-21
 However, the amount of 
response relative to thrombin, a strong platelet activator, has not been explored. This information 
will give a basis for benchmarking how strong of an activator the allergen is compared to the 
common clotting stimulant thrombin. In preliminary bulk cell studies (Fig. 6.5), as expected, 
platelet secretion was stimulated by TNP-Ova only after exposure to IgE. The total amount of 
 
Figure 6.4 Carbon-fiber microelectrode amperometry data for platelets 
stimulated with thrombin: Single cell comparison of thrombin stimulation after 
platelets were incubated without or with IgE. The total amount of serotonin 
secreted per platelet (A) was calculated using the amount of serotonin secretion 
per granule (B) and number of granule release events (C). Platelets incubated 
with IgE demonstrated an average decrease in fusion pore opening time (D) and 
decreased release time (E). The only statistically significant difference was the 
number of post-spike foot features (F). This accumulated data suggests that the 
IgE may have a small impact on the fusion pore’s ability to appropriately open 
and close, but this does not impact platelets’ δ-granule response to thrombin. 
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serotonin secreted (75.1% of the control platelet lysis concentration) was comparable to the 
response seen from thrombin. On a single cell level, platelets and individual granules also 
secreted the same amount of serotonin in response to stimulation with thrombin and TNP-Ova. 
(Fig. 6.6 A,B) In addition, no differences were noted in their ability to traffic granules (Fig. 
6.6C). This amount of secretion from allergen stimulation further supports the platelets’ role in 
inflammation processes.  
The fusion pore kinetics (Trise and T1/2) did not significantly change when comparing 
thrombin and TNP-Ova stimulation (Fig. 6.7A, B). However, many of the amperometric traces 
were characterized by higher amplitude spikes that generally had steep slopes upon TNP-Ova 
stimulation, suggesting that the flux of serotonin was more rapid when compared to thrombin 
stimulation. T1/2 values could not capture the fact that these spikes were reaching higher 
amplitudes since the time was not significantly different than that seen by thrombin. To explore 
 
Figure 6.5 Preliminary platelet δ-granule bulk response to thrombin and TNP-Ova 
stimulation after incubation with IgE. **p≤0.01 **** p≤0.0001 vs. indicated conditions  
 
Figure 6.6 Platelet δ-granule response to thrombin and TNP-Ova stimulation after 
incubation with IgE. No statistical difference was noted in the total amount of serotonin 
released per platelet (A), or granule (B). The number of granule fusion events also stayed 
the same (C). 
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this, the slope from 10 to 90% of the spike amplitude was measured. (Fig. 6.7 C). No significant 
difference was noticed when all the individual spike values were averaged, but a histogram of the 
10/90 slope values show a large spread for stimulation with TNP-Ova compared to thrombin 
stimulation. All the thrombin conditions had 10/90 slopes at 55 pA/ms or under with 95% of 
spikes being in the first bin. By contrast, only 64% of TNP-Ova stimulated event values fell into 
the first bins (Fig. 6.7 D). The quick thrombin induced secretion events often displayed a post-
spike foot feature, typically as seen in Fig. 6.1B. This slope contributed to the significant rise in 
post spike feet features compared to thrombin stimulation from platelets incubated with IgE. (Fig. 
6.7 E)  
 
 
Figure 6.7 Granule fusion pore dynamics upon thrombin and TNP-Ova 
stimulation. Granule fusion pore kinetics were not changed between stimulation with 
thrombin and TNP-Ova on IgE-incubated platelets (A,B). TNP-Ova stimulation’s 10/90 
slope for each spike showed a slight average increase, indicating that serotonin was 
released faster from the granule in many cases (C). The histogram of 10/90 slopes 
shows that TNP-Ova had a greater spread of 10/90 slopes compared to thrombin-
stimulated platelets (D). The increased 10/90 slopes often came with post-spike 
features, which played a role in the significant increase in post spike foot features for 
allergen stimulation compared to thrombin (E).  
+
2 data points at 410 and 580 pA/ms for TNP-Ova stimulation are hidden *p≤0.05 and 
***p≤0.001 vs. thrombin IgE stimulation post spike feet features. 
  102 
The exact signaling cascade for TNP-Ova stimulation in platelets is not fully known, to the 
best of our knowledge. However, these data suggest that platelets respond similarly to allergens 
as to the strong stimulant thrombin in terms of granule trafficking and total serotonin secretion. 
The ability for allergens to stimulate platelets to the same extent as thrombin indicates that 
platelets have the potential to play a large role in inflammation processes by the secretion of their 
granular contents, including vasodilators (ADP, ATP, PAF and serotonin)  and chemokines (PAF, 
CCL5, and CXCL10).  However, examination of the individual granule secretion events suggest 
that there is a wide spread in how fast the serotonin is secreted from the granule and that the 
stability of fusion pore closure is compromised when exposed to allergens compared to thrombin 
stimulation of IgE-incubated platelets. 
6.4.3 Platelet Response to CXCL10, CCL5, and fMLP 
CXCL10, CCL5, and fMLP are known for their involvement in chemotaxis, but not cell 
exocytosis. However, previous research on mast cells discussed in Chapter 7, have shown that 
mast cells secrete their granular contents in response to CXCL10 and CCL5.
28 
To understand if 
platelets will respond similarly, platelet secretion was measured after exposure to CXCL10, 
CCL5, and fMLP for 45 minutes.
 
Only IgE-incubated platelets had significant serotonin secretion 
compared to the negative control (Tyrodes buffer) (Fig. 6.8). This secretion was significantly 
different than the negative control (Tyrodes buffer) with and without IgE incubation and all 
 
Figure 6.8 Secretion of serotonin in response to CXCL10, CCL5, and fMLP on 
platelets incubated without and with IgE incubation. All platelets activated with IgE 
showed significant secretion compared to the negative control. ****P≤0.0001 vs. both 
Tyrodes conditions and all non IgE incubated platelets exposed to the chemoattractants. 
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chemoattractant stimulation of platelets without IgE (p≤0.0001). Further experiments must be 
performed to understand how these chemoattractants affect granule kinetics and fusion pore 
stability in platelets at the single cell level.  
6.4.4 Platelet Adhesion 
In addition to secretion, the ability for platelets to adhere is important for enhancing the 
allergic reaction by allowing infiltration of leukocytes and eosinophil into the lung tissue. In 
addition, attachment of platelets to endothelial cells is known to cause endothelial cells to express 
ICAM and secrete the chemoattractant IL8.
14-16
 IgE-incubated platelets stimulated with CXCL10, 
CCL5, or TNP-Ova were flowed over a straight microfluidic channel, and the number of platelets 
that adhered to an endothelial cell layer were counted and compared to non-stimulated platelets. 
In total 4 analytical replicates were run with 5 images taken along each channel.  The control 
platelets on each device had between 22-40 platelets that adhered with an average of 33 platelets. 
Platelet adhesion was only significantly increased when the platelets were exposed to the allergen 
TNP-Ova.  
6.4.5 Platelet Chemotaxis 
Finally, the ability of platelets to infiltrate the lung can play a large role in enhancing 
inflammation. Previous literature has demonstrated the ability for platelets to move in response to 
 
Figure 6.9 Platelet adhesion in response to CXCL10, CCL5, and TNP-Ova. Platelets 
were stimulated with CXCL10, CCL5, or TNP-Ova before introduction into a 
microfluidic straight channel device lined with endothelial cells. The number of adherent 
platelets were counted and compared to the non-stimulated platelets in each device. 
*P≤0.05 vs. Tyrodes control condition 
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fMLP at ~ 43.7ng/mL.
29
 Initial experiments were performed with 100 ng/mL fMLP to act as a 
positive control within this simple microfluidic device that was initially created to monitor 
neutrophil chemotaxis and angiogenesis.
33,34
  The aim of this experiment was to determine if 
platelets follow a chemoattractant gradient and to see if they are able to move through or on an 
endothelial cell wall, mimicking movement into the lung. In this set of experiments, no platelet 
movement was detected in response to fMLP, the positive control, in either device under various 
conditions including IgE-incubated platelets activated by 5 μm ADP, 100 ng/mL TNP-Ova or no 
activation (data not shown). Therefore, CXCL10 and CCL5 experiments were not performed. 
Two potential reasons that these experiments may not have worked, include that the endothelial 
cells may not be expressing the adhesion molecules that are needed for chemotaxis and both 
devices had flow rates that might have prevented the adhesion and chemotaxis of the platelets. 
6.5 Conclusion 
The aim of this paper was to gain more in-depth information on the role of platelets in asthma 
by looking at the interaction with the chemoattractants CXCL10 and CCL5 known to be secreted 
during an asthma attack, the response to allergens that can trigger asthma, and the effects of IgE 
on platelet function. Results show that platelet incubation with IgE changes the platelet’s ability 
to respond to the strong platelet stimulant thrombin. In addition, the membrane fusion pore 
dynamics change after exposure to IgE. This change in membrane fusion pore dynamics, 
particularly the increase in post spike feet, was enhanced by stimulating the platelets with TNP-
Ova. The post spike-foot increase was partially due to a larger number of spikes, which are 
characterized by the quick release of large amounts of serotonin, and can be quantified using 
10/90 slope. The large 10/90 slope secretion events typically have ramp-like post-spike features 
indicating that there may be variations in the membrane around the granule fusion pore which 
inhibit or enhance the closing between platelets stimulated with TNP-Ova or thrombin . TNP-Ova 
stimulation caused serotonin secretion that is comparable to thrombin stimulation, suggesting that 
platelets have the ability to play a large role in amplifying asthma, making them a potential 
therapeutic target. Platelets were also able to adhere to endothelial cells upon stimulation with 
TNP-Ova which may allow for increased infiltration of immune cells into the lungs. 
 In preliminary experiments, the chemoattractants CXCL10, CCL5, and fMLP showed 
platelet stimulation only after incubation with IgE. Previous studies have demonstrated that, when 
exposed to IgE, platelets up-regulate CD154 which helps with the allergen response.
19
 A similar 
mechanism may be responsible for the platelets ability to respond to chemoattractants only after 
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IgE incubation. The platelet response to the chemoattractants was not as strong as the platelet 
response to TNP-Ova. Finally, even though previous studies have demonstrated platelet 
chemotaxis in response to fMLP, we were not able to verify this with our preliminary work in 
microfluidic models. 
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Chapter 7: Time- and Concentration-Dependent Effects of Exogenous Serotonin 
and Inflammatory Cytokines on Mast Cell Function 
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7.1 Overview 
Mast cells play a significant role in both the innate and adaptive immune response; however, 
the tissue-bound nature of mast cells presents an experimental roadblock to performing 
physiologically relevant mast cell experiments. In this work, a heterogeneous cell culture 
containing primary culture murine peritoneal mast cells (MPMCs) was studied to characterize the 
time-dependence of mast cell response to allergen stimulation, and the time- and concentration-
dependence of the ability of the heterogeneous MPMC culture to uptake and degranulate 
exogenous serotonin using high performance liquid chromatography (HPLC) coupled to an 
electrochemical detector. Additionally, because mast cells play a central role in asthma, MPMCs 
were exposed to CXCL10 and CCL5, two important asthma-related inflammatory cytokines that 
have recently been shown to induce mast cell degranulation. MPMC response to both allergen 
exposure and cytokine exposure was evaluated for 5-HT secretion and bioactive lipid formation 
using ultraperformance liquid chromatography coupled to an electrospray ionization triple 
quadrupole mass spectrometer (UPLC-MS/MS). In this work, MPMC response was shown to be 
highly regulated and responsive to subtle alterations in a complex environment through time and 
concentration dependent degranulation and bioactive lipid formation. These results highlight the 
importance of selecting an appropriate mast cell model when studying mast cell involvement in 
allergic response and inflammation  
7.2 Introduction 
Mast cells are tissue-bound cells of hematopoetic origin widely known for their roles in 
inflammation and allergic response. They also have roles in innate immunity, host defense against 
parasitic and bacterial infection, wound healing, tissue homeostasis, and disease states such as 
vasculitis and fibrosis.
1-3
 Mast cell function is often thought to be dominated by their cytosolic 
granules that contain inflammatory mediators, including enzymes such as tryptase and chymase, 
highly charged biopolymers such as heparin or chondroitin sulfate, and small molecule 
messengers such as serotonin (5-hydroxytryptamine, 5-HT) and histamine. In addition to granule-
stored mediators, mast cells produce and secrete bioactive lipid compounds via enzymatic 
transformations of their phospholipid membranes. In vivo mast cell secretion of both granule-
stored and de novo manufactured inflammatory mediators influence surrounding cell types, 
leading to symptoms commonly associated with allergic response, including mucus 
hypersecretion, bronchoconstriction, and vasodilation.
4, 5
 Based on their significant involvement 
in both innate and adaptive immune response, there are many research groups that aim to study 
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mast cell behavior; however, there are several experimental roadblocks to performing 
physiologically relevant mast cell experiments.  
Mature mast cells are tissue bound, and as such, it is difficult to isolate large numbers of pure 
populations for study; due to this challenge, several different in vitro strategies for mast cell 
culture are commonly used in experimental work. Isolation of pure populations of mast cells 
typically requires tissue homogenization followed by several immunomagnetic separation steps, 
which can affect the activation state of the mast cells and gives low cell yields. To circumvent this 
challenge, studies of mast cells are often performed using immortal tumor-derived cell lines such 
as rat basophilic leukemia 2H3 (RBL) cells or the human mast cell lines HMC-1 or LAD2. 
Benefits of immortal cell lines include homogeneity and ease of culture; however, studies of 
adherence, receptor expression, and enzyme content have shown each of these mast cell-like cells 
lines to be only marginally representative of mature, tissue bound, non-transformed mast cells.
6-8
 
Another strategy for mast cell studies involve culturing mast cell-like cells from bone marrow or 
blood-derived immature precursors for 4-6 weeks with chemokines to drive mast cell maturation. 
Such cell cultures produce generally homogeneous mast cell-like cell populations, but they are 
not ideal due to length of culture time, expense of culture media, scarcity of precursor cells, and 
disparity between in vivo and in vitro culture conditions.  Studies of primary culture mast cells 
employ the isolation of a cell suspension often from a mouse or rat peritoneal cavity. Cell 
suspensions generally contain a mixture of cells including ~3% mast cells, ~ 30% macrophages 
~50-60% B cells and ~5-10% T cells and are co-cultured with fibroblasts to maintain mast cell 
viability.
9,10
 These heterogeneous cell cultures more closely model the in vivo environment of 
mast cells, which are in contact with macrophages and connective tissue cells but present 
challenges because mast cells make up less than 3% of the total cell population. It is already well 
known that IgE-sensitized mast cells secrete serotonin in several different cell models. However, 
how mast cell models change their response to their environment and the effects that the 
environment plays in IgE-allergen secretion over a period of time, in which mediators can 
stimulate other cell types or be cleared from the extracellular milieu, has not been evaluated. In 
this work, a heterogeneous cell culture containing primary culture murine peritoneal mast cells 
(MPMCs) is studied to characterize the time-dependence of mast cell response to allergen 
stimulation. The serotonin secretion behavior of MPMCs in a heterogeneous cell culture was 
compared to that from immortal RBL cells. When an unexpected 5-HT secretion trend was 
observed in the primary culture MPMCs, the time- and concentration-dependence of serotonin 
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uptake in the heterogeneous MPMC culture was examined. Additionally, because mast cells play 
a central role in inflammatory diseases such as asthma, primary culture mast cells were exposed 
to CXCL10 and CCL5, two important asthma-related inflammatory cytokines that have recently 
been shown to induce mast cell degranulation at the single-cell level with different degranulation 
kinetics than IgE-mediated response to allergen.
11
 To further understand these differences in time-
dependent mast cell communication mechanisms, MPMC secretion of 5-HT and bioactive lipids 
was measured at various time points from 10 - 90 min following exogenous 5-HT exposure. 
These experiments aim to reveal differences in mast cell biochemical pathways leading to 
exocytosis. 
7.3 Experimental Approach 
7.3.1 Reagents 
All materials used for cell culture were obtained from HyClone. Recombinant murine 
CXCL10 and CCL5 were purchased from Shenandoah Biotechnology Inc. and stored as 
suggested. LTC4, LTD4, LTE4, PGD2, and PAF and internal standards LTC4-d5, LTD4-d5, LTE4-d5, 
PGD2-d9, and PAF-d4 were purchased from Cayman Chemical and used as received. LC/MS-
grade acetonitrile (ACN) and water were purchased from JT Baker. LC/MS grade isopropyl 
alcohol (IPA) and a penicillin/streptomycin mixture were purchased from Fisher Scientific. Anti-
trinitrophenol (TNP) IgE was purchased from BD Biosciences, while TNP-ovalabumin (TNP-
Ova) was purchased from Fisher Scientific.  
7.3.2 Mast Cell Isolation and Exposure to Chemokines 
MPMCs were harvested from 10 week old C57BL/6J mice purchased from The Jackson 
Laboratory. Briefly, 8-9 mL of DMEM supplemented with 10% bovine calf serum and 1% 
penicillin and streptomycin (henceforth referred to as media) were injected into the peritoneal 
cavity of each mouse immediately following euthanasia (by CO2 asphyxiation according to 
IACUC-approved protocol #0807A40164). Following a 30 second abdominal massage, 
approximately 6-7 mL of peritoneal lavage fluid per mouse were recovered. The collected cell 
suspension was pelleted by centrifugation at 450xg for 10 minutes, resuspended at 2 x 10
6
 cells 
mL
-1
 in fresh media, and plated over Swiss albino 3t3 fibroblasts (purchased from ATCC). Cells 
were then cultured overnight with additional 500 μL of fresh media containing anti-TNP IgE such 
that the concentration of IgE in each well was 0.5 µg mL
-1
. 
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After overnight incubation, MPMCs were washed three times with tris buffer (12.5 mM 
Trizma-HCl, 150 mM NaCl, 4.2 mM KCl, 5.6 mM glucose, 1.5 mMCaCl2, 1.4mM MgCl2) at 37 
°C to remove serum-containing media. To investigate 5-HT processing by the cell culture, 
MPMCs were incubated with 0.1-0.55 µM 5-HT or tris buffer as a control, the supernatant was 
collected at specific time points, and the cells were lysed with 0.5 µM HClO4 for 30 min. The 
supernatant and lysate 5-HT content was assessed by HPLC at various timepoints. For 
experiments evaluating the effect of stimulation with TNP-Ova, CXCL10, or CCL5 on MPMCs, 
cells were incubated for either 2 hours or particular time points of 10, 30, 60, and 90 minutes with 
tris buffer or with tris buffer containing 0.2-200 ng mL
-1
 CXCL10, 0.2-200 ng mL
-1
 CCL5, or 100 
ng mL
-1
 TNP-Ova. Following incubation, degranulation was terminated by incubating the cells on 
ice for 10 minutes, and supernatants were collected for analysis by UPLC-MS/MS or HPLC with 
electrochemical detection. 
7.3.3 HPLC Analysis of Serotonin 
MPMC-secreted serotonin was detected and quantified by HPLC coupled to an 
electrochemical detector using a modified version of a previously published protocol.
12
 Briefly, 
following MPMC incubation, 250 µL of supernatant was collected and filtered using a 0.45μm 
filter plate from Millipore (Billerica, MA) at 3000xg for 5 min. 180 μL of the filtered supernatant 
was added to 20 μL of 5 μM dopamine (used as an internal standard) in 0.5M HClO4 for final 
concentrations of 0.5 µM dopamine and 500 mM HClO4. The samples were vortexed and injected 
by an autosampler into an Agilent 1200 HPLC. Separation was achieved using a 5μm, 4.6 x 150 
mm Eclipse XDB C18 column attached to a Waters 2465 electrochemical detector with a glassy 
carbon-based electrode. The working potential was set at 0.7 V vs. an in situ Ag/AgCl reference 
electrode with a current range of 50 nA. The HPLC flow rate was 2 mL/min using a mobile phase 
mixture consisting of 11.6 mg L
-1
 of the surfactant sodium octyl sulfate, 170μL L-1 dibutylamine, 
55.8 mg L
-1
 Na2EDTA, 10% methanol, 203 mg L
-1
 sodium acetate anhydrous, 0.1M citric acid, 
and 120 mg L
-1
 sodium chloride. 
A 5 point calibration curve was constructed by plotting the ratio of serotonin to dopamine 
(internal standard) spike areas in solutions containing 500 nM dopamine and 28-1000 nM 
serotonin in 0.5 M HClO4. The line of best fit for an average calibration curve for several 
representative experiments was y = 2.0578+0.0088 with R
2
=0.9992, where y = spike area of 5-
HT/spike area of internal standard and x = 5-HT concentration. Cell-secreted serotonin was 
quantified using the experimentally generated calibration curve. 
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7.3.4 UPLC-MS/MS Determination of Secreted Lipids 
UPLC-MS/MS analysis was performed using a previously published method.
13
 Briefly, 
supernatants from MPMCs were collected, spiked with 25 ppb of each of the internal standards 
LTC4-d5, LTD4-d5, LTE4-d5, PGD2-d9, and PAF-d4 and concentrated in a centrifugal evaporator 
until the remaining volume was approximately 50 μL. After concentrating, salts were precipitated 
by the addition of 100 µL ice-cold ethanol containing 0.1% formic acid (FA) and 200 μL mobile 
phase B (90/10 ACN/IPA containing 0.1% FA). Precipitated salts were removed by centrifuging 
for 10 minutes at 12,000 RCF, and supernatants were again concentrated to approximately 20 µL. 
Samples were then resuspended in 100 µL 70/30 mobile phase A/mobile phase B (with A: water 
containing 0.1% formic acid and B: 90/10 acetonitrile/isopropyl alcohol containing 0.1% formic 
acid). For UPLC-MS/MS analysis, a Waters Acquity UPLC coupled to a Waters triple quadrupole 
mass spectrometer (Acquity TQD) were used. Separation was performed on a Waters BEH C-18 
2.1 mm x 50 mm column at 45 °C employing the following 5 min gradient separation at a flow 
rate of 0.6 mL per minute: 30% B, 0 min to 0.5 min; 30% B to 50% B, 0.5 min to 1.0 min; 50% B 
1.0 min to 2.0 min; 50% B to 90% B, 2.0 min to 2.2 min; 90% B, 2.2 min to 3.2 min; 90% B to 
30% B, 3.2 min to 3.5 min; and 30% B, 3.5 min to 5.0 min. 
7.3.5 Assay for β-Hex Secretion 
To determine if incubation with 5-HT directly induced MPMC degranulation, supernatant 
content of the granule-stored enzyme β-hexosaminidase (β-Hex) was assessed as described 
previously.
13, 14
 Briefly, 50 µL supernatant samples were collected in a 96 well plate and stored 
overnight at -80°C. When thawed, supernatants were incubated for 60 min at 37°C with 100 µL 1 
mM 4-nitrophenyl N-acetyl-β-D-glucosaminide in 0.1 M citrate buffer at pH 4.5. After 60 min, 
150 µL ice cold 0.1 M carbonate buffer at pH 9 was added, and absorbance of each well was 
recorded at 405 nm with a background subtraction absorbance reading at 630 nm. 
7.4 Results and Discussion 
7.4.1 Time-dependent MPMC and RBL Cell Response to IgE-mediated Stimulation 
While MPMCs have been used for many studies of single mast cell secretion kinetics (usually 
tracking events on the ms to s timescale), the longer term (min-hrs) serotonin secretion of 
MPMCs in a heterogeneous cell culture has not been explored. To examine the time-dependence 
of mast cell response to IgE-mediated allergen stimulation, MPMCs were incubated overnight 
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with anti-TNP IgE, washed three times, then exposed to 100 ng mL
-1
 TNP-Ova. After exposure to 
TNP-Ova, supernatants from the adherent cell culture were collected and analyzed for secreted 
mediators at discrete time points to probe the kinetics of long-term secretion of preformed 
granules. As previous research has indicated that exocytotic cells only partially secrete their 
granule contents upon direct stimulation,
15
 it was hypothesized that supernatant 5-HT 
concentration would steadily increase over the course of 90 min exposure to allergen stimulation. 
However, Fig. 7.1A shows that over the course of 90 min, exposure to TNP-Ova resulted in an 
increase followed by a decrease in secreted serotonin. Unsurprisingly, after 10 min of incubation 
with TNP-Ova, secreted serotonin increased to 571 ± 30% of control serotonin. After 10 min, 
however, serotonin concentration in MPMC supernatants ([5-HT]supernatant) steadily decreased to 
351 ± 30% of 5-HT control cell concentration at 90 min (Fig. 7.1A).  MPMCs are cultured in a 
heterogeneous cellular environment, and although this type of cell culture more closely models 
the in vivo cellular environment than homogeneous immortal cell lines, heterogeneity can 
obscure the fate of the secreted serotonin. To probe the effect of the heterogeneous cell culture on 
secreted serotonin, MPMC 5-HT secretion was compared to that of the homogenous RBL cell 
line. RBL cells, while widely accepted as different from mast cells, share the common mast cell 
traits of adherence, FcεRI receptor expression, and degranulation in response to IgE-mediated 
stimulation.
8
 Figure 7.1 shows that the RBL cells continually secrete more serotonin over the 
course of 90 min, quite distinct from the serotonin secretion trend exhibited by cultured MPMCs. 
When compared to the steadily increasing RBL cell [5-HT]supernatant concentration (Fig. 7.1B), the 
decreasing trend in MPMC [5-HT]supernatant (Fig. 7.1A) indicates a process of metabolism or 
 
Figure 7.1 Time-dependent effects of serotonin secretion: secretion from A. MPMCs 
and B. RBL cells. ****p < 0.0001 vs. supernatant 5-HT concentration of control 
(unactivated) MPMCs or RBL cells. Control refers to the concentration of 5-HT in the 
supernatant of MPMCs for A RBL cells for B exposed to tris buffer, normalized to 100%. 
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reuptake by the cells in culture. This difference demonstrates the importance of the choice of cell 
culture when examining cell-to-cell communication behavior and interactions in response to 
changes in the environment. 
7.4.2 Exogenous 5-HT Effects on MPMC Culture 
Mast cell secretion of 5-HT (along with other granule-stored and de-novo manufactured 
mediators critical to cell-cell communication and inflammation) has several known downstream 
effects and potentially many other effects on mast cells themselves and surrounding cell types. 
Expression of the 5-HT specific reuptake transporter (SERT) has been detected on mast cells, 
macrophages, and B cells.
16-18
 To explore the role that the cell culture microenvironment plays in 
MPMC 5-HT secretion, MPMCs were incubated with tris buffer containing concentrations of 5-
HT ranging from 0.1 µM to 0.55 µM. These incubations were intended to model the environment 
that un-activated (but IgE-sensitized) cells would experience when in contact with activated 
MPMCs. Data represented in Fig. 7.1 and 7.4 presented as percent of control show that TNP-Ova 
stimulated MPMCs generate supernatant 5-HT concentrations of 0.4 – 5 µM, and MPMCs 
exposed to inflammation-relevant cytokines generate 0.1 – 0.2 µM 5-HT in the cell culture 
supernatant. To create a similar environment, the number of mice and conditions were accounted 
for to achieve similar ratios and amount of cells. At 10, 30, and 60 min of serotonin incubation, 
the cell culture supernatants were collected and analyzed for 5-HT, and the adherent cells were 
lysed and analyzed for 5-HT content. In Fig. 2, the total system 5-HT is presented as a percentage 
of the sum of the control supernatant, control cell lysate, and incubation 5-HT concentrations. For 
this work, the total system 5-HT refers to the 5-HT in the cell supernatants and cell lysates. To 
account for the exogenous concentration of 5-HT in the cell cultures, Equation 7.1 was used to 
calculate the total system 5-HT. 
E uation 7. : Total System 5 HT 
    
 5-HT 
Lysate
+ 5-HT 
Supernatant
Control 5-HT 
Lysate
+ Control  5-HT 
Supernatant
+ 5-HT 
Exogenous
x100% 
 
Surprisingly, the 5-HT content of the cell cultures exhibited a decreasing trend with 
increasing 5-HT incubation concentrations. The correlation between 5-HT as a percent of control 
and 5-HT incubation concentration was significant at 30 min (p = 0.0009) and 60 min (p = 0.02) 
but not at the earliest time point of 10 min (p = 0.07). This indicates that, over the course of 30-60 
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min, the heterogeneous cell culture, including the macrophages, B cells, and mast cells which 
have been shown to contain SERT, processes 5-HT.
17-19
 Exposing the cell culture to higher 
concentrations of exogenous 5-HT leads to a proportionally greater degree of cellular processing 
of 5-HT. To determine if supernatant-contained species were causing degranulation and/or caused 
the secretion of serotonin to be higher than that of our controls, a β-Hex assay was used to 
indicate extents of cell degranulation. When the β-Hex data were analyzed using a one-way 
ANOVA, the supernatants of MPMCs incubated with 0.4 µM and 0.55 µM 5-HT for 60 min 
secreted significantly more β-Hex than control MPMCs at the same timepoints (p = 0.03 and p = 
0.02 for 0.4 µM 5-HT  and 0.55 µM 5-HT incubation, respectively). No significant difference was 
detected between control β-Hex values and β-Hex values for the 0.1 – 0.55 µM 5-HT incubation 
at 10 min or 30 min or between controls and 0.1 – 0.3 µM 5-HT incubation at 60 min (p > 0.05). 
So, only the highest exogenous 5-HT concentrations and the longest incubation times induced 
significant increases in mast cell degranulation, meaning that degranulation alone does not 
account for the cells’ 5-HT processing behavior (β-Hex data not shown). Previous studies on the 
effects of exogenous 5-HT on mast cells using bone marrow-derived or blood progenitor-derived 
mast cell models determined that 5-HT affects mast cell adhesion but does not induce mast cell 
degranulation.
17
 It is likely that mast cells in culture with a heterogeneous mix of other cells (as 
would be present in vivo) experience a different chemical microenvironment than that of mast 
cells derived from blood or bone marrow progenitor cells, and this may result in different 
autocrine and/or paracrine effects of exposure to cell-cell communication species, including 5-
HT. Changes in chemical microenvironment as a result of  incubation with 5-HT after 60 minutes 
may induce secretion of mediators by surrounding cells, which stimulates mast cell degranulation 
of β-Hex  and 5-HT. 
To evaluate whether the trend in cellular processing of 5-HT shown in Fig. 7.2 was a result of 
supernatant 5-HT metabolism, intracellular 5-HT up-take and metabolism (indicating intracellular 
MPMC 5-HT metabolism) or a combination of both, Fig. 7.3 shows the MPMC supernatant and 
lysate 5-HT trends for each 5-HT incubation condition separately.  To compare the supernatant 5-
HT concentrations of MPMCs incubated with exogenous 5-HT to control MPMC supernatants, 
the 5-HT values in the solid bars of Fig. 7.3 are represented as a percentage of the sum of the 
control (MPMC supernatant 5-HT + 5-HT concentration of the MPMC incubation). Trends in 
MPMC supernatant 5-HT content are shown in Table 7.1; after 10 min, the supernatant 
concentrations of 5-HT were significantly decreased in comparison to the 5-HT content of the  
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Fig. 7.2 Time-dependent effects of incubating MPMCs with 0.1-0.55 µM 5-HT: 
Percents of control were calculated using Equation 1. Each data point represents 
the total system serotonin (the sum of 5-HT concentration in supernatant as well as in 
lysed cells) as a percentage of the total system serotonin in control cells. The 0.2 µM 
incubation condition at 60 min was determined to be an outlier using the extra-sum-
of-squares F tests (p ≤ 0.05). 
Outlier, determined by F-test
  
 
Figure 7.3 Supernatant and lysate 5-HT content of MPMCs incubated with 0.1 – 0.55 µM 
5-HT for 10-60 min. #p ≤ 0.05 vs. control; ###p < 0.001 vs. control; ####p < 0.0001 vs. control; 
*p ≤ 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. 
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Exogenous 
[5-HT] 
(µM) 
10 min vs. 
Control 
MPMCs 
10 min 
vs. 30 
min 
30 min 
vs. 60 
min  
10 min 
vs. 60 
min 
0.1 -13.7% ns -23.5% -32.0 
0.2 -16.9% ns    
0.3 -22.9% ns -15.4% -19.2% 
0.4 -27.7% ns ns ns 
0.55 -21.5% ns +23.2%  ns 
Exogenous 
[5-HT] 
(µM) 
10 min vs. 
Control 
MPMCs 
10 min to 
30 min 
30 min 
to 60 
min  
10 min to 
60 min 
0.1 ns +17.1% ns +13.0% 
0.2 ns +20.0%    
0.3 +9.01% +9.97% ns +9.31% 
0.4 ns +15.8% -21.4% -21.4% 
0.55 ns ns -55.8% -51.5% 
Table 7.1 Trends in MPMC supernatant 5-HT content over the course of 60 min 
at varying exogenous concentrations of 5-HT. Where significant (p ≤ 0.05 using 
one-way ANOVA), the percent increase or decrease is indicated, and ns = not 
significant, p > 0.05 using one-way ANOVA 
 
Table 7.2 Trends in MPMC lysate 5-HT content over the course of 60 min at varying 
exogenous concentrations of 5-HT. Where significant, (p ≤ 0.05 using one-way 
ANOVA), the percent increase or decrease is indicated, and ns = not significant, p > 0.05 
using one-way ANOVA 
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supernatant of MPMCs exposed to no exogenous 5-HT (p ≤ 0.05 using one-way ANOVA) at all 
exogenous 5-HT concentrations examined, when controlling for the concentration of 5-HT added 
to the cells. After 30 min of incubation with 5-HT, the supernatant 5-HT content did not change 
significantly from the 10 min timepoint  supernatant 5-HT content at any of the exogenous 5-HT 
conditions (p > 0.05). After 60 min of incubation, however, the 5-HT content of MPMC 
supernatants exhibited a dependence on exogenous [5-HT]. The [5-HT] of supernatants of 
MPMCs incubated with lower concentrations of 5-HT, 0.1 and 0.3 µM, decreased significantly at 
60 min vs. 10 min (p < 0.0001 for both).  However, as the exogenous 5-HT concentration 
increased, the reverse effect was observed: at 0.4 µM and 0.55 µM exogenous 5-HT, supernatant 
5-HT content did not change significantly at 60 min incubation vs. at 10 min of incubation (p > 
0.05). In summary, assessing supernatant β-Hex content indicated that at the longest incubation 
times and highest incubation concentrations, MPMC degranulation was induced, which would 
increase the 5-HT content of the supernatant. This may explain the trend of decreased supernatant 
5-HT in MPMCs incubated with low concentrations of exogenous 5-HT and the opposite trend 
observed at higher concentrations of exogenous 5-HT. Cells exposed to the 0.4 -0.55 µM 
exogenous 5-HT for 60 min likely experience a chemical microenvironment similar to what they 
would experience when MPMCs are responding to allergen (as many mast cells degranulate). 
MPMC secretion of 5-HT must induce surrounding cells to secrete chemical species that in turn 
can induce further activation of mast cells. The difference between trends in supernatant 5-HT 
decrease at low (0.1 and 0.3 µM) and high (0.4 and 0.55 µM) 5-HT incubations indicate that 5-
HT metabolism by the cell culture has both time and concentration dependence. Several studies 
have reported on the mechanisms of clearance of 5-HT in the brain
19-21
 and determined that, while 
SERT has a high binding affinity for 5-HT (Kd = 6.7 nM),
22
 there are also other mechanisms by 
which 5-HT is cleared, as SERT-knockout mice demonstrate the ability to clear 5-HT.
21
 Although 
they have lower binding affinity for 5-HT than SERT, the extraneuronal monoamine transporter, 
plasmalemmal monoamine transporter, and the organic cation transporters 1-3 are several 
receptors with the ability to clear extracellular 5-HT efficiently.
21
 While it is known that mast 
cells and macrophages express SERT, little is known about the non-SERT clearance of 5-HT by 
macrophages and mast cells. Additionally, as 5-HT clearance varies by local area within the 
brain,
23
 it is highly likely that 5-HT clearance in non-neuronal tissue by SERT and non-SERT 
mechanisms will differ from brain synaptosomes. Clearly, further study on the clearance of 
extracellular 5-HT by peripheral tissues is warranted. 
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Figure 7.4 Supernatant 5-HT content as a percent of control MPMC 
supernatant 5-HT content after MPMC exposure to the inflammatory cytokines 
A. CXCL10 and B. CCL5. 
Analysis of the cell lysate 5-HT content revealed interesting trends in the uptake of 5-HT by 
the cell culture, which are detailed in Table 7.2. Of the 5-HT incubation concentrations examined, 
only 0.3 µM 5-HT produced a significant increase in cell-stored 5-HT concentration (compared to 
controls) after 10 min of incubation (p = 0.05). The trends in cell-stored 5-HT over the course of 
10 to 60 min indicate significant increases at 5-HT incubation concentrations of 0.1 and 0.3 µM 
and significant decreases for 5-HT incubation concentrations of 0.4 and 0.55 µM. The overall 60 
min decrease at the higher exogenous concentrations of 5-HT is likely due in part to the induction 
of MPMC degranulation by the incubation itself. 
7.4.3 Stimulation Effects: Inflammatory Cytokines CXCL10 and CCL5 
The concentration and time-dependent trends in supernatant and lysate 5-HT concentration of 
MPMCs exposed to exogenous 5-HT have potential implications for in vivo effects of 
intercellular 5-HT. Mast cells are a critical cell type in the pathogenesis of inflammatory diseases 
such as asthma.
3
 Their involvement in inflammatory diseases is influenced by cell-to-cell 
communication with surrounding cell types, which secrete chemokines recently shown to directly 
induce mast cell degranulation.
11
 Mast cells undergoing degranulation in response to IgE-
mediated stimulation secrete more 5-HT than mast cells responding to inflammatory chemokines 
such as CXCL10 or CCL5. The trends in Tables 7.1 and 7.2 indicate that the cells that surround 
MPMCs (and potentially mast cells localized to other tissues) will have different rates of uptake 
or metabolism of 5-HT, and this will likely affect the pathophysiology of surrounding cell 
response to MPMC secretory behavior following exposure to chemokines vs. allergen.  
To further explore MPMC response to stimulation over the course of min-hrs and 
environmental effects, the long term time-dependent response of MPMCs to inflammatory 
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chemokines was compared to TNP-Ova stimulation. Mast cells are most commonly known for 
their central roles in allergic response, and the TNP-Ova models that response. In this case, the 
MPMCs were incubated overnight with anti-TNP IgE, and then exposing them to TNP-Ova 
induces IgE-mediated degranulation. Although response to allergen stimulation is the most widely 
known function of mast cells, these cells have diverse and complex roles in a number of 
inflammatory diseases. By comparing the effects of inflammatory disease-relevant chemokines 
on MPMCs to the widely studied allergen response of MPMCs, this work attempts to probe the 
complex response of mast cells to subtle changes in chemical microenvironments. The 
inflammatory chemokines CXCL10 and CCL5 were selected because of their roles in mediating 
the cell-to-cell communication processes that give rise to asthma. CXCL10 in particular has a 
central role in the pathogenesis of asthma. IgE-sensitized MPMCs were exposed to 0.2-200 ng 
mL
-1
 CXCL10 or CCL5, and the 5-HT content of the cell supernatants were measured after 2 hrs 
of incubation. Direct stimulation of MPMCs was observed at a wide range of concentrations of 
both CXCL10 and CCL5 (results not shown). Based on the results after 2 hrs of exposure to a 
wide range of concentrations, two concentrations each of CXCL10 and CCL5 were selected for 
further time-dependent study based on the robustness of the MPMC response following exposure 
to them. 
MPMCs were exposed to CXCL10 at 0.2 and 200 ng mL
-1
 or CCL5 at 10 and 100 ng mL
-1
, 
and supernatants were sampled at 10, 30, 60, and 90 min for 5-HT content measurement. Trends 
in 5-HT secretion in response to the cytokines are shown in Fig. 7.4. In contrast to the robust 
degranulation response that decreased over the course of 90 min following MPMC exposure to 
TNP-Ova, exposing MPMCs to CXCL10 or CCL5 generated a smaller degranulation response 
with an overall increasing trend in secreted 5-HT over the course of 90 min. Stimulation with 
CXCL10 induced mast cell degranulation to a lesser extent than TNP-Ova stimulation from the 
same mast cell population, which on average induced a 4.6 times greater secretion of 5-HT than 
CXCL10. The two stimulant concentrations of CXCL10 also induced different time-dependent 
trends in 5-HT secretion. Upon stimulation with 0.2 ng mL
-1
 CXCL10, supernatant 5-HT 
increased continuously over 90 min. MPMC exposure to 200 ng mL
-1
 CXCL10 resulted in an 
initial increase in supernatant 5-HT content at 10 min, followed by a return to control 5-HT levels 
at 30 min and another increase in 5-HT levels from 30-90 min. Interestingly, MPMC stimulation 
with CCL5 resulted in similar overall trends to stimulation with CXCL10, but the chemokine 
concentration dependence was reversed: 5-HT secretion following stimulation with 100 ng mL
-1
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CCL5 followed the same general trend as 5-HT secretion in response to 0.2 ng mL
-1
 CXCL10, 
and stimulation with 10 ng mL
-1
 CCL5 resulted in similar 5-HT concentration fluctuations as 
MPMC exposure to 200 ng mL
-1
 CXCL10. Both CXCL10 and CCL5 are mast cell 
chemoattractants that induce MPMC degranulation over a wide range of chemokine 
concentrations. The contrast in temporal response of MPMCs to low and high concentrations of 
these chemokines highlights the complex role of mast cells in inflammatory diseases. While in 
vivo mast cells are likely exposed simultaneously to multiple chemokines as they move toward 
the site of inflammation, examining the response of mast cells to individual mediators of 
inflammatory diseases can reveal information about MPMC response to different aspects of 
inflammation. 
The response of surrounding cells to different concentrations of exogenous 5-HT is also 
informative of the diverse role of mast cells in inflammation. TNP-Ova stimulation of MPMCs 
generates supernatant 5-HT concentrations of 0.4-0.55 µM, and stimulation with CXCL10 or 
CCL5 generates supernatant 5-HT concentrations of 0.1-0.2 µM. As the trends in Table 7.1 
highlight, exposing MPMCs to 0.4-0.55 µM 5-HT results in an initial decrease in supernatant 5-
HT concentration, likely due to MPMCs and macrophages taking up and/or processing the 5-HT, 
followed by an increase or no change in the supernatant 5-HT concentration. When the 
heterogeneous cultures were exposed to lower concentrations of 5-HT, the decrease in supernatant 
5-HT concentration was more pronounced and continued for 60 min. When MPMCs are exposed 
to TNP-Ova, the concentrations of secreted 5-HT are high enough that the surrounding cell 
culture does not process the secreted 5-HT as efficiently as the lower secreted 5-HT 
 
Figure 7.5 MPMC secretion of the bioactive lipids. A. LTC4 and B. PAF in 
response to TNP-ova or 0.2 ng mL
-1
 CXCL10. *p = 0.02; ****p < 0.0001. 
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concentrations induced by the inflammatory chemokines CXCL10 and CCL5. 
The secretion of 5-HT by mast cells is an important component of understanding mast cell 
function in both allergic response and inflammatory disease; however, mast cells secrete many 
other chemical species that contribute to their roles in physiological processes. In asthma, the 
effect of CXCL10 on mast cells is particularly important,
24, 25
 and previous studies have shown 
that CXCL10 potentially activates MPMCs through a different pathway than IgE-mediated 
allergen stimulation.
11
 To further examine the effects of stimulation by response to allergen vs. 
inflammatory chemokines on MPMC function, the secretion of bioactive lipids from MPMCs 
exposed to 0.2 ng mL
-1
 CXCL10 or 100 ng mL
-1
 TNP-Ova was also examined. MPMC 
supernatant concentrations of LTC4 and PAF were determined using UPLC-MS/MS, and results 
are shown in Fig. 7.5. As expected, TNP-Ova activation of MPMCs induced an increase (vs. 
unactivated MPMCs) of LTC4 secretion and PAF secretion. CXCL10 exposure, however, did not 
significantly increase the secretion of LTC4 or PAF (p > 0.05 vs. control MPMCs). In addition to 
the differences between CXCL10 and TNP-Ova-induced degranulation of MPMCs, the 
mechanism by which CXCL10 activates mast cells likely does not induce bioactive lipid 
secretion. Further studies on the effects of cell-secreted cytokines are clearly needed to better 
understand the complex role that mast cell activation plays in inflammatory diseases.  
7.5 Conclusions 
In this work, MPMC response is shown to be highly regulated and responsive to subtle 
alterations in a complex environment through time- and concentration-dependent degranulation 
and bioactive lipid formation. These results highlight the importance of selecting an appropriate 
mast cell model when studying mast cell involvement in allergic response and inflammation. This 
work probed both the effects of 5-HT concentration and time on surrounding cells in culture with 
MPMCs as well as mast cell response to different stimuli. The MPMC co-culture system actively 
responds to the presence of 5-HT, which in vivo may correspond to the ability of cells localized 
near mast cells to limit the concentration of inflammatory mediators in the extracellular 
microenvironment. The correlation between the processing of exogenous serotonin and time 
supports that heterogeneous cellular systems are able to efficiently respond to inflammation. 
When attempting to apply in vitro mast cell results to in vivo systems, considering the 
environment that the mast cell is experiencing is important for understanding mast cell 
contribution to inflammation.  
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 MPMCs exhibited controlled secretion dependence when exposed to different agents of mast 
cell activation. The relatively small degree of degranulation of MPMCs in response to the 
cytokines CXCL10 and CCL5 in contrast to the robust response of MPMCs to TNP-Ova 
(allergen) are potentially due to the chemoattractant roles of the cytokines. Mast cell contact with 
chemoattractants in vivo generally occurs when mast cells are localized away from the site of 
inflammation. Mast cell secretion of small amounts of serotonin and other granule-associated 
mediators increases vascular dilation, which allows chemoattractants including CXCL10 and 
CCL5 to enable mast cells to move more efficiently to the site of inflammation.  
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Chapter 8: Analysis of Neuropeptide-Induced Mast Cell Degranulation and 
Characterization of Signaling Modulation in Response To IgE Conditioning  
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8.1 Overview 
As tissue-resident immune cells, mast cells are frequently found in close proximity to afferent 
neurons and are subjected to immunoactive mediators secreted by these neurons, including 
substance P (SP) and calcitonin gene-related peptide (CGRP). Neurogenic inflammation is 
thought to play an important role in the pathophysiology of many diseases. Unraveling the 
cellular mechanisms at the interface between the immune response and the peripheral nervous 
system is important for understanding how these diseases arise and progress. In this work, mast 
cell degranulation following direct exposure to CGRP and SP was studied both at the bulk and 
single-cell levels to characterize the mast cell response to neuropeptides and compare this 
response to well-studied mast cell activation pathways. Results show that mast cells secrete fewer 
chemical messenger-filled granules with increased IgE pre-incubation concentrations. The 
biophysical characteristics of mast cell degranulation in response to SP and CGRP is in many 
ways similar to calcium ionophore-induced mast cell degranulation; however, neuropeptide-
stimulated mast cells secrete fewer chemical messengers per secretion event, resulting in an 
overall relative decrease in secreted chemical messengers. 
8.2 Introduction 
Mast cells, often implicated for their role in allergy and inflammation, contain a large number 
of cytoplasmic  granules with preformed mediators including, but not limited to, histamine, 
serotonin, tumor necrosis factor α (TNF-α), and beta hexosaminidase, which are secreted in 
response to a diverse set of environmental signals.  Additionally, chemokines, growth factors, 
prostaglandins, leukotrienes and TNF-α can be synthesized de novo and secreted into the 
extracellular environment upon mast cell activation. These secreted mediators enhance 
inflammation, pain, and vasodilatation at the site of activation. 
1, 2
 This process has been 
extensively described in the context of allergy wherein mast cells are activated via multivalent 
antigen-mediated crosslinking of immunoglobulin E (IgE) bound to the high affinity IgE receptor 
FcRI or the low affinity IgE receptor, FcεRII  (also known as CD23). 3, 4 
Although the central role of mast cells in allergic (IgE-mediated) processes of the immune 
system is well established, their role in many other immune functions, including neurogenic 
inflammation, is not as clearly defined. The localization of mast cells in connective tissue and 
mucosal sites throughout the body facilitates contact with a wide range of complex and diverse 
microenvironments. This diversity is magnified by an equally broad set of functions that mast 
cells perform within their environment, including activation in response to immune signals such 
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as chemoattractants and neuropeptides. 
1, 5-8
  Activation by neuropeptides can initiate and sustain 
feedback signaling between mast cells and the surrounding tissue microenvironment.  
Of particular interest to this work is the secretion of substance P (SP) and calcitonin gene-related 
peptide (CGRP) from peripheral neurons. SP is a member of the tachykinin class of peptides 
which act through the neurokinin family of receptors (NKRs).
9,10
 CGRP, as its name suggests, is 
an alternative splicing product of the calcitonin gene and acts through the calcitonin receptor-like 
receptor (CRL).
10,11
 These neuropeptides are widely recognized for their role in many 
inflammatory diseases including atopic dermatitis, asthma, and arthritis.
12-17
 Both substance P and 
CGRP are secreted from the same subset of capsaicin-sensitive primary afferent neurons and are 
co-localized in, and co-secreted from, dense-core secretory granules at peripheral axon 
terminals.
9,10
  Similarly, both substance P and CGRP have been shown to induce mast cell 
degranulation as part of the pro-inflammatory functionality of these neuropeptides, propagating 
the inflammatory response through the secretion of histamine and TNF-α, which act on the 
afferent peripheral neurons.
9,14,18-20
 Although substance P-induced mast cell degranulation has 
been established in certain mast cell subtypes, the data exploring the effects of CGRP on mast 
cell degranulation are mixed.
8,14,21-23
 Furthermore, despite mast cell expression of both CRL and 
NKRs, it also has been suggested that substance P- and CGRP-induced mast cell degranulation 
may result from direct activation of GTP-binding (G) proteins rather than receptor-mediated 
signaling.
2, 8, 9
 
This intricate system is critical to neurogenic inflammation, and it is important to clearly 
understand the individual roles of each cell type and molecular signaling species at the single cell 
level. However, beyond the limited use of whole-cell patch clamp techniques and fluorescence 
spectroscopy, 
24
  neuropeptide-induced mast cell degranulation has not been extensively studied 
at the single cell level. This work demonstrates the use of carbon-fiber microelectrode 
amperometry (CFMA) to characterize CGRP- and SP-induced mast cell degranulation from 
single cells. CFMA provides sub-millisecond resolution and sufficient sensitivity to detect 
individual cytoplasmic granule secretion events. Here, CFMA was used to explore the 
biophysical and kinetic properties of mast cell degranulation in response to neurogenic peptide 
stimulation. 
6,7,25
 
Several studies by other groups have described IgE-induced upregulation of neuropeptide 
receptors including the NK 1, 2, and 3 receptors for SP.
8,23
 This work describes IgE concentration 
effects on neuropeptide-induced degranulation of mouse peritoneal mast cells in both bulk assays, 
utilizing high performance liquid chromatography (HPLC) with electrochemical detection, and 
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single cell CFMA. To the best of our knowledge, IgE-dependent modulation of neuropeptide-
induced mast cell degranulation has not been reported and may have significant implications for 
neurogenic inflammatory diseases.  
Our results indicate that exposure to IgE decreases mast cell sensitivity to neuropeptide-
induced degranulation. Additionally, CFMA data reveal individual mast cells stimulated by either 
SP or CGRP demonstrate remarkably similar biophysical degranulation kinetics. At the single-
cell level, both neuropeptides induced the secretion of similar levels of serotonin from mast cells 
relative to the ionophore-stimulated control. The similar kinetics and number of granules 
secretion events during mast cell degranulation detected by CFMA suggests both neuropeptides 
act through a similar mechanism. 
8.3 Experimental Approach 
8.3.1 Reagents 
Cell culture media materials were obtained from HyClone. Calcitonin gene related peptide 
(CGRP) (Rat, Mouse) was purchased from Phoenix Pharmaceuticals, Inc. [Tyr8]-Substance P and 
A23187 were purchased from Sigma Aldrich. Anti-trinitrophenol (TNP) IgE and TNP-ovalbumin 
(TNP-Ova) were obtained from BD Biosciences and Fisher Scientific, respectively.  TNP-Ova, 
A23187, SP and CGRP were diluted in Tris buffer (12.5 mM Trizma-HCl, 150 mM NaCl, 4.2 
mM KCl, 5.6 mM glucose, 1.5 mMCaCl2, 1.4 mM MgCl2) on the day of the experiment.   
8.3.2 Mast Cell Isolation and Exposure to Chemokines 
Peritoneal mast cells were isolated as previously described in Chapter 7 and the following 
references.
5, 7
 Briefly, male C57BL/6J male mice from The Jackson Laboratories were euthanized 
via CO2 asphyxiation according to IACUC approved protocol  # 1403-31383A. 8 mL of high 
glucose DMEM supplemented with 10% bovine calf serum and 1% penicillin streptomycin 
(media) was injected into the peritoneal cavity followed by a 30 second abdominal massage. 
Approximately 6-7 mL of the peritoneal lavage media was collected from each mouse. The 
collected mast cells were pelleted at  450 xg for 10 minutes and resuspended in fresh media 
before being plated onto a confluent layer of 3T3-Swiss albino mouse embryo fibroblasts 
(purchased from ATCC). Mast cells were primed with IgE at the specified concentration from 0 
to 1 x 10
-7 
M, as indicated in the experimental procedure, and incubated overnight at 37 
o
C in 5% 
CO2. For single cell experiments, the mast cells were plated in 35 x 10 mm
2
 Petri dishes while 24 
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well plates were used for bulk experiments. After overnight incubation, the cells were washed 
three times with tris buffer and prepared for bulk or single cell experiments. 
8.3.3 Carbon-Fiber Microelectrode and Micropipette Fabrication 
Microelectrodes were fabricated as previously described.
6, 7
 Briefly, individual carbon-fibers 
were aspirated into glass capillaries which were then halved using a pipette puller. The excess 
fiber was cut using a surgical blade underneath a microscope. The electrodes were epoxied 
(Epoxy Technology) and cured at 100
o
C for 24 hours. On the day of the experiment, the 
electrodes were beveled at 45 degrees with a diamond-coated polishing wheel and placed into 
isopropyl alcohol until needed. For the stimulating micropipette, a glass capillary was halved 
using the pipette puller and trimmed to leave a 10-50 μm-diameter opening for the stimulant 
release driven by a Parker Picospritzer III.  
8.3.4 Carbon-Fiber Microelectrode Experiments 
The washed mast cells were placed into a 37
o
C heated petri dish holder on an inverted 
microscope. The carbon-fiber microelectrode and micropipette were placed on top and near the 
mast cell, respectively (Fig. 8.3A). A potential of 700 mV vs. AgAgCl reference electrode (BASi) 
was set using an Axopatch 200B potentiostat, and a 3 second bolus of stimulant was puffed onto 
the cell. The stimulants used were 10 µM A23187, 1 µM SP, or 1 µM CGRP. The change in 
current over time for 90 seconds was recorded using Tar Heel CV software (National 
Instruments, Austin, TX), written by Michael L.A.V. Heien. The data collected were filtered with 
a 200 Hz low-pass Bessel filter and converted to an .abf file format in the data analysis software 
(MiniAnalysis). The individual spikes in each current trace were analyzed for rise time from 10 to 
90% of the spike amplitude (Trise), full width at half max time (T1/2), and total area; in addition, 
the total number of current spikes was counted.  After the data were analyzed, outliers (any trace 
with one of more experimental parameters that was greater than 2 log standard deviations from 
the log mean for that condition) were removed. Data significance was determined using one way 
ANOVA and error is given in SEM. During the experiment, the secretion of 17, 18, and 14 
individual cells was measured for A23187, CGRP, and SP conditions, respectively.   
8.3.5 Bulk Mast Cell Experiments 
Mast cells were stimulated with 250 µL of the selected neuropeptide at 1, 10, or 100 µM 
based on the experiment, 100 ng mL
-1
 TNP-Ova, or Tris and incubated at 37
o
C for 30 minutes for 
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the initial experiments (Fig. 8.1) and 2 hours for the IgE variation experiments (Fig. 8.2) before 
terminating degranulation stimulation by placing cells on ice.  The resulting supernatant was 
placed in a 96 well Millipore Multi Screen 0.45 µm filter plate and filtered by centrifuge at 3000 
xg for 5 min. 180 µL supernatant and 20 µL of 5 µM dopamine internal standard in 0.5 µM 
perchloric acid were combined and placed into an HPLC vial and run using an Agilent 1200 
HPLC with a Waters 2465 electrochemical detector as previously described. 
5
 Briefly, the 
solution was separated using a 5 μm, 4.6 mm × 150 mm Eclipse XDB C18, and the serotonin and 
dopamine were detected using a Waters glassy carbon electrode set at a potential of 700 mV vs. 
Ag/AgCl. The mobile phase, consisting of 11.6 mg L
−1
 of the surfactant sodium octyl sulfate, 170 
μL L−1 dibutylamine, 55.8 mg L−1 Na2EDTA, 10% methanol, 203 mg L
−1
 sodium acetate 
anhydrous, 0.1 M citric acid, and 120 mg L
−1
 sodium chloride, was run at 2 mL min
-1
. In addition, 
a 5 point calibration curve was prepared using a 500 nM dopamine internal standard and 
serotonin concentrations ranging from 62.25-1000 nM serotonin dissolved in 0.5 M HClO4. All 
spikes in the resulting chromatogram were analyzed by dividing the area of the serotonin spike by 
the dopamine spike area (5-HT/dopamine internal standard). For all experiments, the R
2 
of the 
calibration curve was over 0.9993 with a minimum of 3 instrumental replicates for each 
calibration point. All mast cell conditions had 4 biological replicates and were q tested for outliers 
with 95% confidence. Significance between conditions was determined using one way ANOVA. 
Error bars represent standard deviation. 
8.4 Results and Discussion 
The complexity underlying cellular signaling during neurogenic inflammation makes it 
difficult to decipher the individual contributions of separate cell types. Using bulk and single cell 
approaches in combination can aid in differentiating the specific role mast cells play within the 
inflammatory environment. CFMA is used to detect and characterize the real-time secretion of 
serotonin molecules from individual granule secretion events by single cells, providing detailed 
information pertaining to the biophysical mechanisms of SP- or CGRP-induced mast cell 
degranulation. 
16, 17, 25
  HPLC with electrochemical detection, on the other hand, allows us to 
understand how cell response varies in more complex environments taking into account cell-cell 
interactions. While serotonin itself is not directly implicated in the inflammatory response, it is 
packaged with other small molecule mediators (in dense granules) that are secreted 
simultaneously, and thus can be measured as a proxy for small molecule inflammatory mediators.  
Mouse peritoneal mast cells were used in this work as a source of primary culture cells that 
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provided accessibility, abundance, and compatibility with the measurement techniques employed 
herein.  
8.4.1 Bulk Concentration and Initial IgE Incubation Studies 
Studies using bulk assays of mast cell degranulation were conducted to optimize conditions 
for characterization of neuropeptide-induced mast cell degranulation and to assess the effect of 
IgE pre-incubation concentration on neuropeptide-induced mast cell secretion. Mast cells were 
stimulated with varying concentrations of neuropeptide (1 and 10 µM CGRP or 10 and 100 µM 
SP) for 30 minutes with or without 0.5 µg/mL IgE pre-incubation overnight (Fig. 8.1). Both 
positive and negative controls were included (TNP-Ova with and without anti-TNP-Ova IgE pre-
incubation, respectively). A significant increase in secreted serotonin was only detected from 
CGRP-stimulated mast cells at the higher concentration (10 µM CGRP) in the absence of IgE 
pre-incubation (p<0.05). For SP stimulation, enhanced degranulation was observed in mast cells 
at concentrations of 10 µM SP without IgE and 100 µM SP with and without IgE. This 
information suggests direct mast cell degranulation in response to CGRP and SP. Furthermore, 
this neuropeptide-induced mast cell degranulation was both concentration- and IgE-dependent. 
CGRP-stimulated mast cells at low CGRP concentrations (Fig. 8.1A) did not demonstrate 
significant differences between stimulation conditions, however this could be due in part to the 
relatively low stimulation concentrations used. Only the 10 µM CGRP stimulation without IgE 
 
Figure 8.1 Bulk mast cell secretion in response to a 30 minute CGRP (A) or SP (B) 
stimulation at various concentrations. Results are shown as percent of the natural 
allergic (IgE-mediated) reaction pathway secretion. IgE concentrations were at 6.66 x10
-9 
M. The negative control was significantly different than 10 µM CGRP (p<0.05) and for 
all SP (p<0.001) in all conditions except 10 µM SP with IgE.* P≤ 0.05 vs. TNP-Ova  *** 
P≤0.001 vs. 10 µM SP with IgE and TNP-Ova  +++ P≤0.001 Vs. 100 µM SP   
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preincubation induced significantly increased secretion relative to the negative control, 
suggesting that higher concentrations of CGRP are needed to study IgE effects using bulk cell 
detection. SP-induced mast cell degranulation was significantly enhanced in response to increased 
concentration of SP and diminished in the presence of IgE (Fig.8.1B). In the absence of IgE pre-
incubation, the total amount of serotonin secretion from mast cells increased by 153% and 96% 
following stimulation with 10 µM and 100 µM SP, respectively. One possible explanation for this 
response could be the modulation of SP receptors with the addition of IgE as previously reported. 
8, 23
 Conversely, downregulation of FcRI proteins and mRNA has also been demonstrated in 
mast cells following stimulation with SP.
26
 Our data further reinforces the relationship between 
IgE signaling and the mast cell response to neuropeptides. 
8.4.2 IgE Concentration Varriation 
To further explore the effect of IgE conditioning on neuropeptide-induced mast cell 
degranulation, MPMCs were stimulated with either 100 µM SP or CGRP with and without IgE 
pre-incubation. Pre-incubation concentrations of IgE were selected using the reported dissociation 
constants of the IgE receptors FcεRI (kd = 10
-9
-10
-10) and FcεRII (kd = 10
-7
). 
3, 4
  Three IgE 
concentrations were selected - a high concentration to ensure saturation of both FcRI and FcRII 
(1 x 10
-7
 M), a moderate IgE concentration between the respective Kd values of the two receptors 
(3 x 10
-9
 M), and a low concentration just below the FcεRI Kd (7  x 10
-11
 M). Mast cells without 
IgE pre-incubation were also prepared. Mast cells were incubated overnight with their 
corresponding IgE concentration, and washed before exposure to neuropeptide stimulation. TNP-
Ova stimulated mast cells were incubated with 1 x 10
-7 
M IgE overnight to act as the positive 
control.  In all conditions, mast cell supernatants were collected, and total serotonin content was 
analyzed using HPLC with electrochemical detection (Fig. 8.2).  
At high incubation concentrations of IgE, neither CGRP nor SP induced significant mast cell 
degranulation relative to the negative control (Fig. 8.2). With decreasing pre-incubation 
concentrations of IgE, both CGRP (Fig. 8.2A) and SP (Fig. 8.2B) induced increasing amounts of 
mast cell serotonin secretion. SP stimulated mast cells at moderate IgE pre-incubation levels, 
whereas CGRP only induced mast cell degranulation at the lowest IgE concentration.   In 
addition, SP-stimulated serotonin secretion did not continue to increase with decreasing 
concentrations of IgE beyond the 3 x 10
-9
 M IgE concentration, unlike the CGRP stimulation. 
This suggests that mast cells are more responsive to SP at normal IgE levels, while CGRP 
stimulation has a greater dependence on the IgE concentration.  
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These variations in response to the concentration of IgE may explain conflicting findings in 
the literature. Previous research has extensively reported mast cell stimulation in response to SP, 
while contradictory results have been reported for CGRP.
8,14,21-23
  Most often, mast cells are 
primed with IgE at concentrations of 0.5 µg/mL or ~7 x10
-9
 M (assuming a molecular weight of 
75 KDa as reported by BD-BioSciences who produces the IgE antibody used in these 
experiments) overnight. 
5, 6, 8, 26
 This concentration is above the Kd of FcɛRI  but below the Kd of 
FcɛRII. Our findings suggest that this concentration of IgE incubation would significantly limit 
the degree of CGRP-induced mast cell degranulation, while permitting SP-induced serotonin 
secretion as seen in Fig. 8.1B. 
8.4.3 Carbon-Fiber Microelectrode Amperometry 
Neuropeptide-induced mast cell degranulation was also observed at the single cell level using 
CFMA. These experiments were conducted to achieve a more detailed and mechanistic 
understanding of how mast cell degranulation is impacted by SP and CGRP. Mast cell CFMA is a 
technique where a sub-10-μm-diameter carbon-fiber microelectrode is set to a fixed, oxidizing 
potential and placed in direct contact with a single mast cell (Fig. 8.3A).
25
 The selected mast cell 
is then stimulated using a micropipette to deliver a local dose of a stimulating substance. The 
subsequent secretion of granular contents is monitored as discrete spikes in current, each 
corresponding to the exocytosis of a single cytoplasmic granule. For CFMA experiments in this 
work, a 3-second delivery of 1 µM substance P, 1 µM CGRP, or 10 µM A23187 (a calcium 
ionophore) were used to stimulate MPMC degranulation. The secreted serotonin from each 
granule is oxidized and monitored as current over time as the selected cell undergoes exocytosis 
(Fig. 8.3B). The sub-millisecond time resolution of these measurements facilitates detailed insight 
 
Figure 8.2 IgE concentration effects after a two hour MC stimulation with 
100 µM CGRP (A) or 100 µM Substance P (B). * P≤0.05 ** P≤0.01 
***P≤0.001 vs indicated positions. ****P≤0.0001 vs tris and 1x10-7 M IgE 
with SP stimulation 
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into the granule/membrane behavior. Within the collected current trace, individual granule 
secretion events (individual spikes) are analyzed for several kinetic parameters including spike 
rise-time (Trise), full-width at half maximum (T1/2), and total charge underneath the spike (Q) 
which is used to quantify the amount of serotonin secreted from each granule using Faraday’s law 
(Fig. 8.3C). Trise is a measure of the time between  10 to 90% of the full spike height during the 
initial rise in current and reflects the fast secretion of serotonin unassociated with the 
intragranular matrix immediately following fusion pore formation between the cytoplasmic and 
cell membranes. T1/2 measures the length of time the granule fusion pore stays open for chemical 
messenger secretion.  This is also associated with the rate at which the biopolymer matrix 
expands and unfolds to secrete a partial amount of its serotonin content.  In addition to these 
kinetic parameters, the number of spikes (N) can be counted to determine the number of 
exocytotic events the individual mast cell experiences upon activation, taking into account that 
the microelectrode contacts ~10% of the total cell surface area.
25
 Together, these parameters 
provide a detailed picture of the biophysical mechanics that underlie specific changes in mast cell 
secretory function. In particular, observed changes in the pattern of these parameters are often 
very useful when comparing different modes of mast cell stimulation that result in modulation of 
exocytosis.  
To understand if the IgE concentration affects the secretion from isolated mast cells on a 
 
Figure 8.3 Schematic CFMA setup and example traces. A) CFMA setup (Ag/AgCl 
reference electrode not shown) B) Representative traces of single cell MC secretion C) 
Schematic current spike resulting from MC secretion of a single dense-body granule 
showing Trise (the time from 10 to 90% of the spike height), T1/2 (length of time for full 
width at half maximum), and Q (amount of serotonin secretion in units of charge). 
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single cell level, the mast cells were incubated overnight with or without 0.5 µg/mL IgE. After 
washing, individual cells were stimulated with SP or CGRP.  No granule secretion was detected 
with CFMA for mast cells in either condition incubated with IgE. Mast cells not incubated 
overnight with IgE showed degranulation when stimulated with SP, CGRP or the positive control 
(10 µM A23187). Representative amperometric traces can be seen in Fig. 8.3B.  In addition to 
demonstrating the effects of IgE on mast cells, the biophysical characteristics following 
stimulation were quantified using the parameters discussed above (Fig. 8.4 and 8.5). 
8.4.4 CFMA Analysis 
Analysis of the CFMA results revealed that individual mast cells stimulated with either SP or 
CGRP each yielded in less total serotonin than A23187-stimulated controls (SP- and CGRP-
stimulated mast cells both secreted 39% less serotonin per cell than the A23187-stimulated cells, 
Fig. 8.4A). Further analysis of the CFMA data reveals this marked difference in the degree of 
mast cell degranulation is largely accounted for by a lower amount of serotonin secretion per 
granule, with no measureable difference in the number of secretion events per cell (Fig. 8.4B and 
8.4C).  SP- and CGRP-stimulated mast cells secreted 29% and 34% less serotonin per granule, 
respectively, relative to A23187-stimulated controls, with negligible changes in the number of 
granule fusion events. The stimulation-dependent alterations in spike area observed in the 
absence of different cell culture conditions suggests regulated control of the amount of chemical 
messenger 
 
Figure 8.4 CFMA serotonin secretion and granule trafficking in response to 
neuropeptides and A23187. (A) Total amount of serotonin secreted per mast cell, (B) 
Amount of serotonin secreted per granule, as measured using CFMA, for each 
stimulation condition (C) Number of granules secreted per stimulation event, as 
measured using CFMA accounting for 10% coverage of cell by the electrode. *P≤0.05  
***P≤0.001 and ** P≤0.01 vs. A23187  
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 secreted per granule rather than altered granule loading effects. The absence of spike number 
effects also suggests that the granule trafficking and/or docking machinery can be regulated 
independently of the processes that regulate the percentage of granular contents secreted during 
degranulation.  
Decreased secretion of serotonin per granule could be a result of shorter granule fusion times 
if diffusion played the primary role in releasing serotonin upon granule fusion with the cell 
membrane.  However, analysis of the kinetic parameters of mast cell degranulation following 
CGRP- and SP-stimulation reveal that the substantially smaller spike area values observed in the 
substance P- and CGRP-stimulated mast cells, compared to A23187 stimulation, were not 
associated with measureable differences in either spike half-width or spike rise-time (Fig. 8.5). 
Together, these findings indicate a remarkably simple mechanism of modulated mast cell 
degranulation that is largely characterized by a decreased fraction of the granule cargo secretion 
during exocytosis in the setting of neuropeptide stimulation compared to IgE-mediated mast cell 
degranulation. 
8.4.5 Bulk and Single Cell Comparison 
Previous findings have indicated decreased degranulation for TNP-Ova compared to 
ionophore-based stimulation, with anti-TNP-Ova inducing secretion of 79% of the serotonin 
secreted during A23187-induced degranulation on a single cell level.
6
 For the current study, 
CGRP and SP each induced mast cell secretion equal to 61% of A23187 degranulation, therefore 
showing similar trends to the bulk cell level with CGRP/SP releasing less total serotonin than 
TNP-Ova stimulation. However, with similar stimulation concentrations (1µM SP or 1µM 
 
Figure 8.5 CFMA granule fusion pore kinetics in response to CGRP, SP, and A23187. 
Trise (A) and T1/2 (B) of the granule secretion events, as measured using CFMA, for each 
stimulation type. There is no statistical difference among the presented conditions. 
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CGRP), the bulk mast cells did not secrete measurable serotonin, whereas TNP-Ova stimulation 
induced significant chemical messenger secretion. The unexpected lack of degranulation is most 
likely due to the decreased amount of serotonin secretion per granule and that only a fraction of 
total mast cells degranulate following bulk exposure to CGRP and SP, which is not shown in the 
single cell data analysis. 
8.5 Conclusion 
The complex relationship between mast cells and peripheral nerve fibers is fundamental to 
the pathophysiology of many neurogenic inflammatory processes. 
12-15
  This work characterizes 
the direct stimulation of mast cell degranulation in response to both SP and CGRP, critical 
neurogenic inflammatory mediators, using both bulk assays and single-cell electrochemical 
approaches. Our findings indicate that SP and CGRP induce mast cell degranulation in a 
concentration- and IgE-dependent manner. The observed IgE effects suggest that mast cells may 
respond to neuropeptides more effectively in the absence of high levels of circulating IgE. Further 
work will be necessary to understand the signaling mechanisms that drive the decreased 
sensitivity to neuropeptide stimulation. Single cell analysis of SP- and CGRP-induced mast cell 
degranulation show that both neuropeptides induce a similar pattern of mast cell degranulation. 
Mast cell degranulation in response to SP or CGRP stimulation resulted in a similar granule 
secretion times and number of secretion events relative to A23187-stimulated control cells. This 
lack of variation in granule kinetics is consistent with the hypothesis that SP and CGRP activate 
mast cells through a similar mechanism.  
Finally, when compared to previously reported findings,
6
 the amount of serotonin secretion 
following both TNP-Ova and A23187 stimulation is greater than the amount secreted due to 
either SP or CGRP stimulation for both bulk and single cell degranulation. The percentage of 
TNP-Ova serotonin secretion caused by stimulation from SP and CGRP on a bulk cell level is 
significantly less than expected when compared to the releasate on a single cell level, likely due 
to the fact that single cell data only takes into account cells that have granule secretion, whereas 
bulk cell studies include the averaged behavior of all cells.  Bulk assays may also be influenced 
by additional mechanisms such as serotonin re-uptake, giving the cells more control over their 
surroundings. 
5
 In conclusion, neurogenic inflammation is a highly complex process involving 
activation of mast cells by CGRP and SP, which can in return stimulate additional neurons. 
However, secretion in the bulk cell environment is decreased compared to single cell results and 
is dependent upon the IgE concentration the mast cells are exposed to. 
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